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Abstract 
Developing novel iron catalysts for the asymmetric hydrogenation of 
C=O bonds - Naomi Ritchie 
Enantiomerically pure compounds are important in the pharmaceutical and 
agrochemical industries because opposite enantiomers can have considerably 
different effects in a chiral environment.  Asymmetric hydrogenation (AH) is an 
effective method for the synthesis of chiral alcohols and amines; however, this 
method has mainly used expensive and toxic metal catalysts such as 
ruthenium, rhodium and iridium.  This work focuses on the replacement of 
these metals with iron. 
Inspired by the reports of Gao and our group,1, 2 the type of ligand that this 
project focuses on is macrocyclic ligands.  A library of eight new chiral 
macrocyclic ligands with nitrogen and phosphorus donor atoms have been 
synthesised by the condensation of a variety of chiral diamines with 
dialdehydes under high dilution conditions.  The library of macrocycles 
displays a range of ring sizes, denticity, and chiral groups.  A second library, 
comprising eight acyclic ligands of varying size, denticity and chiral groups has 
also been prepared. 
All of the ligands have been tested for the iron catalysed asymmetric 
hydrogenation (AH) and asymmetric transfer hydrogenation (ATH) of 
acetophenone in order to gain an understanding of ligand and macrocyclic 
effects and so direct the design of more active catalyst systems with increased 
substrate scope.  Although none of the ligands proved to be effective in the AH 
of acetophenone under the conditions examined, several of the ligands 
prepared were successfully used for the ATH of acetophenone.  A comparison 
of the ligands tested suggests that the phosphorus donor atoms are important 
for activity.  The best ligands in terms of conversion were the macrocyclic 
ligand 37b and the PNNP acyclic ligand 82. 
 
Reaction conditions including reaction time, temperature, base, mol% of base, 
and ligand/iron ratios were optimised for the ATH of acetophenone using 
PNNP ligand 82, and these optimized conditions were subsequently used in 
the ATH of a variety of acetophenone type substrates and one imine substrate 
to demonstrate the substrate scope of the reaction.  
37b 
82 
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Chapter 1. Introduction 
This chapter introduces enantiomers and discusses the importance of being 
able to synthesise single enantiomers.  Various ways to make enantiomers are 
discussed, followed by a detailed introduction to asymmetric catalysis, 
particularly asymmetric hydrogenation (AH) and asymmetric transfer 
hydrogenation (ATH).  Examples of AH and ATH using ruthenium and iron are 
given.  An introduction to the synthesis of the ligands will be given at the 
beginning of Chapter 2 (Synthesis of Macrocyclic Ligands, p 29) and Chapter 
3 (Synthesis of Acyclic Ligands, p 67). 
 
1.1. The importance of enantiomers 
Chirality is the geometric property of an object of being non-superimposable 
on its mirror image.3  The word chiral is derived from the Greek word for ‘hand’, 
which is the most familiar chiral object.  Many man-made objects are chiral and 
are designed to be operated using one hand, for example, scissors.  Other 
things have a chiral set up to favour a dominant hand, such as a drum kit 
(Figure 1, left).  Nature is chiral, although it is often only seen on a molecular 
level.  An example of chirality which can easily be seen in nature is a snail’s 
shell (Figure 1, right). 
  
Figure 1 – left: The chiral set up of a drum kit for a right-handed drummer. 
right: A snail showing its chiral shell. 
Enantiomers are molecules which are chiral.3  When carbon is sp3 hybridised 
it has a tetrahedral shape, so when four different groups are attached to it, its 
mirror image is non-superimposable (Figure 2). 
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Figure 2 – A tetrahedral carbon atom (grey) bonded to 4 different groups showing 
its non-superimposable mirror image. 
In an achiral environment, enantiomers have exactly the same physical and 
chemical properties, apart from the rotation of plane-polarized light, but in a 
chiral environment they have diastereomeric interactions with the 
enantiomerically pure natural products and can have considerably different 
effects. 
There are many examples of compounds where the enantiomers have 
different effects (Figure 3).  One of the most famous examples is thalidomide,4 
where the R enantiomer acts as a sedative but the S enantiomer is 
teratogenic.4   
 
Figure 3 – Examples of compounds of which the enantiomers have different 
effects. 
Other examples include dopa, limonene and ibuprofen.  The S enantiomer of 
the amino acid dopa is used to treat Parkinson’s disease, but the R enantiomer 
is ineffective and toxic.5  (R)-Limonene smells of oranges and is used in food 
and cosmetics, whereas (S)-limonene has a turpentine smell.6  (S)-Ibuprofen 
is an anti-inflammatory drug but its R enantiomer is inactive.7  Therefore, the 
synthesis of enantiomerically pure compounds is extremely important in the 
synthesis of pharmaceuticals, agrichemicals, flavours and fragrances. 
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1.2. The synthesis of enantiomers 
There are various ways to synthesise enantiomerically pure compounds, but 
all of the methods must involve an enantiomerically pure source at some stage, 
which must initially be taken from nature. 
One way is chiral pool synthesis which uses naturally occurring chiral 
compounds which are then modified to make the desired product.  Commonly 
used chiral compounds from nature include amino acids and carbohydrates.  
Disadvantages with this method include the difficulty in extracting the products 
from the natural sources, the limitation of products available and that usually 
only one enantiomer of a compound is available.8 
Another method is resolution, which is the separation of the enantiomers of a 
racemic mixture by use of an enantiomerically pure resolving agent.  One way 
this can be achieved is by reacting the racemic mixture with an 
enantiomerically pure compound to form diastereoisomers which are then 
separable by crystallisation or column chromatography, for example.  An 
advantage of this method is that both enantiomers are available.  However, 
the disadvantage is that if only one enantiomer is needed, the yield is limited 
to 50% and the other enantiomer is waste.8 
Another form of resolution is dynamic kinetic resolution (DKR) which allows up 
to 100% yield of a single enantiomer.  It works by continually racemising the 
starting material whilst a chiral catalyst selectively reacts with only one of the 
enantiomers (Figure 4).  Another advantage over standard kinetic resolution 
is that the ee of the product does not depend on the extent of conversion, since 
the ratio of enantiomers in the starting material remains the same throughout 
the reaction.  An important requisite of this method is that the product must not 
be racemised under the same conditions as the starting material.9 
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Figure 4 – Dynamic kinetic resolution. 
Another method is asymmetric synthesis using chiral auxiliaries.  A chiral 
auxiliary is an enantiomerically pure compound which is temporarily attached 
to another molecule to allow a diastereoselective reaction to occur, producing 
a new chiral centre.  The auxiliary is then removed, for example by hydrolysis, 
leaving a single enantiomer of product.  Disadvantages of this method is that 
a stoichiometric quantity of auxiliary is needed (although some auxiliaries can 
be recovered and reused) and extra steps are needed to add and remove the 
auxiliary.8 
The method used in this project is asymmetric catalysis. 
 
1.3. Asymmetric catalysis 
Asymmetric catalysis uses a chiral catalyst to selectively produce one 
enantiomer from a prochiral substrate.  A prochiral substrate is a compound 
which can be made chiral by the addition of a new atom or group.3  An 
advantage of asymmetric catalysis is that only a very small amount of chiral 
source is needed to produce a large amount of chiral product.10, 11  Ideal 
catalyst systems should have a broad substrate scope and should be able to 
operate with low levels of catalyst.12 
The catalysis can be divided into three groups: heterogeneous catalysis, 
homogeneous catalysis or catalysis with nanoparticles.  Catalysts for 
homogeneous catalysis typically consist of a transition metal complex with one 
or more organic ligands coordinated.13  Advantages of homogeneous catalysis 
are that the catalyst and the substrate are in the same phase so it is not 
hindered by diffusion problems, the catalyst can be tuned by changing the 
metal, ligand or counter ion, and the molecular nature of the catalyst makes 
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mechanistic studies easier (e.g. by NMR).  Disadvantages of homogeneous 
catalysis are the separation of the catalyst from the product and the instability 
of the catalyst.13 
Heterogeneous catalysis typically involves a metal which is deposited onto a 
support such as silica, aluminium oxide or carbon.  Advantages of 
heterogeneous catalysis are that the catalysts are usually very robust and are 
not easily deactivated, which means they can be used at high temperatures 
and for extended periods of time, and they are easily separated from the 
product.  Disadvantages include the fact that only the metal atoms on the 
surface are active and it is more difficult to tune the activity and selectivity.13 
Nanoparticles are a collection of metal atoms, between 1 and 100 nm, 
stabilised by ligands which form a steric or charge barrier which prevents them 
from growing into larger particles.  Nanoparticles can be prepared by the 
reduction of a metal salt in the presence of a stabiliser, or they can sometimes 
be formed accidentally during catalysis.  Advantages are that the stabilising 
ligands are often cheaper than commonly used ligands in homogeneous 
catalysis, and the ligands are usually not very strongly bound so can be easily 
displaced by substrate.  Disadvantages are the instability of the nanoparticles 
at higher temperatures and they can sometimes precipitate from the reaction 
mixture.13 
Distinguishing between these three types of catalysis is often not easy.  Also, 
sometimes a mixture of types may be present due to, for example, leaching 
from a heterogeneous catalyst, or decomposition of a homogeneous metal 
complex into nanoparticles.  Various tests to distinguish which type of catalysis 
is occurring include poisoning studies (e.g. PPh3 or mercury) and kinetic 
evidence (e.g. the observance of an induction period).13 
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1.4. Asymmetric hydrogenation (AH) and asymmetric 
transfer hydrogenation (ATH) 
One of the most commonly used asymmetric catalysis reactions is asymmetric 
hydrogenation (AH) (Figure 5).  Hydrogen is added selectively to one of the 
enantiotopic faces of a prochiral substrate, such as ketones, imines or alkenes. 
 
Figure 5 – Asymmetric hydrogenation of ketones (AH). 
Asymmetric transfer hydrogenation (ATH) is the transfer of hydrogen from a 
source other than molecular H2 (Figure 6).  The most commonly used 
hydrogen sources for transfer hydrogenation are isopropanol and formic 
acid.14 
 
Figure 6 – Asymmetric transfer hydrogenation (ATH) of ketones using isopropanol 
as the hydrogen source. 
There are advantages and disadvantages for each method.  The use 
molecular H2 is atom economical as all of the atoms in the starting materials 
end up in the product.  The disadvantages of using molecular H2 are the extra 
safety precautions needed for the handling highly flammable gas and the 
specialist equipment needed for high pressure reactions.  The advantages of 
transfer hydrogenation are that no specialist equipment or safety precautions 
are needed.  The disadvantages include the production of waste products (e.g. 
acetone from isopropanol) and often the reactions are reversible because the 
product can act as a hydrogen source.14 
 
1.4.1. Hydrogenation mechanisms 
An example of heterogeneous hydrogenation is the hydrogenation of alkenes 
using Pd/C.  The hydrogen adsorbs to the metal surface which results in the 
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breakage of the H-H bond and then the alkene coordinates to the metal surface 
which can then react with the hydrogen.8 
There are two main pathways for homogeneous hydrogenation: direct 
hydrogen transfer or a hydridic route.11, 15-17  Direct hydrogen transfer is 
thought to be the main pathway for main group metals, whereas the hydridic 
route operates when transition metals are used.  The hydridic route is further 
split into two routes: monohydride and dihydride.   
Direct hydrogen transfer, also known as the MPV mechanism, is when the 
hydrogen donor and the substrate both coordinate to the metal, and then 
hydrogen is transferred directly from the hydrogen donor to the substrate via a 
six-membered ring transition state (Figure 7).  The hydridic mechanisms 
involve the reaction of the hydrogen donor with the metal to form an 
intermediate metal hydride species which then transfers the hydrogen to the 
substrate in a subsequent step (Figure 8). 
 
Figure 7 – Direct hydrogen transfer mechanism. 
 
Figure 8 – The hydridic route. 
The two hydridic routes can be distinguished by deuterium labelling of the 
hydrogen source.  The monohydride mechanism results in the exclusive 
transfer of hydride from donor carbon to substrate carbon.  The dihydride 
mechanism results in hydride transfer from donor carbon to both substrate 
carbon as well as substrate oxygen. 
The monohydride mechanism can go by an inner sphere pathway where the 
substrate coordinates to the metal, or an outer sphere pathway where the 
substrate does not coordinate to the metal (Figure 9).  The outer sphere 
pathway is also known as metal ligand bifunctional catalysis.17 
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Figure 9 – Inner sphere (top) and outer sphere (bottom) mechanisms. 
M = metal, L = ligand. 
 
1.5. AH and ATH of ketones with noble metals 
The AH of functionalised ketones was achieved by the use of ruthenium BINAP 
dihalide complexes 1 (Figure 10).10  The nitrogen, oxygen or halogen atoms 
near the ketone coordinate to the metal and direct the reactivity and 
stereochemical outcome.  A wide variety of functionalised ketones can be 
hydrogenated to the corresponding chiral alcohols in 90-100% ee.  However, 
these catalysts are unable to hydrogenate simple, unfunctionalized ketones. 
 
Figure 10 – AH of functionalised ketones using ruthenium BINAP complexes 1.10 
In 1995, the AH of simple ketones was accomplished using ruthenium 
BINAP/diamine complexes 2 (Figure 11).10   This efficient catalyst system is 
highly enantioselective and is able to hydrogenate aromatic, heteroaromatic 
1 
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and olefinic ketones.  The steric and electronic properties of the ligands can 
be varied to enhance the reactivity and enantioselectivity.  The hydrogenation 
goes by a metal-ligand bifunctional mechanism where the ketone does not 
coordinate to ruthenium.  The hydride on ruthenium and a proton from the 
nitrogen ligand are simultaneously transferred to the C=O via a six-membered 
ring transition state (Figure 12).18 
 
Figure 11 – AH of ketones by ruthenium BINAP/diamine complexes 2.10 
 
Figure 12 – The mechanism of AH of ketones by ruthenium BINAP/diamine 
complexes 2.18 
There have been some variations on the ruthenium catalyst 2 such as the 
ruthenabicyclic complex 3 which has excellent activity (Figure 13).  This 
achieves >99% conversion of acetophenone in just one minute to give the 
product in >99% ee, compared to catalyst 2 which takes 4 hours to achieve a 
similar result (>99% conversion, 98% ee).19  Catalyst 4 allows for the base-
2 
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free AH of base-sensitive ketones with excellent yields and ee.20  Complex 5 
allows for the reduction of sterically congested t-alkyl ketones, giving the 
products in high ee.21 
 
Figure 13 – Variations of the ruthenium catalyst 2. 
An example of ATH using noble metals is the ATH of carbonyl compounds and 
imines catalysed by chiral ruthenium complexes 6 (Figure 14), giving the 
products in high ee.10  Isopropanol or a mixture of formic acid/triethylamine can 
be used as the hydrogen source.  This involves a metal-ligand bifunctional 
mechanism via a 6-membered ring transition state (Figure 16).22 
 
Figure 14 – ATH of carbonyl compounds and imines catalysed by chiral ruthenium 
complexes 6.10 
Various ligands have been tested as alternatives of the N-(p-toluenesulfonyl)-
1,2-diamine ligand in complex 6 (Figure 15).  For example, the use of the rigid 
amino alcohol ligand 7 does better than complex 6 in some cases; however, it 
does not work with a formic acid/triethylamine system and longer reaction 
times can result in a lower ee.23  The conformationally rigid, sterically bulky 
ligand 8 is an excellent catalyst for ATH of aryl ketones, including sterically 
bulky ketones, showing high activity and ee.24 
 
Figure 15 – Alternative ligands used for the ATH catalyst 6. 
6 
3 4 5 
7 8 
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Figure 16 – The mechanism of ATH of carbonyl compounds using chiral ruthenium 
complexes 6.22 
 
1.6. AH and ATH of ketones with iron 
Up until recently, AH and ATH have mainly used rhodium, ruthenium and 
iridium metal catalysts.10, 11, 14  In recent years a considerable amount of 
research has gone into asymmetric catalysis reactions which use base metals 
such as iron, cobalt and nickel instead of precious metals.25-33  Iron is the most 
abundant metal in the earth’s crust and is also an essential element in nature 
as it is found in haemoglobin in the blood and in many other metalloproteins.34  
This makes it a lot cheaper and less toxic than the precious metals. 
 
6 
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1.6.1. Transfer hydrogenation 
In 2004, a chiral diaminodiphosphine ligand 9,35 was combined with 
[Et3NH][HFe3(CO)11] for the ATH of aromatic ketones using KOH as the base 
and isopropanol as solvent (Figure 17).36  Ten different ketones were reduced 
giving moderate to high yields in most cases, although a chlorine atom in the 
ortho position resulted in a very low yield (5%).  Moderate to good ees were 
obtained except with some very sterically hindered ketones which gave 
excellent ee.  Monitoring the reaction by infrared spectroscopy indicated that 
the iron carbonyl cluster remained intact during the reaction. 
 
Figure 17 – ATH of aromatic ketones using chiral diaminodiphosphine ligands.36 
In 2006, a three-component catalyst system consisting of an iron source, terpy 
10 and PPh3 was used for the transfer hydrogenation of aliphatic and aromatic 
ketones (Figure 18).15  A small amount of product (23%) is obtained without 
the use of any ligands, but the yield was improved to 78% with a 1:1 mixture 
of terpy 10 and PPh3. Various iron sources and bases were examined and the 
best results were obtained with the iron carbonyls Fe2(CO)9 and Fe3(CO)12, 
and with iPrONa as the base.  Ten different ketones were reduced to give the 
alcohol products in good to excellent yield.  However, a chlorine atom adjacent 
to the carbonyl group gave very low yield (5%).  Mechanistic studies suggested 
9 
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that the reaction was homogeneous and went via a monohydride reaction 
pathway. 
 
Figure 18 – Transfer hydrogenation of ketones using a [Fe]/terpy/PPh3.15 
In a subsequent paper,37 iron porphyrin catalysts were also used for the 
transfer hydrogenation of ketones (Figure 19).  Different temperatures, bases, 
iron sources, ligands and metal-ligand ratios were investigated.  The products 
were generally obtained in good to excellent yield.  Low yields were obtained 
for ketones substituted adjacent to the carbonyl group.  The reaction also 
worked without any ligand to give around 50% yield of 1-phenylethanol.  α-
Substituted ketones were added to the substrate scope in a later paper, using 
FeCl2 as the iron source.38 
 
Figure 19 – Transfer hydrogenation of ketones using iron porphyrin catalysts.37 
The transfer hydrogenation of acetophenone was carried out using Knölker’s 
iron complex 1239 in isopropanol to give 1-phenylethanol in 87% yield (Figure 
20).40  The iron complex 12 has a hydridic hydrogen on the iron and an acidic 
hydrogen on the oxygen which can be transferred to the ketone.  This complex 
12 also catalyses the hydrogenation of ketones with H2 (see p 23). 
 
Figure 20 – Transfer hydrogenation of acetophenone using Knölker’s iron 
complex.40 
10 
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Morris’s group have done a lot of work with iron complexes with PNNP ligands.  
In 2008, iron complexes 13 with a diiminodiphosphine PNNP ligand analogous 
to 9 were used for the ATH of polar bonds, including ketones, aldehydes and 
imines (Figure 21).41 
 
Figure 21 – Asymmetric transfer hydrogenation of polar bonds using an iron 
complex with a PNNP ligand.41 
This gave generally good conversions above 70%, but a couple of substrates 
including cyclohexanone and the ketimine derived from acetophenone did not 
work.  The ees were poor, with only two substrates achieving above 60% ee.  
Reduction of an α,β-unsaturated ketone resulted in some reduction of the C=C 
bond.  The mechanism of catalysis was uncertain. 
In 2009, a similar iron complex 14 was reported to catalyse the ATH of 
aromatic and aliphatic ketones using KOtBu as base in isopropanol at room 
temperature (Figure 22).42  Good catalytic activities were observed and 
excellent ees were obtained for bulky substrates. A later paper suggests that 
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the active catalyst species are iron(0) nanoparticles functionalised with PNNP 
ligands.43 
 
Figure 22 – ATH of aromatic and aliphatic ketones by a PNNP iron complex.42 
A paper in 2012 performed spectroscopic and DFT studies on transfer 
hydrogenation using a related PNNP iron complex 15.  An unusual 
ferraaziridinido complex 16 was detected during the catalytic reaction, where 
one of the imine bonds in the ligand is reduced and the benzylic carbon is 
coordinated to iron (Figure 23).  Complex 16 was not catalytically active, 
however it was suggested that this could be a route towards nanoparticles.44 
 
Figure 23 – PNNP iron complex forms unusual ferraaziridinido complex. 
14 
15 16 (65%) 
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Another PNNP iron complex 17 was synthesised in 2009 (Figure 24),45 which 
has higher activity and selectivity compared to the previous complex 13.  
Reduction of acetophenone produced the alcohol product with 75% conversion 
and 83% ee after 8 minutes, but a longer reaction time (30 min) resulted in 
racemisation giving 90% conversion but only 12% ee.  The best 
enantioselectivity (99%) was obtained with a bulky tertiary butyl group 
substituent.  An outer sphere mechanism involving an H-Fe-N-H motif is 
suggested. 
Variations of the ligand in complex 17 were made by changing the phenyl 
groups on phosphorus to alkyl substituents.46  It was found that bulky 
substituents (Cy and iPr) rendered the complex inactive, whereas ethyl groups 
on phosphorus produced an active catalyst, but was less active and 
enantioselective than 17.  Another paper added substituents to the phenyl 
rings on phosphorus to vary the electronic and steric properties.47  Electron 
donating methyl groups in the para- and 3,5- positions worked well, whereas 
a methyl group in the ortho- position was completely inactive.  Electron 
withdrawing CF3 groups also rendered the complexes completely inactive.  
These variations show that there is a fine balance between sterics and 
electronics. 
 
Figure 24 – ATH of ketones catalysed by PNNP iron complex.45 
Another paper investigated the incorporation of different diamines into the 
backbone of the PNNP ligand in complex 17.48  There did not seem to be any 
good correlation between the basicity of the nitrogen ligands and catalytic 
activity, but increased steric bulk of the groups in the backbone increased the 
activity.  Towards the end of the reaction, the rate decreased due to 
17 
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competition between acetone and acetophenone for the active site on the 
catalyst.   
In 2011, another paper found that the role of the base is to doubly deprotonate 
the PNNP ligand in complex 18 at the carbons α to phosphorus to produce the 
5-coordinate iron(II) complex 19 (Figure 25).49  Complex 19 was tested for the 
ATH of acetophenone without the addition of base which gave similar results 
to the use of 18 with base.  This suggests that both complexes lead to the 
same active catalyst species and that the base plays no further role in the 
catalysis. 
 
Figure 25 – Double deprotonation of the tetradentate PNNP ligands 18.49 
Further mechanistic studies suggest that one of the imine groups is reduced 
to produce the active catalyst species (Figure 26).50 
 
Figure 26 – Proposed mechanism for the transfer hydrogenation of 
acetophenone.50 
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Figure 27 – ATH of ketones, aldehydes and imines using an 
amine(imine)diphosphine iron complex.51 
In 2013, iron catalysts 20 with partially saturated amine(imine)diphosphine 
ligands (Figure 27) were synthesised and were used for the ATH of ketones 
and imines with isopropanol as the hydrogen source.51  TOF as high as 200  
s-1 (720,000 h-1) at 28 °C and high yields and enantioselectivities were 
reported.  A chemoselectivity for the polar C=O versus the nonpolar C=C 
indicated an outer-sphere mechanism of proton and hydride transfer (Figure 
28). 
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Figure 28 – Proposed mechanism for ATH of ketones using the 
amine(imine)diphosphine complex 20.51 
In 2014, iron complexes 21 with 14-membered N2P2 macrocyclic ligands  were 
synthesised (Figure 29),52 and were used for the ATH of a broad scope of 
aromatic ketones giving excellent yields (up to 98%) and high ee (up to 91%).53  
Reduction of the ligand to give the diamino analogue 22 increases the activity 
substantially, allowing the catalyst loading, temperature and reaction time to 
be reduced (Figure 30).  This catalyst was also able to reduce a phosphoryl 
imine and an α,β-unsaturated ketone.  Both the activity and enantioselectivity 
are strongly influenced by varying the isonitrile ligands.54 
20 
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Figure 29 – ATH using iron complexes with a N2P2 macrocyclic imine ligand.53 
 
Figure 30 - ATH using iron complexes with a N2P2 macrocyclic amine ligand.54 
22 
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In 2012, a 22-membered macrocyclic ligand 23 (Figure 40) was made which 
has 6 potentially coordinating nitrogen and phosphorus donor atoms and a 
crystal structure was obtained which confirmed its C2 symmetry.1  In 
combination with Fe3(CO)12, 23 catalysed the ATH of aromatic ketones, 
showing high activity (TOF up to 1940 h-1) and giving excellent 
enantioselectivities (90 - 99%) and generally good conversions (Figure 31).1   
 
Figure 31 – ATH of ketones using macrocyclic ligand 23.1 
An iron complex 24 was made by reacting Fe3(CO)12 with 23 in acetonitrile 
(Figure 32).55  This complex 24 was tested for the ATH of ketones and was 
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found to give lower activity and enantioselectivity compared to the catalyst 
formed in situ from Fe3(CO)12 and 23.  Therefore, it was speculated that 24 
was not the active catalyst.  However, a mixture of toluene and isopropanol 
was used as solvent because the complex 24 was insoluble in isopropanol, so 
these results are not directly comparable. 
 
Figure 32 – Formation of an iron complex using the 22-membered macrocycle.55 
 
1.6.2. Hydrogenation using H2 
In 2007, Knölker’s iron complex 1239 was used for the hydrogenation of 
aldehydes and ketones (Figure 33).40  The reaction was performed using low 
hydrogen pressure (3 atm) at room temperature to produce the alcohol 
products in moderate to high yield.  Epoxides, esters and isolated alkenes and 
alkynes were not reduced, and functional groups including halide bonds, nitro 
groups, benzyl ethers and cyclopropyl rings were tolerated.  An imine substrate 
was also reduced to the corresponding amine in 50% yield. 
The mechanism was investigated in a subsequent paper.56  Firstly, alcohol 
complexes were synthesised by the stoichiometric reduction of aldehydes by 
Knölker’s iron complex 12.  Then intramolecular trapping experiments and a 
study of the kinetic and thermodynamic stability of the formed complexes 
towards substitution reactions led them to suggest an outer-sphere 
mechanism of reduction, with concerted transfer of a proton from the OH and 
hydride from the iron (Figure 34). 
 
24 (13%) 23 
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Figure 33 – Hydrogenation of aldehydes and ketones using Knölker’s iron 
complex.40 
 
Figure 34 – Mechanism of hydrogenation of aldehydes and ketones using 
Knölker’s iron complex.56 
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The catalyst 12 was modified by adding chiral phosphoramidite ligands 25 
(Figure 35), which replace one of the CO ligands on iron, to produce 
acetophenone with up to 31% ee.57 
 
Figure 35 – Chiral phosphoramidite ligands.57 
In 2009, six different PNNP iron complexes 26 were synthesised and used for 
the AH of acetophenone (Figure 36).58  Comparison of the activity of 
complexes 26a and b suggested that the diimine ligand is reduced to the 
diamine before becoming an active catalyst.  Complexes 26a, b and c have 
moderate activity whereas complexes 26d and e have very low activity.  
Complex 26d gave essentially racemic product but 26e gave 61% ee.  DFT 
studies indicated that the reaction may go via an H-Fe-N-H outer sphere 
mechanism (Figure 37). 
 
Figure 36 – Various PNNP ligands used to make iron complexes for AH of 
acetophenone.58 
26 
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Figure 37 – H-Fe-N-H outer sphere mechanism. 
In 2011, an iron pincer complex 27 (Figure 38) was developed for the 
hydrogenation of ketones.59  The reaction takes place under mild conditions 
(4.1 atm H2, room temperature) and gives the alcohol products in high yield.  
NMR studies suggested that the reaction proceeds through a dearomatized 
intermediate (Figure 39). 
 
Figure 38 – Hydrogenation of ketones using an iron pincer complex.59 
 
Figure 39 – Proposed mechanism of hydrogenation of ketones catalysed by 27 via 
a dearomatized intermediate.59 
27 
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In 2014, the 22-membered macrocyclic ligand 23 was shown by the group of 
Gao and our group to catalyse the hydrogenation of a wide variety of ketones 
using molecular H2 (Figure 40),2 giving the corresponding alcohols with ees 
near or better than those obtained with noble metal catalysts.  The 
hydrogenation appears to be heterogeneous involving iron particles as the 
active catalytic species.  Observations to support this include the cloudiness 
of the reaction mixture throughout the reaction and dynamic light scattering 
confirmed the existence of iron particles.  Also, the catalyst needs an induction 
period in order to form the catalytically active species and a significant 
poisoning effect occurred upon addition of PPh3 or Hg(0). 
 
Figure 40 – Iron catalysed ATH and AH of ketones using a 22-membered 
macrocyclic ligand.2 
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The macrocyclic ligand 23 is the most enantioselective ligand for iron catalysed 
AH of ketones so far.  The cyclic structure of the ligand may be responsible for 
the high ee due to its restricted flexibility.55  However, there are some 
disadvantages including the low TOF, the high H2 pressure needed (50 bar), 
and its inability to hydrogenate other substrates such as imines. 
 
1.7. Aims of the project 
Most of the examples of iron catalysed reactions found in the literature use 
multidentate ligands, which reflects the lower stability of iron complexes in 
comparison with those made with noble metals.2  Following the success of the 
macrocyclic ligand 23 (Figure 40), the aim of this project is to synthesise a 
variety of macrocyclic ligands with nitrogen and phosphorus donor atoms, and 
test them for iron catalysed AH and ATH of ketones and imines, with the hope 
of obtaining an iron catalyst with increased activity and substrate scope.  Some 
acyclic ligands will also be synthesised for comparison.  Comparison of the 
various ligands will enable the optimisation and understanding of the catalyst 
with regards to the activity and ee.  The first ligands to be synthesised will be 
based on (S)-phenylethylamine and phenyl phosphines (Figure 41), since 
these incorporate features similar to those ligands which have previously been 
shown to have some success, such as the macrocyclic ligand 23. 
 
Figure 41 – Ligands to be synthesised. 
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The ligands will then be tested for the iron catalysed AH and ATH of ketones 
and imines. If the ee is not satisfactory, the ligands may be modified by 
changing the phenyl groups on phosphorus,46, 47 or the methyl group on the 
chiral centre next to the amine.48  Greater steric bulk may lead to improved ee, 
but too much may decrease the activity. The electronic properties of the 
ligands will affect the stability of the complexes. Strongly σ donating ligands 
would be expected to form more stable complexes, however, ligands bearing 
electron withdrawing substituents are expected to facilitate heterolytic H2 
activation.  Ligands with alkyl spacers instead of aryl spacers could be 
investigated,45 as these will be more flexible so may be able to coordinate more 
easily to the iron centre. This may result in more stable complexes and higher 
ees.  To enhance the stability of the complex, the phosphine unit may be 
replaced by a pyridine unit to make the complex more stable in air. Another 
alternative would be to replace the phosphine unit with an N-heterocyclic 
carbene (NHC) unit. These are very strongly σ donating and NHC complexes 
are generally stable to oxidation.60 
Mechanistic studies including the formation of complexes and deuterium 
labelling studies may be carried out in order to try and understand the 
mechanism of hydrogenation with this type of ligand, and therefore enable the 
design of new ligands. 
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Chapter 2. Synthesis of Macrocyclic 
Ligands 
2.1. Introduction 
Macrocyclic ligands are large cyclic molecules which are generally made up of 
carbon frames with heteroatoms interspersed which are capable of binding to 
metal atoms.61  There are many naturally occurring macrocyclic ligands 
including the porphyrin ring found in the iron complex haem, the corrin core to 
vitamin B12 and the chlorin ring found in chlorophyll (Figure 42).62 
 
Figure 42 – Examples of macrocyclic ligands found in nature. 
Macrocyclic ligands are desirable because they form more stable complexes 
due to the macrocyclic effect.  This effect is similar to the chelate effect, which 
is the greater stability of the resulting complex compared to a complex with 
analogous monodentate ligands.  The chelate effect is due to the increase in 
entropy when a multidentate ligand displaces monodentate ligands.63  The 
macrocyclic effect is a combination of the increase in entropy, plus an 
additional energetic contribution coming from the pre-organised arrangement 
of the coordinating groups.63  Also, once coordinated, macrocyclic ligands are 
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less likely to dissociate because if one donor atom dissociates, it is still held in 
close proximity to the metal ion by the rest of the ligand framework.61 
The success of a macrocyclisation reaction depends on many different factors 
including thermodynamic and kinetic factors.  There are two main ways to 
make macrocycles; one way is the condensation of two or more fragments 
under high dilution conditions, and the other way is template synthesis where 
the fragments are first coordinated to a metal and then react around the metal 
to form the macrocycle.64 
High dilution favours intramolecular reactions leading to cyclisation over 
intermolecular reactions leading to oligomerisation or polymerisation.  One 
reactant is usually added slowly to the other reactant in a high volume of 
solvent so only a very small amount is present in the reaction at any one time.  
The cyclisation step requires the open-chain precursor to have an appropriate 
conformation which places the reactive groups in close proximity for 
cyclisation.  Template synthesis can induce an appropriate conformation by 
the coordination of the open-chain precursor(s) to a metal before cyclisation.64 
An example of the high dilution method is the synthesis of the macrocyclic 
ligand 23 (Figure 43).1  Dialdehyde 45 reacts with 1,2-diaminocyclohexane at 
high dilution in the presence of sodium sulfate to remove the water, giving the 
imine macrocycle in 75% yield.  This is followed by reduction with sodium 
borohydride in ethanol to give the final amine macrocycle 23 in 60% overall 
yield. 
 
Figure 43 – High dilution synthesis of macrocyclic ligand 23.1 
Another example of a macrocycle made by the high dilution method is 
macrocyclic ligand 29 (Figure 44) used in complex 22 (see also Figure 29).52  
23 (60%) 
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Dialdehyde 28 is reacted with 1,2-diaminocyclohexane at 0.01 M in ethanol to 
give the imine macrocycle (67% yield) which is then reduced using lithium 
aluminium hydride to give the amine macrocycle 29 in 69% yield. 
 
Figure 44 – High dilution synthesis of macrocyclic ligand 29.52 
An example of the template method is the synthesis of P2N2 macrocyclic ligand 
34 (Figure 45).65  The NPPN ligand 30 is coordinated to nickel to give the 
dicationic complex 31.  This is then deprotonated by triethylamine to give the 
neutral complex 32 where the nitrogen atoms have nucleophilic activity.  
Reaction with 1,3-propanediol di-p-tosylate in toluene at reflux in the presence 
of potassium carbonate gives the macrocyclic complex 33.  The nickel is then 
removed using an aqueous solution of cyanide to give the free ligand 34. 
 
Figure 45 – Template synthesis of P2N2 macrocyclic ligand.65 
The method used in this project is the high dilution method.  The synthesis of 
the diamine precursors proved to be quite challenging.  Two synthetic routes 
22 29 (69%) 
28 
34 33 
32 31 30 
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were studied; the first route did not work, but the second route worked well and 
a variety of macrocycles were synthesised. 
 
2.2. Route 1 
To prepare ligands having features similar to the most efficient ligand 23, we 
targeted ligands of the type 37 (Figure 46).  The R group and the linker that 
ring closes 36 are variable, making 37 modular and therefore increasing the 
likelihood of finding a more effective ligand for AH or ATH with iron. 
 
Figure 46 – The first synthetic route towards macrocycles. 
The first synthetic route (Figure 46) started from (S)-phenylethylamine 35a (R 
= Me), following the same method used to make (S)-1-[2-
(diphenylphosphino)phenyl]ethylamine 81 from literature (Figure 47).12  
Firstly, one equivalent of n-BuLi was added to deprotonate the amine, and then 
trimethylsilylchloride was added as a protecting group.  Next, more n-BuLi was 
added to deprotonate the aromatic ring in the ortho position, followed by the 
addition of Cl2PPh (Figure 47). 
 
Figure 47 – The synthesis of diamine 36a. 
After purification by column chromatography, a pale-yellow oil was obtained, 
which was a mixture of two very similar products.  There were two singlets in 
the phosphine region of the 31P NMR spectrum at -29.8 and -30.5 ppm, and 
the 1H NMR spectrum contained two overlapped multiplets at 5.0 and 4.9 ppm, 
37 36 
35 
35a 
36a 
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which is where the peak for the hydrogen adjacent to the phenyl ring would be 
expected (ArCH(Me)NH2).  These two products ran very closely on TLC and 
were therefore difficult to separate by column chromatography.  A mass 
spectrum of this mixture was obtained which indicated that the expected 
product 36a had not been formed. 
On inspection of the details of the method used, it was decided to attempt the 
reaction using a smaller amount of n-BuLi for the ortholithiation step (step 3, 
Figure 47).  The reaction was repeated twice, first using 1.2 equivalents, and 
the second using 2.2 equivalents.  A mixture of different products was formed 
for each attempt, but mass spectrometry revealed that none of the expected 
product 36a had been formed. 
 
Figure 48 – A comparison of the 31P{1H} NMR spectra of the crude products, using 
(a) 2.2, (b) 1.2 or (c) 3 equivalents of n-BuLi for the ortholithiation step. 
A comparison of the 31P{1H} NMR spectra of the crude products (Figure 48) 
shows the considerably different results obtained for each reaction.  The use 
of 2.2 or 3 equivalents of n-BuLi produces a mixture of different products in the 
phosphine region of the spectrum, whereas the use of 1.2 equivalents shows 
no product in the phosphine region. All three spectra show the absence of 
dichlorophenylphosphine (δ31P approx. 160 ppm). 
2.2 eq. 
1.2 eq. 
3 eq. 
a) 
b) 
c) 
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In order to simplify the reaction mixture, it was decided to try to synthesise and 
isolate the TMS protected amine 38 (Figure 49), to avoid any by-products of 
this step interfering with any subsequent steps.  One equivalent of n-BuLi was 
added dropwise to a solution of 35a in dry ether at -35 °C.  This mixture was 
stirred for 15 minutes and 1.1 equivalents of trimethylsilylchloride were added 
slowly.  The mixture was stirred for one hour at -35 °C and then was slowly 
warmed to room temperature, filtered and the solvent was removed.  However, 
this gave no product 38 and 67% of the starting material 35a was recovered. 
 
Figure 49 – The synthesis of TMS protected (S)-phenylethylamine. 
A subsequent literature search revealed that mono-TMS protected primary 
amines are deprotonated by n-BuLi.66-68  This was unexpected since TMS was 
used as a protecting group for the synthesis of related primary amines.  
However, this may provide an explanation as to why such amines are only 
obtained in low yield.12 
Therefore, the synthesis of bis-TMS protected phenylethylamine 39 was 
attempted by addition of one equivalent of n-BuLi to deprotonate the amine 
followed by one equivalent of trimethylsilylchloride, then repeating this 
sequence once more (Figure 50, top).  However, workup by addition of water 
and extraction with ether gave recovered starting material 35a. 
 
Figure 50 - The synthesis of bis-TMS protected (S)-phenylethylamine. 
Another method for the synthesis of bis-TMS protected primary amines was 
found,69 which used triethylamine as the base (Figure 50, bottom).  Both 
triethylamine and trimethylsilyl chloride were used in excess (3.5 and 3.1 
equivalents respectively) and the mixture was stirred in DCM at room 
35a 38 
35a 39 
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temperature overnight.  The next day, the volatiles were removed under 
vacuum and the residue was extracted with hexane.  This gave a mixture of 
starting material and a new product.  Purification by vacuum distillation gave a 
yellow oil, but this was mono-TMS protected phenylethylamine 38 (42% yield) 
instead of the bis-TMS protected amine 39.  The 1H NMR spectrum of 38 
agreed with the literature,70, 71 showing a singlet at -0.01 ppm with an 
integration of 9 for the three methyl groups on silicon, a doublet at 1.37 ppm 
with an integration of 3 for the methyl group on the chiral centre, and a multiplet 
at 4.04 ppm with an integration of 1 for the hydrogen on the chiral centre. 
The reaction was repeated at a higher temperature (reflux) to try and 
encourage formation of the bis-TMS protected amine 39; however, this also 
did not work. 
 
Figure 51 – The synthesis of ‘Stabase’ protected (S)-phenylethylamine.72 
A literature search revealed a silicon based protecting group 40, called 
‘Stabase’, which is a cyclic version of bis-TMS protected amine (Figure 51).72  
The formation of a ring would be more entropically favourable than adding two 
separate TMS groups, and the product 41 may be more stable than 39. 
A solution of 40 in anhydrous DCM was added dropwise to a solution of 35a 
in DCM with 2 equivalents of triethylamine.  Upon addition, the solution 
became cloudy and white.  The mixture was stirred for 2 hours at room 
temperature and was then filtered through sintered glass, which removed a 
white solid.  This gave the product 41 as a pale-yellow oil in 87% yield (Figure 
51).  Two singlets were present in the 1H NMR spectrum at -0.14 and 0.05 ppm 
with integrations of 6 for the methyl groups on silicon, there was a singlet at 
0.68 ppm with an integration of 4 for the CH2 groups, a doublet at 1.51 ppm 
with an integration of 3 for the methyl group on the chiral centre and a quartet 
at 4.34 ppm with an integration of 1 for the hydrogen on the chiral centre. 
35a 
41 (87%) 
40 
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Figure 52 – The synthesis of (1S,1'S)-1,1'-((phenylphosphanediyl)bis(2,1-
phenylene))bis(ethan-1-amine). 
In an attempt to prepare 36a, this Stabase protected (S)-phenylethylamine 41 
was reacted with just over one equivalent of n-BuLi overnight at room 
temperature, followed by the addition of dichlorophenylphosphine.  A mixture 
of many products was formed, however, none of the products were 36a. 
Next, the reaction was repeated but was heated under reflux for 5 hours in 
order to deprotonate the phenyl ring (Figure 52), following a procedure for the 
deprotonation of N,N-dimethylbenzylamine.73  To this was added 
dichlorophenylphosphine at -78 °C and the mixture was left to react overnight.  
Unfortunately, no product 36a was obtained from this reaction and some 
phenylethylamine 35a was recovered. 
 
Figure 53 – The addition of different electrophiles to Stabase protected 
phenylethylamine. 
Next, in an attempt to help to determine if the ortholithiation step takes place, 
two different electrophiles were added after the deprotonation step, instead of 
Cl2PPh (Figure 53). Firstly, n-bromosuccinimide was added to put a bromine 
atom in the ortho position,74  but no product 42 was obtained from this reaction.  
TMSCl67 was tried next which also failed, as only starting material 41 was 
recovered from this reaction. 
41 
36a 
41 42 
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Different conditions for the deprotonation step were tried next (Figure 54), 
using hexane as the solvent and t-butyl methyl ether as an additive (1.5 eq.).75  
This reaction also gave recovered starting material 41. 
 
Figure 54 – The use of different conditions for the ortholithiation step. 
A literature search on directing groups for ortholithiation revealed that -NMe2 
works well.73  Therefore, (S)-N,N-dimethyl-1-phenylethan-1-amine 43 was 
synthesised from (S)-phenylethylamine 35a using formaldehyde and formic 
acid,76 to give product 43 in 53% yield (Figure 55). 
 
Figure 55 – The synthesis of (S)-N,N-dimethyl-1-phenylethan-1-amine.76 
This then underwent ortholithiation and reaction with Cl2PPh to give 44 in 52% 
yield (Figure 56).73  The 1H NMR spectrum showed two doublets at 1.04 and 
1.16 ppm with integrations of 3 which correspond to the methyl groups at the 
chiral centres.  A singlet at 2.14 ppm with an integration of 12 corresponds to 
the four methyl groups on the amines, and two quintets at 3.98 and 4.11 ppm 
correspond to the hydrogens on the chiral centres.  The 31P{1H} NMR spectrum 
showed a singlet at -29.4 ppm. 
 
Figure 56 – The synthesis of (1S,1'S)-1,1'-((phenylphosphanediyl)bis(2,1-
phenylene))bis(N,N-dimethylethan-1-amine).73 
41 42 
35a 
43 (53%) 
43 
44 (52%) 
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Two papers were found in which R-NMe2 was converted into R-NH2 through 
conversion into a good leaving group, followed by substitution with ammonia 
(Figure 57 and Figure 58).77, 78 However, the papers did not present any 
explanation as to how there was retention of stereochemistry, since 
theoretically it could go either via SN1 or SN2.  Retention also occurs without 
the presence of the phosphine or sulfide group and earlier papers suggest 
participation of the iron.79, 80  No other papers could be found which showed 
that the conversion of R-NMe2 into R-NH2 could proceed with clean retention 
or inversion of stereochemistry. 
 
Figure 57 – Conversion of R-NMe2 into R-NH2 via an ammonium salt.77 
 
Figure 58 – Conversion of R-NMe2 into R-NH2 via an acetate.78 
In conclusion, method 1 was unsuccessful because a suitable protecting group 
for the primary amine was not found. 
 
2.3. Route 2 
Therefore, a different route towards the chiral diamine 36 was pursued (Figure 
59), which adds the phosphorus before the amine, and avoids the requirement 
of a protecting group for the primary amine.  This route starts from dialdehyde 
45 which can be converted to diimine 46 using a chiral sulfinamide.  Chiral 
sulfinamides, particularly t-butanesulfinamide, are popular reagents for the 
synthesis of chiral amines.81  Factors which make these reagents popular 
include the availability of both enantiomers at reasonable prices, and the 
straightforward and robust synthetic steps towards chiral amines with a broad 
substrate scope.  The chiral diimine 46 can then undergo diastereoselective 
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Grignard addition to give the chiral diamine 47, which can be converted to the 
free diamine 36 by removal of the sulfoxide groups.  An advantage of this route 
is that a variety of different Grignard reagents can be added to generate a 
series of chiral diamines 36 with different chiral groups.  The disadvantage of 
this route is the greater number of steps. 
 
Figure 59 – The second synthetic route towards macrocycles. 
 
2.2.1. Synthesis of dialdehyde 45 
Dialdehyde 45 is a known compound and was synthesised according to Figure 
60.82 
 
Figure 60 – An outline of the synthesis of 2,2'-
(phenylphosphanediyl)dibenzaldehyde.82 
2-Bromobenzaldehyde 48 was reacted in refluxing toluene with ethylene 
glycol, catalysed by p-toluenesulfonic acid, to give 49 in 92% yield after 
purification by column chromatography (Figure 61).83  Dean-Stark apparatus 
45 46 
47 
36 37 
48 
49 50 45 
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was used to remove the water from the reaction as it was formed.  The workup 
involved the addition of ethanolic potassium hydroxide to neutralise the acid 
catalyst, before washing with water.  By allowing more time (about 30 mins) 
for the acid catalyst to be neutralised, the yield was increased to 99% and there 
was no need for purification. 
A commercial sample of product 49 was obtained, but this gave much lower 
yields (around 30%) for the next step (Figure 62).  This commercial sample 
was not kept under an inert atmosphere, so it could have contained water 
and/or 2-bromobenzaldehyde 48, both of which would react with the n-BuLi, 
decreasing the yield of 50. 
 
Figure 61 – The synthesis of 2-(2-bromophenyl)-1,3-dioxolane.83 
This protected product 49 then underwent lithium-halogen exchange with n-
BuLi at -78 °C, followed by reaction with dichlorophenylphosphine to give the 
protected dialdehyde 50.  This was recrystallized from hot methanol to give the 
pure product in 60% yield.  The yield was increased to 73% by increasing the 
time for lithium-halogen exchange from 1 hour to 2 hours (Figure 62).82  The 
1H NMR spectrum showed a multiplet at 4.0 ppm with an integration of 8 
corresponding to the four CH2 groups, and a doublet (coupling to P) at 6.37 
ppm with integration of 2 corresponding to the hydrogens on the carbons 
adjacent to the aromatic rings.  The 31P{1H} NMR spectrum showed a singlet 
at -26.2 ppm and the IR spectrum showed a C-O stretch at 1087 cm-1. 
 
Figure 62 – The synthesis of bis(2-(1,3-dioxolan-2-yl)phenyl)(phenyl)phosphane.82 
48 49 (99%) 
49 
50 (73%) 
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Deprotection of 50 in acetone catalysed by p-toluenesulfonic acid initially gave 
the dialdehyde 45 in around 40% yield (Figure 63), which was much lower 
than the literature yield of 97%.82 
 
Figure 63 – Deprotection to give the dialdehyde.82 
However, the literature does not mention whether the acetone used was dry 
or not, so 2 equivalents of water were added to try and improve the yield.  This 
increased the yield to around 60%, but another product was observed which 
was the oxidation-reduction of the dialdehyde 45 by water, giving the product 
51 (Figure 64).84  The product 51 was characterised by 1H NMR, 31P{1H} NMR 
and mass spectrometry and the data agrees with the literature.84  It exists as 
a mixture of two diastereoisomers and the 31P{1H} NMR showed two singlets 
at 33.3 and 27.5 ppm. 
 
Figure 64 – Oxidation-reduction of dialdehyde 45 by water.84 
The reaction is similar to a previous report involving the reaction of (2-
phenylethynylphenyl)phosphines with water,85 which suggests that the 
mechanism involves intramolecular nucleophilic attack of phosphorus onto the 
alkyne followed by addition of water.  Oxidation-reduction does not occur with 
the mono-aldehyde,84 which suggests that the both aldehydes must be 
involved in the mechanism.  This leads to the suggested mechanism shown in 
Figure 65. 
50 45 
45 51 
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Figure 65 – Suggested mechanism of oxidation-reduction of dialdehyde 45 to give 
51. 
Due to the low yield of dialdehyde 45, it was decided to try and optimise the 
conditions for this step (Figure 63).  The workup for this reaction involves 
addition of water and then evaporation of acetone to produce a yellow 
precipitate which is filtered, washed with water and dried.82  This precipitation 
step was often very difficult to achieve since it tended to form a thick yellow oil 
rather than a solid, and multiple attempts were required.  Therefore, in order 
to simplify the workup, and also to see any other products being formed, the 
workup was changed to neutralise the acid catalyst using a solution of 
potassium carbonate, then evaporate the acetone, extract with DCM and wash 
with water.  The results are summarised in Table 1 below. 
45 
51 
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Table 1 – Optimisation of reaction conditions for the formation of dialdehyde 45 (Figure 
63). 
 percentage of product from 
the 31P NMR of the crude 
products 
time 
(min) 
water 
(eq.) 
notes 
 45 50 53 51 52    
1 38 2 37 23 - 70 0 
original workup was attempted 
first, before neutralisation and 
extraction with DCM 
2 77 - 21 - 2 110 0  
3 87 - 6 - 7 170 0  
4 84 - 4 4 8 70 2  
Conditions: Protected dialdehyde 50 (0.087 M), p-toluenesulfonic acid (0.22 eq.), water, acetone, 
reflux. Workup – add K2CO3(aq.) (0.04 M, 0.22 eq.), evaporate acetone, extract with DCM, wash with 
water, dry with MgSO4. 
In the first entry (Table 1), after 70 mins reaction time the original workup was 
attempted first, as recommended by the paper.82 Then, since no precipitate 
could be obtained, the mixture was neutralised and extracted with DCM.  The 
31P NMR spectrum of the crude product showed only 38% of the dialdehyde 
45.  A small amount of starting material 50 remained (2%), 37% was half-
deprotected product 53 (Figure 67) and 23% was the oxidation-reduction with 
water product 51.  This result may explain why the precipitation step was 
difficult to achieve.  The next two entries (entry 2 and 3) show no formation of 
oxidation-reduction product 51, which indicates that the neutralisation of the 
acid catalyst stops the oxidation-reduction with water occurring.  Increased 
reaction time produces more product, but also increases the oxidation-
reduction with acetone, giving product 52 (Figure 66).84  Adding 2 equivalents 
of water (entry 4) requires a much shorter reaction time.  The crude product 
could be taken to the next step without further purification.  However, if a purer 
product was needed it could be obtained by crystallisation with water/acetone. 
The dialdehyde 45 was characterised by 1H NMR, 31P{1H} NMR, 13C{1H} NMR, 
mass spectrometry and CHN and the data agrees with the literature,84, 86 
showing a singlet in the 31P{1H} NMR spectrum at -16.2 ppm, and in the 1H 
NMR there is a doublet (coupling to P) at 10.5 ppm with an integration of 2 
corresponding to the hydrogens on the aldehydes. 
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Figure 66 – Oxidation-reduction of dialdehyde 45 by acetone.84 
 
Figure 67 – Half-deprotected product. 
During the optimisation process, in order to try and prevent the formation of 
the oxidation-reduction products 51 and 52, the phosphorus atom of 50 was 
protected with BH3 in THF at -78 °C to give 54 (Figure 68).87  The 31P{1H} NMR 
spectrum showed a singlet at 20.9 ppm.  Unfortunately, it was difficult to purify 
this product.  This protection with BH3 was not optimised any further since the 
optimisation of the formation of dialdehyde 45 in Table 1 resulted in a good 
yield of dialdehyde 45 (84 - 87% yield compared to 97% literature yield).82 
 
Figure 68 – Protection of 50 with BH3. 
 
2.2.2. Synthesis of chiral diimine 46 
Next, the diimine 46 was made by reaction of the dialdehyde 45 with chiral 
sulfinamide 55 in THF at 50 °C.  Titanium isopropoxide acts as both a Lewis 
acid and a water scavenger (Figure 69).88  This worked relatively well and, 
after purification by column chromatography, the pure product was obtained in 
up to 70% yield.  The only difficulty with this step was the purification because 
50 54 
45 52 
53 
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there was an impurity which ran very closely to the product on TLC; some 
mixed fractions were always obtained which required further purification.  The 
1H NMR spectrum of 46 showed two singlets at 0.99 and 1.09 ppm each with 
an integration of 9 for the methyl groups on the t-butyl groups, and two doublets 
(coupling to P) at 8.95 and 9.07 ppm each with an integration of 1 for the imine 
hydrogens.  The 31P{1H} NMR spectrum showed a singlet at -15.1 ppm and 
the IR spectrum showed a C=N stretch at 1574 cm-1. 
 
Figure 69 – The synthesis of the chiral diimine. 
 
2.2.3. Diastereoselective Grignard addition to diimine 46 
 
Figure 70 – Diastereoselective Grignard addition to the chiral diimine 46. 
The diimine 46 was then reacted with various Grignard reagents at -48 °C in 
DCM to give the corresponding chiral diamines 47 (Figure 70).89  The reaction 
is diastereoselective and goes via the 6-membered ring transition state 56 
shown in Figure 71.81  The bulky tertiary butyl group and the R1 group on the 
imine strongly prefer equatorial positions, while the lone pair and the hydrogen 
can occupy the axial positions.  The metal coordinates to the sulfoxide oxygen 
as the R2 group adds into the imine carbon. 
45 46 (70%) 
55 
46 47 
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Figure 71 – Diastereoselective Grignard addition via a 6-membered ring transition 
state.81 
An open transition state 57 (Figure 72)81 occurs in the presence of 
coordinating solvents such as THF, which leads to the formation of the 
opposite diastereoisomer.  The solvent coordinates to the metal which 
prevents the 6-membered ring transition state 56 from forming. 
 
Figure 72 – Open transition state in the presence of coordinating solvents.81 
(M = metal, S = solvent) 
There are three possible diastereoisomers: SS, RR and SR (Figure 73).  If the 
reaction goes via transition state 56, the favoured diastereoisomer should be 
SS.  However, if it goes via transition state 57, RR will be preferred.  In practice, 
a mixture of all three diastereoisomers is formed.  A summary of the various 
Grignard additions is shown in Table 2 below. 
 
Figure 73 – Possible diastereoisomers from Grignard addition. 
57 
56 
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Table 2 – A summary of the Grignard additions. 
 Grignard 
reagent 
concentration/ 
solvent 
DCM:Grignard 
reagent ratio 
(by volume) 
diastereoselectivity* dr of major 
product(s) after 
purification 
1 MeMgBr 3 M / ether 3:1 19 : 62 : 18 83 : 17 
2 PhMgBr 3 M / ether 3:1  4  : 85 : 11 98 : 2 
3 PhMgBr 3 M / ether 6:1  3  : 86 : 11 98 : 2 
4 p-TolMgBr 0.5 M / ether 1:2  1  : 66 : 33 95 : 5 
5 p-TolMgBr 0.5 M / ether 3:1  4  : 83 : 13 98 : 2 
6 3,5-XylMgBr 0.5 M / THF 3:1  5  : 62 : 33 100 
7 
 
iPrMgCl 
 
2 M / ether 
 
6:1 
 
38 : 39 : 23 
 
96 : 4 
84 : 16 
*the ratio of peaks in the 31P{1H} NMR of the crude product. 
The first Grignard reagent used was methylmagnesium bromide (entry 1) to 
give 47a (Figure 74).  This had poor diastereoselectivity and one of the minor 
diastereoisomers was unable to be separated from the major product.  The 
31P{1H} NMR spectrum of this mixture had two singlets at -28.9 and -28.6 ppm.  
Also, this final mixture contained 40% oxidation products.  All attempts to purify 
this mixture further, either by crystallisation or column chromatography, failed. 
 
Figure 74 – Products from Grignard addition to diimine 46. 
Next, phenylmagnesium bromide was used (entry 2), which gave better 
diastereoselectivity and these diastereoisomers were separable by column 
47a 
47e 
47d 
47c 
47b 
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chromatography to give the main diastereoisomer 47b in good yield.  The 1H 
NMR spectrum showed two doublets at 3.59 and 3.85 ppm each with an 
integration of 1 corresponding to the hydrogens on the chiral centre.  The 
31P{1H} NMR spectrum showed a singlet at -27.8 ppm and the IR spectrum 
showed an N-H stretch at 3195 cm-1. 
p-Tolylmagnesium bromide was used next, which gave a lower 
diastereoselectivity at first (entry 4).  However, the selectivity was increased 
by adjusting the amount of DCM to give a DCM:Grignard reagent ratio of 3:1 
(entry 5) as previously used, taking into account the lower concentration of the 
Grignard reagent.  This gave the product 47c in good yield.  The 1H NMR 
spectrum showed two singlets, each with an integration of 3, at 2.15 and 2.20 
ppm for the methyl groups on the tolyl groups, and two doublets at 3.55 and 
3.76 ppm for the hydrogens on the chiral centre.  The 31P{1H} NMR spectrum 
showed a singlet at -27.8 ppm and the IR spectrum showed an N-H stretch at 
3214 cm-1. 
3,5-Dimethylphenylmagnesium bromide (entry 6) gave slightly lower 
diastereoselectivity, possibly due to the more strongly coordinating solvent 
(THF compared to ether).  The diastereoisomers were easily separated by 
column chromatography to give a single diastereoisomer 47d in moderate 
yield.  The methyl groups on the aromatic rings give two singlets in the 1H NMR 
spectrum at 2.03 and 2.08 ppm, each with integrations of 6.  The hydrogens 
on the chiral centres gave two doublets (coupling to P) at 3.59 and 3.97 ppm.  
The 31P{1H} NMR spectrum showed a singlet at -28.4 ppm and the IR spectrum 
showed an N-H stretch at 3223 cm-1. 
Finally, isopropylmagnesium chloride gave very poor diastereoselectivity 
(entry 7), so that it was unclear which diastereoisomer was the desired one 
(47e).  One of the diastereoisomers was separated by column chromatography 
which had a singlet at -27.5 ppm in the 31P{1H} NMR spectrum.  The other two 
diastereoisomers were unable to be separated and also contained 39% oxide 
products.  The 31P{1H} NMR spectrum had singlets at -27.6 and -26.7 ppm plus 
oxide peaks at 37.5 and 38.1 ppm. 
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2.2.4. Removal of the sulfoxide groups 
The sulfoxide groups from the diamines 47 can then be removed by acid 
catalysed hydrolysis to give the free diamines 36 (Figure 75).90  The products 
47a and 47e (R = Me, iPr) were not continued since they could not be purified, 
and also the configuration of 47e was unknown. 
 
Figure 75 – Removal of the sulfoxide groups by acid hydrolysis. 
The sulfinamides 47 were dissolved in THF, 2 M HCl was added and the 
reaction was stirred at room temperature for 3 days.  The mixture was then 
basified with sodium hydroxide and extracted with ethyl acetate.  The first 
eluent tried for the column chromatography (EtOAc/hexane/Et3N) gave a 
mixture of many extra products in the phosphine region which were not present 
in the crude product.  Changing the eluent to methanol/DCM gave the pure 
diamines 36 in around 70% yield (Figure 76). 
 
Figure 76 – Chiral diamines. 
The hydrogens on the chiral centres gave peaks in the 1H NMR spectra at 5.88 
and 6.06 ppm for 36b, 5.79 and 6.01 ppm for 36c, and 5.96 and 6.02 ppm for 
36d.  The 31P{1H} NMR spectra showed singlets at -26.7 ppm for 36b, -26.7 
ppm for 36c and -27.8 ppm for 36d. 
36d (70%) 36c (73%) 
36b (74%) 
47 36 
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2.2.5. Cyclisation 
Next, the cyclisation of the diamine 36b with various dialdehydes was carried 
out at 50 °C in chloroform at high dilution in the presence of sodium sulfate 
(Figure 77).  High dilution reduces the possibility of polymerisation and sodium 
sulfate removes the water to prevent the reaction from running backwards. 
 
Figure 77 – Cyclisation of diamine 36b with various dialdehydes. 
Conditions: 36b (0.002 M), dialdehyde (1 eq.) Na2SO4 (13 eq.), chloroform, 50 °C, 
48 h. 
The first cyclisation was carried out by Dr George Cheng from the Xiao group 
using [1,1'-biphenyl]-3,3'-dicarbaldehyde 59 (Figure 77).  This was purified by 
36b 
61 
45 
60 
59 
58d 
quantitative yield (crude) 
58c  
quantitative yield (crude) 
58b 
58a (30%) 
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column chromatography to give the pure product 58a in 30% yield.  At first, it 
was unclear whether the product was the 1+1 macrocycle or the 2+2 
macrocycle (Figure 78). 
 
Figure 78 – 1+1 vs 2+2 macrocycles. 
Confusion could occur between these two possible products, since the 
analytical data would be very similar.   Mass spectrometry showed a peak at 
m/z 647.26, which could either correspond to the [M+H]+ ion for the 1+1 
macrocycle, or the [M+2H]2+ ion for the 2+2 macrocycle.  A peak at m/z 
1293.51 was also present which could either correspond to the [M+H]+ ion for 
the 2+2 macrocycle, or a dimer of the 1+1 macrocycle.  The deciding factor 
was the presence of another peak at m/z 647.76, with equal intensity to m/z 
647.26.  These peaks indicate doubly charged species since they are 0.5 mass 
units apart.  Therefore, the product is the 2+2 macrocycle 58a. 
The next dialdehyde used was isophalaldehyde 60 (Figure 77), which gave a 
complicated mixture of products.  The reaction was repeated at a higher 
concentration, which still gave the same mixture of products but in different 
ratios.  The 31P{1H} NMR spectra for the crude mixtures are shown in Figure 
79 and the peak for the starting diamine 36b is marked with an asterisk.  A 
broad peak at -28.2 ppm could correspond to a polymer or oligomer product.  
A pair of doublets at -26.0 and -25.1 with similar integration and coupling 
constants (9.2 Hz) could correspond to a 2+2 macrocycle where the 
phosphorus atoms are inequivalent, possibly due to isomers of the imine 
bonds or the phenyl rings on phosphorus.  The peak at -23.9 ppm looks as 
though it could be a doublet, but since there is no coupling partner, it must be 
a mixture of peaks.  The mass spectra of the crude product mixtures indicated 
1+1 
2+2 
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that the desired product 58b had been formed, but attempts to purify or reduce 
these mixtures failed. 
 
Figure 79 –31P{1H} NMR spectra for the crude products from reaction of 36b with 
60. 
The starting concentration of 36b = 0.1 M (top), 0.00184 M (bottom). 
The peak for the starting diamine 36b is at -26.7 ppm (marked with *). 
Dialdehyde 45 was used next which, in contrast to the previous two 
dialdehydes, gave the 1+1 macrocycle 58c in quantitative yield (Figure 77).  
The 1H NMR spectrum showed two doublets (coupling to P) for the imine 
hydrogens at 9.54 and 10.27 ppm.  The 31P{1H} NMR spectrum for this product 
is interesting as it shows two doublets with coupling constants of 8.9 Hz, which 
indicates that the two phosphorus atoms couple to each other, even though 
they are 8 bonds away from each other.  Through-space P-P couplings are 
obtained when the phosphorus lone pairs point toward each other and overlap, 
enabling the transmission of nuclear spin information.91  A phosphorus-
phosphorus COSY was performed to confirm this (Figure 80). 
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Figure 80 – A P-P COSY spectrum of 58c. 
The next macrocycle was made by cyclisation with 2,2’-iminobisbenzaldehyde 
61 (Figure 77) which gave one major product 58d in quantitative yield.  The 
1H NMR spectrum showed two singlets for the imine hydrogens at 8.31 and 
9.10 ppm and the 31P{1H} NMR spectrum showed a singlet at -15.4 ppm. 
The cyclisation with dialdehyde 45 was repeated with the corresponding 
diamines 36c and 36d to give macrocycles 58e and 58f in quantitative yields 
(Figure 81). 
 
Figure 81 – Cyclisation with dialdehyde 45 with diamines 36c and 36d. 
 
36c (R = p-tol) 
36d (R = Xyl) 
58e (R = p-tol) 
58f (R = Xyl) 
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2.2.6. Reduction of imine macrocycles 
The imine macrocycles were then reduced to the amine macrocycles using 
sodium borohydride. 
The reduction of imine macrocycle 58a using sodium borohydride in methanol 
failed, which may have been due to the insolubility of 58a in methanol.  The 
synthesis of the macrocycle 58a was repeated by MChem student Liam 
Williams, under my supervision.  It was found that reduction of the crude 
product 58a worked by using a mixture of methanol and DCM.  After 
purification by column chromatography, the amine macrocycle 37a was 
obtained as a 4:1 mixture of products in 22% yield (Figure 82).  The 31P{1H} 
NMR spectrum showed two singlets at -26.6 and -27.3 ppm in a ratio 4:1.  The 
NMR spectra for the two products were very similar, so it was speculated that 
it was stereoisomerism at phosphorus (with the phenyl rings on the 
phosphorus atoms either both pointing the same way, or opposite ways).  
Attempts to crystallise this product failed.  A pure product could possibly be 
obtained by purifying the imine macrocycle before reduction. 
The 1H NMR spectrum of 37a showed four doublets for the CH2 groups at 3.05, 
3.40, 3.48 and 3.57 ppm in contrast to the imine hydrogen peak for 58a at 8.28 
ppm. 
 
Figure 82 – The reduction of macrocycle 58a. 
The imine macrocycle 58c was also insoluble in methanol, so a mixture of 
methanol/DCM was used for the reduction using sodium borohydride to give 
the amine macrocycle 37b.  At first, the method involved dissolving the 
macrocycle in methanol/DCM and then adding sodium borohydride to this.  
However, this method gave a significant amount of phosphine oxide product.  
The method was improved by putting the sodium borohydride in the flask first, 
58a 37a (22%) 
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flushing with nitrogen, then adding a solution of imine macrocycle in DCM, 
followed by the slow addition of methanol.  This gave the product 37b in good 
yield (Figure 83). 
 
Figure 83 – Reduction of imine macrocycle 58c. 
 
Figure 84 – A P-P COSY spectrum of 37b. 
The 1H NMR spectrum showed two doublets and two doublets of doublets for 
the CH2 groups.  The 31P{1H} NMR spectrum of 37b (Figure 84) had a much 
larger P-P coupling than 58c of 66.5 Hz, which indicates that the lone pairs on 
the phosphorus atoms overlap more and therefore couple more strongly. 
A crystal structure of the protonated macrocycle 62 was obtained which is 
shown in Figure 85 (see Figure 101 for formation of 62).  This confirms the 
size of the macrocycle (1+1 not 2+2), the chirality (S,S) as predicted by 
transition state 56 and the P-P distance (4.17 Å) which is in the range 
previously observed for through-space P-P coupling.91 
58c 37b (69%) 
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Figure 85 – Crystal structure of the protonated macrocycle 62. 
BF4 counter ions and solvent (chloroform) are omitted for clarity. 
 
Figure 86 – The HOMO{-2} molecular orbital of 62, showing overlap between the 
two phosphorus atoms.  Calculated using Density Functional ωB97x-D 6-31* in 
Spartan (Spartan 16 Wavefunction Inc. Irvine CA). 
62 
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The molecular orbitals of crystal structure 62 were calculated using Spartan.  
The HOMO{-2} molecular orbital shows overlap between the two phosphorus 
atoms (Figure 86), which adds further support for the idea that the phosphorus 
lone pairs must overlap. 
The imine macrocycles 58e and 58f were also reduced using sodium 
borohydride in methanol/DCM to give the corresponding amine macrocycles 
37c and 37d.  The 1H NMR spectra show peaks for the CH2 groups at 3.40, 
3.48, 4.12 and 4.46 ppm for 37c and 3.44, 3.53, 4.10 and 4.44 for 37d.  The 
31P{1H} NMR spectra show doublets at -26.7 and -23.3 ppm for 37c and -26.6 
and -23.3 ppm for 37d. 
 
Figure 87 – Reduction of the imine macrocycles 58e and 58f. 
The crude imine macrocycle 58d was also reduced using sodium borohydride 
in methanol/DCM to give, after purification by column chromatography, 37e in 
51% yield (Figure 88).  The 1H NMR spectrum showed a doublet with 
integration of 2, and two doublets with integration of 1 for the CH2 groups.  The 
31P{1H} NMR spectrum showed a singlet at -18.1 ppm. 
 
Figure 88 – Reduction of imine macrocycle 58d. 
 
37c (R = p-tol) (72%) 
37d (R = Xyl) (39%) 
58d 37e (51%) 
58e (R = p-tol) 
58f (R = Xyl) 
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2.4. Other macrocycles 
Method 2, via a sulfinamide, can be adapted to synthesise a variety of different 
macrocycles (Figure 89) by starting with a different dialdehyde.  These 
macrocycles show varying size, denticity and donor groups.  An analogue of 
the 22-membered macrocycle 23 from literature is also synthesised 
(macrocycle 65).1 
 
Figure 89 – Other macrocycles. 
 
2.4.1. Synthesis of macrocycle 63 
The macrocycle 63 was synthesised by MChem student Zac Ellis, under my 
supervision.  The synthesis (Figure 90) follows the same route as in Figure 
59 (p 39) but starts with a different dialdehyde. 
 
Figure 90 – An outline of the synthesis of macrocycle 63. 
65 64 63 
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The required dialdehyde 59 was made via a Suzuki coupling between 3-
bromobenzaldehyde 66 and 3-formylphenylboronic acid 67, giving the product 
59 in excellent yield (Figure 91).92  The 1H NMR spectrum showed a singlet at 
10.12 ppm with an integration of 2 for the hydrogens on the aldehydes. 
 
Figure 91 - Suzuki coupling to make dialdehyde 59.92 
Next, chiral sulfinamide 55 was added to produce chiral diimine 68 in good 
yield (Figure 92), following the same procedure as in Figure 69 above.  The 
1H NMR spectrum showed a singlet for the imine hydrogens at 8.67 ppm, and 
a singlet at 1.28 ppm with an integration of 18 for the hydrogens on the tertiary 
butyl groups.  This was followed by diastereoselective Grignard addition to 
produce 69. The problem with this step was the separation of 
diastereoisomers.  After purifying by column chromatography, TLC analysis 
showed only one product, but the 1H NMR spectrum showed an 8:1 mixture of 
diastereoisomers.  When the same TLC plate was run a second time, this 
separated out into two spots.  Many different eluents were tried in order to 
separate the products in one TLC run, but none succeeded. Therefore, a 
longer column was run which improved the diastereomeric ratio to 15:1.  The 
yield is low because only a few fractions were pure and the mixed fractions 
were discarded.  The 1H NMR spectrum of 69 showed a doublet at 5.70 ppm 
for the hydrogens on the chiral centres. 
 
Figure 92 – The synthesis of the chiral diimine 68, followed by Grignard addition. 
59 (91%) 67 66 
59 
55 
68 (60%) 
69 (18%) 
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Figure 93 – Removal of the sulfoxide groups by acid hydrolysis. 
After this, the sulfoxide groups were removed by acid catalysed hydrolysis as 
above, using 4 M hydrochloric acid, to give the diamine 70 in 52% yield (Figure 
93).  The workup was slightly different from before because the HCl salt 
precipitated out of the reaction, which could then be filtered off and potassium 
carbonate was added to give the free diamine 70 with no further purification 
needed.  The 1H NMR spectrum showed a singlet at 5.27 ppm with an 
integration of 2 for the hydrogens on the chiral centres. 
Cyclisation with dialdehyde 45 was carried out at high dilution in chloroform 
with sodium sulfate at 50 °C, giving one major product 71 in quantitative yield.  
This crude product was reduced with sodium borohydride in MeOH/DCM to 
give the final macrocycle 63 in good yield (Figure 94).  The 1H NMR spectrum 
of 71 showed peaks for the imine hydrogens at 8.85 and 9.14 ppm and the 1H 
NMR spectrum of 63 showed peaks for the CH2 groups at 3.75, 3.84, 4.15 and 
4.27 ppm.  The 31P{1H} NMR spectrum of 71 showed a singlet at -18.1 ppm 
and the 31P{1H} NMR spectrum of 63 showed a singlet at -23.1 ppm.  
 
Figure 94 – Cyclisation followed by reduction. 
 
69 70 (52%) 
70 63 (50%) 71 
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2.4.2. Synthesis of macrocycle 64 
The synthesis of macrocycle 64 (Figure 89) also follows the same route as in 
Figure 59 (p 39) but starts with dialdehyde 61 (Figure 95).  A sample of 
dialdehyde 61 was available in the lab, which is accessible via Ullmann 
coupling of 72 and 73 to give the diester 74, followed by reduction to the 
dialcohol 75 by lithium aluminium hydride and then oxidation to the dialdehyde 
61 by MnO2.93 
 
Figure 95 – The synthesis of dialdehyde 61.93 
The addition of sulfinamide 55 to dialdehyde 61, catalysed by titanium 
isopropoxide, gave the product 76 in good yield (Figure 96).  The 1H NMR 
spectrum showed a singlet at 8.67 ppm with an integration of 2 for the imine 
hydrogens.  This then underwent diastereoselective Grignard addition with 
methylmagnesium bromide and the diastereoisomers were separated by 
column chromatography to give 77 in 69% yield (Figure 96).  The 1H NMR 
spectrum showed a doublet at 1.60 ppm with an integration of 6 for the two 
CH3 groups on the chiral centres, plus a doublet of quartets at 4.82 ppm for 
the two hydrogens on the chiral centres. 
75 
74 
73 72 
61 
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Figure 96 – Formation of chiral diimine followed by diastereoselective Grignard 
addition. 
Removal of the sulfoxide groups by acid catalysed hydrolysis was first 
performed using aqueous hydrochloric acid, followed by addition of sodium 
hydroxide and extraction with ethyl acetate.  However, this crude product was 
very difficult to purify.  Performing the reaction with hydrochloric acid in dioxane 
resulted in precipitation of the HCl salt which was filtered off, treated with 
aqueous potassium carbonate and extracted with ethyl acetate to give the pure 
product 78 in 62% yield (Figure 97).  The 1H NMR spectrum showed a doublet 
at 1.47 ppm with an integration of 6 for the two CH3 groups, coupling to a 
quartet at 4.33 ppm with an integration of 2 for the two hydrogens on the chiral 
centres.  A broad singlet was present at 8.88 ppm for the NH group in between 
the aromatic rings. 
 
Figure 97 – Removal of the sulfoxide groups by acid catalysed hydrolysis. 
Cyclisation with dialdehyde 45 at high dilution in chloroform gave the imine 
macrocycle 79 with a singlet in the 31P{1H} NMR spectrum at -24.3 ppm.  
Reduction with sodium borohydride in methanol/DCM then gave the final 
macrocycle 64 in 42% yield (Figure 98).  The 1H NMR spectrum showed two 
doublets for the CH3 groups at 1.09 and 1.49 ppm, four peaks for the CH2 
groups and two quartets at 3.99 and 4.07 ppm for the hydrogens on the chiral 
centres.  The 31P{1H} NMR spectrum showed a singlet at -24.3 ppm. 
61 
77 (69%) 76 (76%) 
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Figure 98 – Cyclisation followed by reduction to give the final macrocycle 64. 
 
2.4.3. Synthesis of macrocycle 65 
The availability of dialdehyde 61 also gave access to the final macrocycle 65, 
which is an analogue of the 22-membered macrocycle 23 from literature.  
Cyclisation of dialdehyde 61 with 1,2-diaminocyclohexane gave crude product 
80.  Attempts to purify this product by crystallisation failed, but mass 
spectrometry confirmed the existence of the desired product.  Reduction of this 
crude product gave the 22-membered macrocycle 65 (Figure 99).  The 1H 
NMR spectrum showed two doublets at 3.51 and 3.74 ppm for the CH2 groups 
adjacent to the aromatic rings. 
 
Figure 99 – Cyclisation followed by reduction. 
 
2.5. Attempted formation of metal complexes 
The synthesis of complexes was carried out in order to try and obtain a better 
understanding of the complexes which may form in the catalytic cycle.  
Complex formation with macrocyclic ligand 37b was attempted using iron 
bromide in THF at room temperature overnight (Figure 100).94  The dark red 
64 (42%) 79 
45 
78 
61 
80 
65 (90%, crude) 
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solid formed gave a very broad NMR spectrum, and so was likely 
paramagnetic.  However, the mass spectrum showed only the mass of the 
ligand. 
 
Figure 100 – An attempt at forming a complex. 
A different method was used next with iron(II) tetrafluoroborate hexahydrate 
as the iron source in acetonitrile/DCM at 50 °C.52  However, this protonated 
the macrocycle instead of forming an iron complex (Figure 101).  The 31P{1H} 
NMR showed two doublets at -28.7 and -26.4 ppm with a coupling constant of 
105 Hz (See Figure 85 for the crystal structure of 62). 
 
Figure 101 – Another attempt at complex formation. 
 
37b 
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2.6. Summary 
 
Figure 102 – A summary of the macrocyclic ligands synthesised. 
In summary, the first synthetic route starting from the primary amine 35 was 
unsuccessful due to the difficulty in finding a suitable protecting group for the 
ortholithiation step.  However, the second route via Grignard addition to a 
sulfinamide (section 2.3, p 38) worked well and eight different macrocyclic 
ligands have been synthesised (Figure 102), plus their imine analogues.  A 
selection of ring sizes has been made, from 16 to 34 membered rings.  The 
denticity has been varied from three to six, and the combination of donor 
groups (P2N2, P2N3, PN2, P2N4, N6) has also been varied.  Also, a range of 
chiral groups has been used (Me, Ph, p-tol and 3,2-dimethylphenyl, Cy). 
37b 
37c 
37d 
37e 64 63 
37a 65 
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Chapter 3. Synthesis of Acyclic Ligands 
The acyclic ligands studied in this project are multidentate, containing 
phosphorus and nitrogen donor atoms, because these have been shown to 
have some success with iron catalysed AH and ATH previously (see section 
1.6, page 11). 
Complexes with multidentate ligands have a greater stability compared to 
analogous complexes with monodentate ligands.  This is because of the 
chelate effect, which is mainly due to the increase in entropy when a 
multidentate ligand displaces monodentate ligands.63  Another factor to 
consider is that once one of the donor atoms in a multidentate ligand has 
coordinated, the other donor atoms are then held in close proximity to the metal 
and will therefore be more likely to coordinate.  This factor also makes a 
multidentate ligand less likely to dissociate once coordinated.  The size of the 
chelate ring formed is an important aspect to consider when choosing the 
linkage between donor atoms – 5 membered rings are the most favoured, but 
6 membered rings are also common.  A ring size of 8 or more is not expected 
to show a chelate effect.95 
A general route towards tetradentate PNNP ligands, such as those made by 
Morris’s group (Figure 103), is shown in Figure 104.96  Two equivalents of a 
phosphino-aldehyde react with a diamine to give the free PNNP ligand, 
followed by complexation with iron.  Alternatively, a template synthesis can 
lead directly to the iron complexes. 
 
Figure 103 – Acyclic PNNP ligands synthesised previously.36, 42, 58 
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Figure 104 – General synthetic route towards acyclic PNNP ligands and iron 
complexes.96 
The PNNP ligands which have been made previously (Figure 103, see also 
section 1.6, page 11) have their chiral groups in between the two nitrogen 
atoms.  However, the target PNNP ligands in this project (82 and 86, Figure 
105) have the chiral group on the other side of the amine.  This means a 
different approach is needed.  The ligand synthons, and possible PN ligands, 
81 and 85 need to be synthesised first and then these can be joined together 
via a dihalide or dialdehyde. 
Not only do these ligands expand the toolbox of multidentate chiral ligands, 
they can also be used to compare with the macrocyclic ligands in Chapter 2, 
providing insight into a possible macrocyclic effect on catalytic activity and 
selectivity in iron catalysed AH and ATH reactions. 
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Figure 105 – Acyclic ligands synthesised. 
The synthesis of NPN ligand 44 was already discussed in Chapter 2.2 on page 
37 (Figure 56).  The NPN ligand 84 is a modification of the chiral diamine 36b 
which was discussed in the previous chapter (page 49).  The diamine 36b is 
reacted with benzaldehyde, followed by reduction.  The pentadentate ligand 
87 is made be reaction of PN ligand 81 with the dialdehyde 45 discussed in 
the previous chapter (page 39). 
 
3.1. Synthesis of bidentate PN ligands 
3.1.1. Synthesis of PN ligand 81 
Ligand 81 is a known compound and was synthesised following a procedure 
from literature (Figure 106).12 
 
Figure 106 – Synthesis of (S)-1-[2-(diphenylphosphino)phenyl]ethylamine.12 
One equivalent of n-BuLi was added to (S)-phenylethylamine 35a to 
deprotonate the amine, and then trimethylsilyl chloride was used to add a TMS 
protecting group.  Next, more n-BuLi (3 eq.) was added to deprotonate the 
35a 81 (32%) 
87 
86 85 
84 
44 
82 81 
83 
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benzene ring.  The nitrogen coordinates to the lithium to direct the 
deprotonation ortho to the substituent.  Next, chlorodiphenylphosphine was 
added to put a PPh2 substituent at that position.  The reaction was finished by 
workup with aqueous 1 M HCl which removes the TMS protecting group and 
quenches any unreacted ClPPh2 or n-BuLi.  Extraction with ether and 
purification by column chromatography gave the product 81, a white solid, in 
32% yield (Figure 106). 
The product was much more polar than expected, given the eluent system 
used for column chromatography in the paper (hexane/acetate, 8/1).12  TLC 
analysis showed that the product was on the baseline using this eluent system.  
Ethyl acetate/hexane (60/40) plus 2% triethylamine worked much better.  The 
triethylamine neutralises the acid sites on the silica gel which stops the product 
from sticking to the column.  For TLC analysis using this type of eluent system, 
it is important to soak the TLC plate in the eluent with 2% triethylamine first, 
then let it dry, add the product and run the TLC.  If the TLC plate was not 
soaked beforehand, the 2% triethylamine had little effect on the Rf values. 
 
3.1.2. Synthesis of PN ligand 85 
The first method for the synthesis of the second PN ligand 85 started from 
aldehyde 88,  which was reacted with chiral sulfinamide 55 in THF at 50 °C 
using titanium isopropoxide as Lewis acid and water scavenger (Figure 107).88  
After purification by column chromatography, the chiral imine 89 was obtained 
in 68% yield, showing a doublet at 9.12 ppm in its 1H NMR spectrum for the 
imine hydrogen and a singlet in the 31P{1H} NMR spectrum at -12.3 ppm. 
 
Figure 107 – Synthesis of chiral imine 89, followed by diastereoselective Grignard 
addition. 
89 (68%) 
88 
55 
90 (66%) 
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This then underwent diastereoselective Grignard addition with 
isopropylmagnesium bromide (Figure 107).89  After purification by column 
chromatography, the product was obtained in 66% yield.  The 1H NMR 
spectrum showed a peak at 1 ppm for the CH3 groups, a doublet of doublets 
at 4.43 ppm for the CH on the isopropyl group, and a doublet of doublet of 
doublets at 4.64 ppm for the hydrogen on the chiral centre.  The 31P{1H} NMR 
spectrum showed a singlet at -16.3 ppm.  Unfortunately, the sulfoxide group 
from 90 could not be removed without the phosphorus getting oxidised. 
Therefore, a second route towards PN ligand 85 was pursued in which the 
phosphorus atom was added at a later stage.  This started from the addition of 
sulfinamide 55 to isobutyraldehyde 91, following a procedure from literature 
(Figure 108).97  This gave the product 92 in 72% yield, showing a doublet in 
its 1H NMR spectrum at 7.99 ppm for the imine hydrogen.  Diastereoselective 
addition of phenylmagnesium bromide, followed by separation of the 
diastereoisomers by column chromatography, gave the product 93 in 72% 
yield.  The 1H NMR spectrum showed a triplet at 4.16 ppm for the hydrogen on 
the chiral centre. 
 
Figure 108 – Addition of chiral sulfinamide followed by diastereoselective Grignard 
addition.97 
Removal of the sulfoxide group by acid-catalysed hydrolysis gave the chiral 
amine 94 in excellent yield.  Then ortholithiation with n-BuLi, followed by 
addition of chlorodiphenylphosphine gave 85 in 18% yield (Figure 109).  The 
1H NMR spectrum showed two doublets for the CH3 groups at 0.67 and 1.00 
ppm, an octet at 1.96 ppm for the CH on the isopropyl group, and a triplet at 
4.46 ppm for the hydrogen on the chiral centre.  The 31P{1H} NMR spectrum 
showed a singlet at -16.7 ppm. 
93 (72%) 92 (72%) 
91 
55 
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Figure 109 – Removal of the sulfoxide group followed by addition of 
chlorodiphenylphosphine. 
 
3.2. Synthesis of tetradentate PNNP ligands 
3.2.1. Synthesis of PNNP ligand 82 
The tetradentate PNNP ligand 82 could be prepared via several methods.  The 
method initially attempted is shown in Figure 110, where two molecules of 
product 81 were joined together via a dihalide to produce 82. 
 
Figure 110 – The synthesis of PNNP ligand 82. 
First of all, a method used to join two molecules of norephedrine was 
followed,98 in which a mixture of the amine 81 (1 eq.) and 1,2-dibromoethane 
(0.5 eq.) were heated together at 100 °C for 8 h.  The mixture became very 
thick during this time and was unable to stir.  Aqueous sodium hydroxide (0.5 
M) was added and the product was extracted with chloroform.  31P{1H} NMR 
analysis of the crude product showed there was only 22% product. 
Next, since the mixture was too thick to stir, the reaction was carried out using 
DMF as solvent.  Unfortunately, this gave no product.  Next, the reaction was 
repeated using Na2CO3 in the reaction mixture with DMF as solvent, which 
gave about 15% product. 
Another method was found in which an excess of the amine was used (4.3 
equivalents).99  Triethylamine was added to this followed by 1,2-
dibromoethane at 110 °C under a nitrogen atmosphere.  The mixture was 
stirred for 22 h at 110-130 °C.  Workup by addition of a saturated KOH solution 
and extraction with DCM gave a mixture of starting material and product (40% 
product by NMR).  Purification by column chromatography using 10% 
81 82 (20%) 
93 
94 (94%) 85 (18%) 
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MeOH/DCM gave the product 82, a white solid, in 20% isolated yield (Figure 
110).  The 1H NMR showed a doublet at 1.25 ppm with an integration of 6 for 
the two CH3 groups, a broad singlet at 2.50 ppm with an integration of 4 for the 
CH2 groups and a multiplet at 4.61 ppm with an integration of 2 for the 
hydrogens on the chiral centres.  The 31P{1H} NMR showed a singlet at -17.2 
ppm. 
Due to the low yield, two other methods were tried.  Firstly, 81 was dissolved 
in isopropanol, then an aqueous solution of glyoxal was added and the mixture 
was heated to 70 °C for 1 h (Figure 111).100  This gave mainly recovered 
starting material 81, plus oxide products. 
 
Figure 111 – Reaction of 81 with glyoxal. 
The next method (Figure 112) used glyoxal trimer dihydrate 95 following a 
method used to make N,N'-bis-((S)-1-phenylethyl)ethane-1,2-diimine.101  On 
the first attempt, this appeared to work well, giving one major product in 
quantitative yield, with a peak at -16.5 ppm in the 31P{1H} NMR spectrum.  The 
1H NMR spectrum showed a singlet at 7.56 ppm for the imine hydrogens, a 
multiplet at 5.32 ppm for the hydrogens on the chiral centres, and a doublet at 
1.37 ppm for the hydrogens on methyl groups. 
 
Figure 112 – Reaction of 81 with glyoxal trimer dihydrate 95. 
The reduction of this crude product was carried out using sodium borohydride 
in methanol/DCM (Figure 113).  This resulted in a mixture of many products, 
including some left-over starting material.  This crude product was re-dissolved 
96 (quantitative yield, crude) 
95 
81 
81 96 
Chapter 3. Synthesis of Acyclic Ligands 
74 
 
in DCM and was added to more sodium borohydride, followed by the addition 
of methanol.  The reaction was continued for another day, but this still resulted 
in a mixture of many products.  It was later discovered that the methanol bottle 
actually contained acetone, so this would explain why the reaction was 
unfinished because the sodium borohydride would have reacted with the 
acetone. 
 
Figure 113 – Attempted reduction of the diimine 96. 
Unfortunately, the reaction in Figure 112 could not be repeated, as any further 
attempts resulted in either a mixture of many products, or just remaining 
starting material 81.  Therefore, the dibromoethane method in Figure 110 was 
chosen for further reactions.  Even though the yield was low for this method, 
the reaction is clean and the starting material can be recovered and reused. 
 
3.2.2. Synthesis of racemic PNNP ligand 83 
The racemic analogue of 82 was synthesised in order to be able to measure 
the ee of 82.  This followed exactly the same method, but starting from racemic 
phenylethylamine 97 (Figure 114).  A mixture of diastereoisomers of 83 were 
formed which were difficult to separate, so only a very small amount of pure 
product could be obtained (3%). 
 
Figure 114 – Synthesis of the racemic analogue 83. 
Unfortunately, the enantiomers of 83 could not be separated by chiral HPLC; 
so, the ee of 82 was not determined. 
 
96 82 
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3.2.3. Synthesis of PNNP ligand 86 
Next, two molecules of 85 were joined together in the same way, to produce 
tetradentate PNNP ligand 86 in 50% yield (Figure 115). 
 
Figure 115 – The synthesis of PNNP ligand 86. 
The peaks in the NMR spectra for ligand 86 were very broad, but the resolution 
was improved with increased concentration, as can be seen from the 
comparison of the spectra in Figure 116.  The peaks for the CH2 groups 
(CH2CH2, 2.26 and 2.49 ppm) and the CH in the isopropyl group (CH(CH3)2, 
2.08 ppm) are indistinguishable at low concentration as they are very broad 
and overlap.  The peaks for the methyl groups (CH3, 0.59 and 1.05 ppm) 
appear as broad singlets at low concentration but are doublets at higher 
concentration. 
 
Figure 116 – 1H NMR spectra of PNNP ligand 86 at different concentrations in 
CDCl3. The amounts of ligand shown at the right-hand side are the amount per 0.6 
ml of chloroform. Impurities are marked with a *. 
86 (50%) 85 
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This effect is also observed in the 1H NMR spectrum of PNNP ligand 82, but 
is not so noticeable.  This is unusual because the resolution of an NMR 
spectrum normally decreases with increased concentration, due to 
intermolecular chemical exchange.  Chemical exchange means that a nucleus 
moves between a set of magnetic environments,102 consequently varying the 
chemical shift slightly, producing a broad peak.  Increased concentration would 
produce more intermolecular interactions, increasing the amount of chemical 
exchange, reducing the resolution. 
 
3.3. Synthesis of tridentate NPN ligands 
The synthesis of the tridentate NPN ligand 44 was already discussed in 
Chapter 2.2 on page 37 (Figure 56).  To expand the scope of the NPN ligands, 
compound 84 was targeted. 
The NPN ligand 84 was synthesised from the chiral diamine 36b (see Figure 
75) by reaction with benzaldehyde to give diimine 99, followed by reduction 
with sodium borohydride to give NPN ligand 84 in 42% yield (Figure 117).  The 
1H NMR spectrum showed two doublets with integrations of 1 and a singlet 
with an integration of 2 for the two CH2 groups, and two doublets (coupling to 
P) for the two hydrogens on the chiral centres.  The 31P{1H} NMR showed a 
singlet at -26.0 ppm. 
 
Figure 117 – Synthesis of NPN ligand 84. 
 
3.4. Synthesis of pentadentate ligand 87 
In addition to the tetradentate and tridentate ligands described, a pentadentate 
ligand 87 was synthesised by reaction of dialdehyde 45 with PN ligand 81, 
followed by reduction with sodium borohydride in methanol/DCM to give 87 in 
36b 99 (83%, crude) 84 (42%) 
Chapter 3. Synthesis of Acyclic Ligands 
77 
 
excellent yield (Figure 118).  The 1H NMR spectrum showed two doublets at 
0.87 and 0.89 ppm for the CH3 groups, and a multiplet at 4.53 ppm for the two 
hydrogens on the chiral centres.  The 31P{1H} NMR showed three peaks with 
equal integrations at -25.8, -17.9 and -17.6 ppm. 
 
Figure 118 – Synthesis of pentadentate ligand 87. 
 
3.5. Complex formation 
Complex formation with the PNNP ligands 82 (R = Me) and 86 (R = iPr) was 
carried out using [Rh(COD)Cl]2 in deuterated DCM in an NMR tube under 
nitrogen (Figure 119).  The synthesis of rhodium complexes was carried out 
with the aim of gaining a better understanding of what kind of complexes may 
form in the catalytic cycle. 
 
Figure 119 – Complex formation using [Rh(COD)Cl]2. 
Rhodium was used because it is NMR active.  The presence of Rh-P coupling 
in the NMR spectra confirms coordination of the ligand, and the position of the 
other donor groups in the complex strongly influences the size of the coupling.  
The ligand trans to phosphorus affects the coupling constants much more than 
the ligands cis to phosphorus.103, 104  The trans influence is the extent to which 
a ligand weakens the bond trans to itself, decreasing the metal-ligand coupling 
constant.63  The trans influence depends on the electronic properties (e.g. σ-
donor or π-acceptor) of the ligand, metal oxidation state, coordination number 
and geometry.105 
45 
81 
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There are 4 possible ligands which could be trans to phosphorus in this 
reaction: chloride, amine, phosphine or alkene.  Table 3 summarises the 
different values of JRh-P for different trans ligands and geometries. 
Table 3 – Values found in literature of JRh-P for different geometries and trans ligands. 
 range of values for JRh-P (Hz) 
Ligand 
trans to P 
Square 
planar106-108 
Trigonal 
bipyramidal109-113 
square based 
pyramid111, 114 
Octahedral 
(Rh(III))103, 113 
chloride 186-200 108-120 134-156 111-113 
amine 172-173   96-107 
phosphine 130-142 94-108 84-108 69-84 
alkene 119-147    
 
The vast majority of rhodium(I) complexes are 4-coordinate square planar, but 
5-coordinate trigonal bipyramidal or square based pyramid geometries are 
also a possibility.111, 115 In trigonal bipyramidal complexes, a further 
consideration is that the rhodium to equatorial phosphine coupling is typically 
20-30% larger than the coupling to the axial phosphorus.109, 111 
There is a small number of reports in the literature of similar PNNP ligands 
reacting with [Rh(COD)Cl]2, forming square planar complexes 101 (Figure 
120).107, 108, 116, 117  In contrast to the 31P{1H} NMR spectra reported here, Gao 
et al.116, 117 report singlets in the 31P{1H} NMR spectra, which is an unexpected 
observation given resolvable Rh-P couplings are expected.  Thus, both Cooper 
et al.107 and Marxen et al.108 report a doublet in the 31P{1H} NMR of complex 
101 with a coupling constant of 172 - 173 Hz.  Other acyclic PNNP ligands 
have been shown to give trans-spanning rhodium complexes 102,107, 118 which 
have rhodium-phosphorus coupling constants of 130 - 135 Hz.118  Dinuclear 
rhodium PNNP complexes 103 have also been reported.119  Trigonal 
bipyramidal rhodium(I) complexes with tripodal tetradentate ligands have been 
reported.120  No papers with trigonal bipyramidal rhodium(I) complexes with 
linear tetradentate ligands have been found, although there is an example with 
zinc.121 
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Figure 120 – Possible structures of the rhodium PNNP complexes. 
L = unspecified ligand. 
The reaction proved to be more complicated than anticipated because a 
mixture of products is formed for each ligand, as can be seen from the 31P{1H} 
NMR spectra shown in Figure 121 and Figure 127.  Intermediate complexes 
are seen after 1 h for both ligands, however, free ligand is no longer seen after 
4 days using ligand 82 (Figure 121, top) but is still seen after 8 days with ligand 
86 (Figure 127, top).  This might indicate either that the later steps in the 
substitution reaction sequence are considerably slower with the bulkier ligand 
86, or that the reaction is an equilibrium and the position of equilibrium is 
influenced by the steric bulk of the ligand. 
 
Figure 121 – The 31P{1H} NMR spectra of complex formation with PNNP ligand 82. 
101 
103 
102 
104 
A        B       .  
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The 31P{1H} NMR spectrum at 4 days reaction time with ligand 82 in Figure 
121 is dominated by the resonances of two complexes; a doublet at 11.1 ppm 
with a coupling constant of 106 Hz corresponding to Rh-P coupling, complex 
A, and a pair of doublets of doublets of doublets at 24.6 and 35.4 ppm, complex 
B. 
Complex A with doublet at 11.1 ppm and a coupling constant of 106 Hz must 
come from a complex where the phosphorus atoms are equivalent and are 
coordinated to Rh.  Mass balance indicates it is unlikely that this is a dinuclear 
complex 103 because there is no free ligand left.  The Rh-P coupling constant 
(106 Hz) is much smaller than previously reported square planar complexes 
101 with P trans to N (172-173 Hz),107, 108 indicating that a complex analogous 
to 101 is unlikely.  A square planar complex with P trans to P such as trans-
spanning complex 102 would be expected to have JRh-P around 130-135 Hz,118 
while a trigonal bipyramidal complex with axial phosphines such as 104 
(Figure 122) would be consistent with the observed small value of the Rh-P 
coupling constant.109, 111  Another possibility for this complex is a complex with 
P trans to alkene such as 105 or 106 (Figure 122), which would again be 
consistent with a small value for JRh-P due to the high trans-influence of the 
alkene. 
 
Figure 122 – Possible structures for complex A with P trans to P or alkene.106 
 
Figure 123 – Expansions of the 31P{H} NMR spectrum for complex B in Figure 121 
showing two doublets of doublets of doublets. 
Complex B shows doublets of doublets of doublets at 24.6 and 35.4 ppm (see 
Figure 123 for expansions). These integrate close to 1:1 in all spectra; the 
106 105 
104 
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differing intensities are due to the degree of overlap of the lines of the small 
doublet splitting assigned to 3JRh-P (3.6 Hz for the peak at 24.6, and 1.5 Hz for 
the peak at 35.4).  The coupling constant of 28 Hz is the same in both doublets 
of doublets of doublets and can be assigned to P-P coupling, and the largest 
coupling constants (121 and 123 Hz, respectively) correspond to one-bond Rh-
P coupling.  The presence of 3JRh-P coupling in B confirms that B is a dimer 
complex with two inequivalent phosphine donors, i.e. the ligand chelates the 
rhodium - a bridging ligand, although possible, is unlikely.  Possible structures 
for B are complexes 107 or 108 (Figure 124) in which the phosphorus centres 
are made inequivalent by the conformation of the ligand backbones.  However, 
the Rh-P coupling constants (121-123 Hz) are too small for P trans to chloride 
(186-200 Hz).106  Trigonal bipyramidal structures, such as complexes 109 or 
110, in which the axial Ps are mutually trans could account for the small Rh-P 
coupling. 
 
Figure 124 – Possible structures for complex B.106 (L=ligand) 
At shorter reaction times (bottom two spectra in Figure 121), two additional 
sets of resonances are seen: a broad doublet at 18.2 ppm with a coupling 
constant of 160 Hz, complex C, and a sharp doublet at 18.7 ppm with a 
coupling constant of 157 Hz, complex D.   
Complex C, since it is broad, might be an intermediate complex where only 
one of the phosphorus atoms has coordinated, although the expected 
corresponding broad singlet near to the free ligand peak is not seen in Figure 
121.  Instead, we favour an analogous reaction to that reported for the reaction 
of bis-[(2-diphenylphosphino)phenyl] ether (DPEPhos) with [Rh(COD)Cl]2 to 
form a mixture of complexes 107, showing a sharp doublet, and 108, 
overlapping with a broad doublet (Figure 125).  However, we note that much 
108 107 
110 109 
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larger JRh-P (205 and 201 Hz) are reported for the DPEPhos complexes than 
are observed here (157 and 160 Hz).106 
 
Figure 125 – Possible structures for C and E (107) and D and G (108).  
The NMR spectra in Figure 127 for the reaction of PNNP ligand 86 (R = iPr) 
are more complicated.  After 1.5 h reaction time, there are 3 doublets at 19.2, 
18.0 and 17.6 ppm, complexes E, F, and G.  The doublet for complex E is 
sharp with Rh-P coupling of 160 Hz, whereas for complexes F and G the 
doublets are broad, with Rh-P coupling constants of 158 Hz.  A broad singlet 
is also present at -19.3 ppm, next to the free ligand peak, which integrates 
roughly 1:1 compared to the broad doublet for complex F and, in the bottom 
spectrum, it integrates 1:1 compared to the resonance of free ligand.  This 
indicates that in complex F only one of the phosphorus donors is coordinated 
to the metal, such as complex 111 (Figure 126).  The breadth of the 
resonances indicates a dynamic process is occurring.  The differential 
broadening of the free ligand and decoordinated end of 86 in complex F 
indicates that the ends of the coordinated ligand exchange more rapidly than 
the exchange of coordinated and free 86, indicating either an intramolecular 
process, or that 86 does not leave the solvation shell of the complex during the 
exchange.  A second slower exchange process can then exchange free and 
coordinated 86.  Complexes E and G are assigned as the dimer complexes 
107 and 108, as discussed above (Figure 125). 
 
Figure 126 – Possible structure of complex F. 
111 
107 108 
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Figure 127 – The 31P{1H} NMR spectra of complex formation with PNNP ligand 86. 
At longer reaction times in Figure 127, the resonances of 4 additional 
complexes are seen: two doublets at 21.8 and 9.0 ppm, complexes H and I, 
and two sets of doublets of doublets at 36 ppm, complex J, and 14.6 ppm, 
complex K. 
The Rh-P coupling constants for H and I are 111 and 106 Hz, respectively, 
which would be consistent with P trans to P in a trigonal bipyramidal complex 
104, or a square planar complex with P trans to alkene such as 105 or 106 
(Figure 128), as discussed above. 
 
Figure 128 – Possible structures for H and I. 
 
Figure 129 – An expansion of the 31P{H} NMR of the doublet of doublets at 37.8 
ppm for complex J in Figure 127. 
I H 
K 
J 
E F G 
104 105 106 
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For complexes J and K, the doublets of doublets show no coupling to a remote 
rhodium, as for the complex with 82 above, and the lines are very sharp which 
indicates that there are no unresolved Rh-P couplings (Figure 129).  This 
means that these complexes are most likely not dimers.  This may be due to 
the increased steric bulk of the ligand which makes the formation of a dimer 
complex less likely. 
Complex J has P-P coupling constants of 43 Hz and Rh-P coupling constants 
of 184 and 176 Hz.  The large Rh-P coupling constants would suggest a 
structure where one P is trans to Cl and the other trans to N.  An example of a 
complex which fulfils these requirements would be a square based pyramid 
structure 112 (Figure 130), although this looks like an unusual coordination 
geometry for the PNNP ligand. 
 
Figure 130 – A possible structure for complex J, with one P trans to N and the 
other trans to Cl. 
Complex K has P-P coupling constants of 23.6 Hz and Rh-P coupling 
constants of 105 and 106 Hz.  The small Rh-P coupling constants would 
suggest either a trigonal bipyramidal complex with P trans to P or a square 
planar complex with P trans to alkene.  However, it is difficult to imagine such 
complexes having inequivalent phosphorus atoms.  Another possibility would 
be the oxidation of Rh(I) to Rh(III) to form an octahedral complex, which are 
known to have smaller Rh-P coupling constants (see Table 3).111 
The observations above suggest that the sterically more demanding ligand 86 
is less likely to coordinate to a metal centre than ligand 82. 
Unfortunately, no crystals were obtained from these NMR solutions. 
 
3.6. Summary 
In summary, eight acyclic ligands were synthesised (Figure 105), with varying 
denticity (bidentate, tridentate, tetradentate and pentadentate) and chiral 
groups (Me, iPr, Ph).  The PNNP ligands were reacted with [Rh(COD)Cl]2 and 
112 
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the NMR spectra show rhodium-phosphorus coupling which confirms complex 
formation.  However, the ease of complex formation appears to vary with the 
ligand’s steric property, with the bulkier one less likely to coordinate to a metal 
centre.  
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Chapter 4. Catalysis 
As mentioned in the introduction, until recently asymmetric hydrogenation (AH) 
and asymmetric transfer hydrogenation (ATH) reactions have mainly used 
expensive and toxic rhodium, ruthenium and iridium metal catalysts.  In recent 
years a considerable amount of research has gone into AH and ATH reactions 
which use base metals instead of precious metals.25-33  Iron is the most 
abundant metal in the earth’s crust and is also an essential element in nature.34  
This means it is a lot cheaper and less toxic than the precious metals, making 
iron a good candidate for the replacement of precious metals. 
Examples of iron catalysed hydrogenations are given in section 1.6 (page 11), 
including the use of the 22-membered macrocycle 23 which is the most 
enantioselective ligand for iron catalysed AH of ketones so far.  However, it 
has a low TOF, high H2 pressure is needed (50 bar), and it is unable to 
hydrogenate other substrates such as imines.2 
Therefore, the macrocyclic and acyclic ligands described in Chapter 2 and 
Chapter 3 were tested for the iron catalysed AH and ATH of acetophenone, 
with the hope of obtaining an iron catalyst with increased activity and substrate 
scope.  The initial reaction conditions were based on those for the AH and ATH 
using the 22-membered macrocyclic ligand 23 from literature.1, 2  The 
conditions for the best ligand were optimised and a variety of ketones and one 
imine were reduced to demonstrate the substrate scope. 
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The following ligands were tested for iron catalysed hydrogenation:  
   
37b (R=Ph) 
37c (R=p-Tol) 
37d  (R=Xyl) 
58c 37a 
   
63 37e 58a 
   
64 65 23 
    
36b (R=Ph) 
36c (R=p-Tol) 
36d (R=Xyl) 
87 84 44 
   
82 86 
 
81 
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4.1. Asymmetric Hydrogenation (AH) 
AH of acetophenone was studied first and this was undertaken at AstraZeneca 
in Macclesfield from July-September 2018.  All of the ligands synthesised were 
sent over in order to test them using the screening equipment available at 
AstraZeneca.  The AH experiments were based on the procedure used for the 
22-membered macrocycle 23 from literature (Figure 131), with the catalyst 
formed in situ.2  In the literature procedure, the iron source (Fe3(CO)12) and the 
ligand are placed into a dry autoclave under nitrogen, followed by the addition 
of dry methanol.  Then the autoclave is filled with hydrogen and the mixture is 
stirred at 45 °C under 5 bar of hydrogen for 1 h.  After this, KOH in methanol 
is added followed by acetophenone.  Then 50 bar of hydrogen is added and 
the mixture is stirred at 45 °C.2 
 
Figure 131 – The AH of acetophenone. 
At AstraZeneca, the ligands were weighed out in air and then taken into a 
glovebox under nitrogen.  Then Fe3(CO)12 was weighed out into these vials 
using an automatic weighing machine inside the glovebox.  Unfortunately, this 
was not always very accurate, so the ratios of iron/ligand were sometimes 
unusual.  Potassium hydroxide was also weighed out in the glovebox into a 
large vial to make a solution in methanol to which acetophenone was added.  
Then an appropriate amount of this solution was added to each reaction vial.  
The reaction vials were placed into a 48-well metal plate which was then 
placed into a hydrogenation reactor.  This was tightened up before removing it 
from the glovebox and installing it in the hydrogenation machine.  90 bar of 
hydrogen was added and the reactions were heated to 45 °C and were left 
overnight. 
Samples were taken from each reaction and were analysed using SFC.  No 
product was obtained from any of the reactions apart from the 22-membered 
macrocycle 23 from literature (76% conversion). 
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Next, a slightly different method was used in which the ligand and Fe3(CO)12 
were stirred in methanol under 5 bar of hydrogen for 1 hour at 45 °C before 
cooling and adding a solution of KOH and acetophenone in methanol.  Then 
90 bar of hydrogen was added and the mixtures were stirred overnight at 45 
°C.  Unfortunately, this method also gave no product. 
 
4.2. ATH under Schlenk conditions 
The ATH experiments were based on the literature procedure used for the 22-
membered macrocycle 23 (Figure 132).1  The reactions were performed under 
nitrogen using a Schlenk line.  In the literature procedure, the iron source, 
ligand and NaBH4 are placed in a tube under nitrogen.  Isopropanol is then 
added, and the mixture is stirred at 65 °C for 30 min before the addition of base 
in isopropanol.  The mixture is stirred for a further 10 min before the addition 
of ketone.1 
 
Figure 132 – The ATH of acetophenone. 
Table 4 – The screening of ligands for the ATH of acetophenone. 
 ligand time (h) conversionb (%) ee c (%) 
ia 37a 19 0 - 
ii 37b 16 0 - 
iii 37e 19 0 - 
iv 37c 16 3 - 
v 37d 16 0.5 - 
vi 36b 16 2 - 
vii 84 16 0 - 
viiia 84 17 0 - 
ix 63 15 0 - 
x 65 18 0.5 - 
xi 82 16 99 50 
xii 87 17 1 - 
conditions: acetophenone (0.3 mmol), ligand (0.5 mol%), Fe3(CO)12 
(0.5 mol%), KOH (12 mol%), iPrOH (3 ml), 55 °C. 
a NH4Cl additive (6 mol%). 
b Determined by 1H NMR. 
c Determined by chiral HPLC. 
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Firstly, the exact conditions used for the 22-membered macrocycle were used, 
apart from the additive since the role of this is unknown and was only shown 
to increase the conversion by 5%.1  Very low conversions (≤3%) were 
observed for almost all ligands (Table 4).  However, the PNNP ligand 82 gave 
99% conversion and about 50% ee (entry xi). 
Table 5 – Screening of metals, bases and ligands for ATH of acetophenone. 
 ligand metal source base time (h) conversiond 
(%) 
ee e 
(%) 
i 37b Fe3(CO)12 KOH 21 0.3 - 
ii 37b Fe3(CO)12 KOtBu 23 4 - 
iii 37b Fe3(CO)12 K2CO3 22 0.6 - 
iv 37b FeBr2 KOH 20 9 - 
v 37b FeSO4.7H2O KOH 23 7 - 
vi 37b Fe2(CO)9 KOH 22 8 - 
vii 37b Fe(OAc)2 KOH 23 16 4 
viii 37b Fe(OAc)2 KOtBu 22 12 3 
ixb 37b Fe(OAc)2 KOH 24 57 1 
xc 37b [Ru(p-cymene)Cl2]2 KOH 24 92 3 
xi 58c Fe3(CO)12 KOH 21 0 - 
xii 36b Fe3(CO)12 KOH 22 4 - 
xiii 37e Fe3(CO)12 KOH 23 0 - 
xiv 37e Fe(OAc)2 KOH 23 17 - 
xv 37e FeSO4.7H2O KOH 23 13 - 
xvi 23 Fe3(CO)12 KOH 1 42 95 
xviia 23 Fe3(CO)12 KOH 1 89 96 
conditions: acetophenone (0.3 mmol), ligand (1.7 mol%), metal source (1.7 mol%), base  
(12 mol%), 90 °C. 
a ligand (0.5 mol%), Fe3(CO)12 (0.5 mol%), NH4Cl additive (6 mol%), 55 °C. 
b 50 mol% base 
c metal source (0.85 mol%) 
d Determined by 1H NMR. 
e Determined by chiral HPLC. 
Next, various iron sources and bases were tested, and the catalyst loading and 
the temperature were increased.  The results are summarised in Table 5 
above.  The first ligand tested was the macrocyclic ligand 37b (entries i-x).  
Fe3(CO)12 gave very low conversions (entry i-iii) but was slightly improved with 
a stronger base (entry ii).  Other iron sources (entry iv-viii) improved the yield 
slightly, however these have different iron/ligand ratios so they may not be 
directly comparable.  The best iron source was Fe(OAc)2 and the conversion 
was improved by increasing the amount of base to 50 mol% giving 57% 
conversion (entry ix).  However, there was no enantioselectivity.  A ruthenium 
source gave 92% conversion (entry x) but still no enantioselectivity. 
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The imine version of this macrocycle (58c) was also tried with Fe3(CO)12 (entry 
xi) but gave no conversion.  The free diamine 36b gave 4% conversion under 
the same conditions (entry xii). 
Macrocycle 37e was tested with three different iron sources (entries xiii-xv).  
Fe3(CO)12 gave no conversion whereas iron acetate and iron sulfate gave low 
conversions. 
The ATH using the 22-membered macrocycle from literature was repeated as 
a comparison, which gave 42% conversion and 95% ee (entry xvi).  This was 
increased to 89% conversion and 96% ee (entry xvii) by using the exact 
conditions used in the paper, which is comparable to the literature results (97% 
conversion, 98% ee). 
 
4.3. ATH in a glovebox 
The ATH of acetophenone was also examined at AstraZeneca (Figure 133) 
and was carried out in small glass vials inside a glovebox under nitrogen. 
 
Figure 133 – The ATH of acetophenone in a glovebox at AZ. 
The first ligand to be tested was the macrocyclic ligand 37b (Table 6).  This 
had given very low conversions previously (see section 4.2) when Schlenk 
techniques were used.  However, in a glovebox it gave very high conversions, 
but still low ee (≤15 %).  The low ee may be the result of reaction reversibility 
which can cause racemization of the product on longer reaction times.47  
Future work should include shorter reaction times to test this. 
The conversion was improved with stronger base (compare entries i and ii).  A 
mixture of toluene and isopropanol was tested next (entry iii) since the ligand 
is not very soluble in isopropanol, but this gave a lower conversion.  The use 
of formic acid/triethylamine as a hydrogen source gave no product (entry iv).  
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Increasing the mol% of ligand and iron to 2% (entry v) increased the 
conversion to >99%. 
Table 6 – ATH of acetophenone using ligand 37b. 
 ligand mol% 
ligand 
mol% 
Fe3(CO)12 
base solvent conversionb 
(%) 
ee b 
(%) 
i 
37b 
0.5 0.5 KOH iPrOH 73 14 
ii 0.5 0.5 KOtBu iPrOH 92 12 
iii 0.5 0.5 KOtBu 
toluene/iPrOH 
(1/4) 
66 8 
iv 0.5 0.5 - 
HCOOH/Et3N 
iPrOH 
0 - 
v 2 2 KOtBu iPrOH >99 8 
via 2 1.4 KOH iPrOH 96 15 
vii 2 1.4 KOH iPrOH 98 12 
conditions: acetophenone (0.1 M), Fe3(CO)12, ligand, base (12 mol%), solvent, 60 °C, overnight. 
a2.5 μl of water was added (0.14 mol%). 
b Determined by chiral SFC. 
In order to understand why the reaction did not work in a Schlenk flask, a small 
amount of water (2.5 μl) was added (entry vi).  This had a minimal effect on 
the results (compare entries vi and vii), which would suggest that the reaction 
may be air sensitive rather than water sensitive. 
The next ligand to be tested was macrocyclic ligand 64 (Table 7).  Very low 
conversion was obtained when KOH was used as the base (entry i), but a 
stronger base (KOtBu) gave a higher conversion and moderate ee (entry ii).  
The addition of toluene to try and increase the solubility of the ligand resulted 
in a slightly lower conversion and ee (entry iii).  Formic acid/Et3N as the 
hydrogen source gave no product (entry iv). 
Table 7 – ATH of acetophenone using macrocyclic ligand 64. 
 ligand mol% 
ligand 
mol% 
Fe3(CO)12 
base solvent conversiona 
(%) 
ee a 
(%) 
i 
64 
0.5 0.5 KOH iPrOH 4 2 
ii 0.5 0.5 KOtBu iPrOH 22 44 
iii 0.5 0.5 KOtBu 
toluene/iPrOH 
(1/4) 
15 20 
iv 0.5 0.5 - 
HCOOH/Et3N 
iPrOH 
0 - 
conditions: acetophenone (0.1 M), Fe3(CO)12, ligand, base (12 mol%), solvent, 60 °C, overnight. 
a Determined by chiral SFC. 
The bidentate PN ligand 81 was also tested (Table 8).  This gave low 
conversions but moderate ee using KOH as base (entries i and ii).  An 
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increased amount of ligand and iron source, plus KOtBu as base, gave 64% 
conversion and 66% ee (entry iii). 
Table 8 – ATH of acetophenone using PN ligand 81. 
 ligand mol% 
ligand 
mol% 
Fe3(CO)12 
base conversiona 
(%) 
ee a (%) 
i 
81 
0.5 0.5 KOH 6 32 
ii 1 0.5 KOH 6 26 
iii 2 2 KOtBu 64 66 
iv 6 5 KOtBu 12 64 
v 12 3.6 KOtBu 13 47 
vi 18 2.1 KOtBu 21 48 
vii 2 1.4 NaOtBu 22 38 
viii 2 1.3 KOH 18 67 
ix 2 1.4 KOtBu 29 59 
conditions: acetophenone (0.1 M), Fe3(CO)12, ligand, base (12 mol%), solvent, 60 °C, overnight. 
a Determined by chiral SFC. 
An excess of ligand compared to iron (entries iv-vi) gave lower conversions 
and ee than a 1:1 mixture (entry iii).  A comparison of bases (entries vii-ix) 
showed that KOtBu was the best in terms of conversion, but KOH gave the 
best ee. 
PNNP ligand 82 consistently gave full conversions (Table 9), apart from when 
a great excess of iron was used (entry iii) which gave no conversion.  However, 
the ee was not reliable. 
Table 9 – ATH of acetophenone using PNNP ligand 82. 
 ligand mol% 
ligand 
mol% 
Fe3(CO)12 
base conversiona 
(%) 
ee a 
(%) 
i 
82 
2 2 KOtBu 100 20 
ii 2 1.4 KOtBu 98 0.4 
iii 2 11.5 KOH 0 - 
iv 2 1.5 KOH 99 2 
v 2 1.5 KOtBu 98 8 
conditions: acetophenone (0.1 M), Fe3(CO)12, ligand, base (12 mol%), iPrOH, 60 °C, overnight. 
a Determined by chiral SFC. 
Various other ligands were also tested (Table 10).  PNP ligand 44 gave very 
low conversion (entry i) and the use of a stronger base and increased catalyst 
loading did not improve this (entry ii).  The macrocyclic ligand 37a, along with 
its imine analogue 58a, gave low conversion and ee (entries iii and xi).  The 
macrocyclic ligands 63 and 37e gave both low conversions and ee (entries viii 
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and iv), whereas macrocyclic ligands 37c and 37d gave good conversions but 
low ee (entries v and vi). 
Table 10 – ATH of acetophenone in a glovebox at AZ. 
 ligand mol% 
ligand 
mol% 
Fe3(CO)12 
base conversiona 
(%) 
ee a 
(%) 
i 44 0.5 0.5 KOH 2 - 
ii 44 2 2 KOtBu 0 - 
iii 37a 2 2 KOtBu 8 4 
iv 37e 2 2 KOtBu 2 12 
v 37c 2 2 KOtBu 85 8 
vi 37d 2 2 KOtBu 69 12 
vii 65 2 2 KOtBu 0 - 
viii 63 2 2 KOtBu 4 12 
ix 87 2 2 KOtBu 0 - 
x 84 2 2 KOtBu 4 6 
xi 58a 2 2 KOtBu 10 4 
xii 23 2 2 KOtBu 98 80 
conditions: acetophenone (0.1 M), Fe3(CO)12, ligand, base (12 mol%), iPrOH, 60 °C, overnight. 
a Determined by chiral SFC. 
The macrocyclic ligand 65, which is an amino analogue of the 22-membered 
macrocycle 23 from literature, gave no conversion (entry vii) compared to 98% 
conversion for 23 (entry xii).  The pentadentate ligand 87 gave no conversion 
(entry ix).  The benzyl protected PNP diamine ligand 84 gave low conversion 
and ee (entry x). 
A comparison of the macrocyclic ligands suggests that the phosphorus donor 
atoms are important for activity.  The 22-membered macrocycle 23 from 
literature which has 2 phosphorus atoms gave 98% conversion (entry xii) 
whereas the amino analogue 65 gave no conversion (entry vii).  Also, the 
macrocyclic ligands 37b, 37c and 37d which have 2 phosphorus donors gave 
good conversions whereas 37e, where one of the phosphorus atoms is 
replaced with an NH, and 63, where one of the phosphorus atoms is removed, 
gave very low conversions. 
 
4.4. Optimisation of PNNP ligand 82 
After returning from AstraZeneca, the PNNP ligand 82 was optimised under 
Schlenk conditions.  This ligand was chosen to be optimised because it gave 
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good conversions and the ATH can be carried out under Schlenk conditions, 
unlike the macrocyclic ligand 37b which only works in a glovebox. 
Firstly, some control experiments were conducted (Table 11) which show that 
each component of the reaction is essential to its success. 
Table 11 – Control experiments. 
 ligand base iron source conversiona (%) 
i - KOH Fe3(CO)12 0 
ii 82 - Fe3(CO)12 0 
iii 82 KOH - 0 
acetophenone (0.3 mmol), Fe3(CO)12 (0.5 mol%), ligand 82 (0.5 mol%), KOH (12 mol%), 
iPrOH (3 ml), 55 °C, 1 hour. 
a Determined by 1H NMR. 
Secondly, the reaction time was varied (Table 12).  No change in conversion 
was observed until the reaction time was decreased to 30 minutes, showing 
the catalyst formed to be highly active.  The ee appears to increase slightly on 
shorter reaction times, but not to any significant extent.  This would suggest 
that the reaction is not easily reversible because this would result in 
racemisation of the product with prolonged reaction times.42  The optimum 
reaction time chosen was 1 hour. 
Table 12 – Optimisation of reaction time. 
 time conversiona (%) ee b (%) 
i 16 h 98 50 
ii 2 h 98 46 
iii 1 h 98 51 
iv 30 min 96 57 
v 10 min 20 56 
acetophenone (0.3 mmol), Fe3(CO)12 (0.5 mol%), ligand 82 (0.5 mol%), 
KOH (12 mol%), iPrOH (3 ml), 55 °C. 
a Determined by 1H NMR. 
b Determined by chiral HPLC. 
Next, different reaction temperatures were tried (Table 13).  The conversion 
decreases slightly with lower temperature, as would be expected, but the ee 
remains around the same value.  The chosen temperature was 55 °C. 
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Table 13 – Optimisation of reaction temperature. 
 temperature (°C) conversiona (%) ee b (%) 
i 25 82 55 
ii 35 92 46 
iii 55 98 51 
iv 80 99 47 
acetophenone (0.3 mmol), Fe3(CO)12 (0.5 mol%), ligand 82 (0.5 mol%), 
KOH (12 mol%), iPrOH (3 ml), 1 hour. 
a Determined by 1H NMR. 
b Determined by chiral HPLC. 
Different bases were tried next (Table 14).  A series of hydroxides was 
examined (entries i-iv).  Lithium and potassium hydroxide gave the same 
results, whereas sodium hydroxide gave a much lower conversion and 
enantioselectivity, and caesium hydroxide still gave good conversion but lower 
ee.  Strength of base was examined next; a weaker base (potassium 
carbonate, entry v) gave no conversion, and a stronger base (potassium t-
butoxide, entry vi) gave lower conversion and enantioselectivity.  The base of 
choice was potassium hydroxide since this is readily soluble in isopropanol. 
Table 14 – Choice of base. 
 base conversiona (%) ee b (%) 
i LiOH 98 52 
ii NaOH 14 36 
iii KOH 98 51 
iv CsOH 95 31 
v K2CO3 0 - 
vi KOtBu 11 40 
acetophenone (0.3 mmol), Fe3(CO)12 (0.5 mol%), ligand 82 (0.5 mol%), 
base (12 mol%), iPrOH (3 ml), 55 °C, 1 hour. 
a Determined by 1H NMR. 
b Determined by chiral HPLC. 
The amount of base was also varied (Table 15).  Either an increase or 
decrease in the amount of base lowered both the conversion and 
enantioselectivity.  Therefore, the mol% KOH was kept at 12 mol%. 
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Table 15 – Variation of mol% KOH. 
 mol% KOH conversiona (%) ee b (%) 
i 6 22 32 
ii 12 98 51 
iii 30 6 12 
acetophenone (0.3 mmol), Fe3(CO)12 (0.5 mol%), ligand 82 (0.5 mol%), 
iPrOH (3 ml), 55 °C, 1 hour. 
a Determined by 1H NMR. 
b Determined by chiral HPLC. 
The ligand/iron ratio was investigated next (Table 16).  The ligand/iron ratio 
used so far has been 1/1, following the literature method for the 22-membered 
macrocycle 23.1  The reaction time was reduced to 10 minutes in order to see 
any difference in conversion.  The conversion is increased with increasing 
amounts of ligand up until the ratio 3/1.   However, increasing the amount of 
ligand further decreases the conversion.  This would suggest that the active 
catalyst may be an iron complex containing one iron atom with one ligand 
coordinated.  Further ligand may coordinate to the active sites of the catalyst, 
blocking the coordination of substrate and therefore lowering the conversion. 
Table 16 – The variation of ligand/iron ratio. 
 L/Fe3(CO)12 conversiona (%) ee b (%) 
i 1/1 20 56 
ii 2/1 29 52 
iii 3/1 84 50 
iv 4/1 42 48 
acetophenone (0.3 mmol), Fe3(CO)12 (0.5 mol%), ligand 82, KOH 
(12 mol%), iPrOH (3 ml), 55 °C, 10 min. 
a Determined by 1H NMR. 
b Determined by chiral HPLC. 
Finally, PPh3 was added (Table 17) which did not have any effect on the 
conversion, but the ee was lowered slightly.  This may suggest that the reaction 
is homogeneous because PPh3 can be used as a poison which strongly binds 
to a metal, blocking substrate access.  However, further experiments must be 
conducted in order to distinguish homogenous from heterogeneous catalysis 
as there is no single definitive experiment for making this distinction.122 
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Table 17 – Investigating the effect of an additive. 
 additive conversiona (%) ee b (%) 
i PPh3 97 39 
ii - 98 55 
acetophenone (0.3 mmol), Fe3(CO)12 (0.5 mol%), ligand 82 (1.5 mol%), 
PPh3 (1.5 mol%), KOH (12 mol%), iPrOH (3 ml), 55 °C, 1 hour. 
a Determined by 1H NMR. 
b Determined by chiral HPLC. 
The isopropyl analogue of this ligand, PNNP ligand 86, was also tested in the 
hope that the bulkier isopropyl groups would improve the ee (Table 18).  
However, the conversion was only 1% when the optimised conditions for 
PNNP ligand 82 were used (entry i).  Increasing the temperature to 80 °C only 
increased the conversion to 4% (entry ii).  Leaving the reaction overnight (entry 
iii) gave 32% conversion but only 3% ee.  These results indicate that the 
formation of an active iron catalyst is highly sensitive to the steric property of 
the ligands.  
Table 18 – The ATH of acetophenone using PNNP ligand 86. 
 temperature (°C) time (h) conversiona (%) ee b (%) 
i 55 1 1 - 
ii 80 1 4 - 
iii 80 24 32 3 
acetophenone (0.3 mmol), Fe3(CO)12 (0.5 mol%), ligand 86 (1.5 mol%), KOH (12 mol%), 
iPrOH (3 ml). 
a Determined by 1H NMR. 
b Determined by chiral HPLC. 
 
4.5. Substrate scope of PNNP ligand 82 
Following the optimisation of the conditions for the ATH of acetophenone using 
PNNP ligand 82 (section 4.4), various substrates were reduced using the 
optimised conditions to demonstrate the substrate scope (Table 19). 
The first substrates were tried before the optimisation of the ligand/iron ratio 
(entries i-iii).  Increasing steric bulk of the substrate increases the ee but lowers 
the conversion.  A comparison of entry (i) and entry (iv) shows that increasing 
the ligand/iron ratio to 3/1 has little effect on the ee. 
From entry (v) lower ees were obtained using exactly the same conditions 
(compare entries v and i).  One reason for this could be that a new batch of 
ligand was used.  There was no difference in the NMR spectra, but there could 
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potentially be an undetectable impurity which could affect the ee.  It is unlikely 
that this batch of ligand had been racemised because this would result in a 
mixture of diastereoisomers which would be distinguishable by NMR.  Another 
reason for the decrease in ee could be that a new solution of KOH/iPrOH was 
made.  The KOH solutions were made by crushing a KOH pellet and then 
weighing it out into a glass vial.  During this time the KOH sometimes appeared 
to get wet.  The amount of water would differ depending on the humidity of the 
lab and the time taken to weigh it out.  Therefore, the amount of KOH used 
may have been different which would affect the ee (see Table 15).  
Table 19 – The ATH of different acetophenone type substrates. 
 substrate L/Fe3(CO)12 conversiona 
(%) 
ee b 
(%) 
notes 
i 
 
1/1 98 51  
ii 
 
1/1 89 57  
iii 
 
1/1 88 74  
iv 
 
3/1 98 55  
v 
 
1/1 98 40 
new batch of ligand from 
this row, giving lower ee 
(compare to row i) 
vi 
 
3/1 96 29 
slight overlap with an 
unknown peak in HPLC 
vii 
 
3/1 >99 68  
viii 
 
3/1 6 71  
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 substrate L/Fe3(CO)12 conversiona 
(%) 
ee b 
(%) 
notes 
ix 
 
3/1 >99 23 
enantiomers slightly 
overlap in HPLC 
x 
 
3/1 82 35  
xi 
 
3/1 98 58  
xii 
 
3/1 98 49 
a mixture of products was 
formed, including amine 
and alcohol 
xiii 
 
3/1 0 -  
substrate (0.3 mmol), Fe3(CO)12 (0.5 mol%), ligand 82, KOH (12 mol%), iPrOH (3 ml), 55 °C, 1 hour. 
a Determined by 1H NMR. 
b Determined by chiral HPLC. 
A methyl group in the para position (entry vi) appears to give lower ee 
compared to acetophenone (entry v), but there was a slight overlap of peaks 
in the HPLC so this may be misleading.  A methyl group in the ortho position 
(entry vii) gave full conversion, compared to only 64% conversion using 
macrocyclic ligand 23 from literature (in 2 hours at 75 °C),1 and a higher ee 
(68%) than acetophenone (40%, entry v).  A methyl group in both of the ortho 
positions (entry viii) decreased the conversion considerably (6%) but the ee 
was increased to 71%. 
An electron withdrawing group in the para position (entry ix) gave full 
conversion but lower ee.  Unfortunately, the peaks for enantiomers were 
slightly overlapping in the HPLC so the ee is only approximate.  The 
macrocyclic ligand 23 from literature required much longer reaction times for 
electron withdrawing groups in the para position (p-cyanoacetophenone 
needed 3 h to achieve full conversion).1 
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An electron donating group in the para position (entry x) gave a slightly lower 
conversion (82%) which is comparable to the macrocyclic ligand 23 from 
literature (86% conversion, 30 min, 75 °C).1  A similar ee is obtained (35%) in 
comparison to acetophenone (40%, entry v). 
The next substrate contained two extra methyl groups on the other side of the 
ketone (entry xi) which gave 98% conversion and higher ee (58%) than 
acetophenone.  The conversion is much better than macrocyclic ligand 23, 
which gave only 90% conversion after 12 h at 75 °C.1 
A couple of imine substrates were also tried (entries xii and xiii).  The 
phosphinyl imine (xii) gave a mixture of products including the expected amine 
product, but also some 1-phenylethanol resulting from hydrolysis of the imine 
before reduction.  The ratio between the amine and alcohol products in the 1H 
NMR spectrum of the crude product was 1:1.1.  The amine product was 
separated from the mixture in 20% isolated yield and the ee was 49%.  The 
benzyl imine (xiii) gave no product. 
 
4.6. Summary 
 
Figure 134 – The best ligands for the iron catalysed ATH. 
In summary, all of the ligands were tested for the AH and ATH of 
acetophenone.  All of them were unsuccessful for AH, but some worked for 
ATH (Figure 134).  The best ligands were macrocyclic ligand 37b, giving full 
37b 
82 
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conversion but low ee, and PNNP acyclic ligand 82 giving full conversion and 
moderate ee.  The conditions for ATH with PNNP ligand 82 were optimised, 
including reaction time, temperature, base, mol% base and ligand/iron ratio.  
Then a range of ketones and one imine were reduced, demonstrating the 
substrate scope. 
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Chapter 5. Conclusions and suggestions 
for future work 
A variety of new chiral macrocyclic ligands containing phosphorus and nitrogen 
donor atoms (Figure 135) have been synthesised by the condensation of a 
variety of chiral diamines with a selection of dialdehydes under high dilution 
conditions. 
 
Figure 135 – Macrocyclic ligands synthesised. 
The first synthetic route towards the chiral diamines was unsuccessful due to 
the difficulty in finding a suitable protecting group for the ortholithiation step; 
however, the second route via Grignard addition to a chiral sulfinamide worked 
37b 
37c 
37d 
37e 64 63 
37a 65 
Chapter 5. Conclusions and suggestions for future work 
106 
 
well.  The collection of macrocycles exhibits a selection of ring sizes from 16 
to 34 membered rings, denticity ranging from three to six, variations in the 
combination of donor groups (P2N2, P2N3, PN2, P2N4, N6), and a range of chiral 
groups (Me, Ph, p-tol and 3,2-dimethylphenyl, Cy). 
Eight acyclic ligands containing phosphorus and nitrogen donor atoms have 
also been made (Figure 136) with varying size, denticity and chiral groups 
(Me, iPr, Ph).  The PNNP ligands 82 and 86 were reacted with [Rh(COD)Cl]2 
and the NMR spectra show rhodium-phosphorus coupling which confirms 
complex formation. 
 
Figure 136 – Acyclic ligands synthesised. 
All of these ligands were tested for the iron catalysed AH and ATH of 
acetophenone.  Unfortunately, none of the ligands worked for the AH of 
acetophenone under the conditions examined, but some ligands did work for 
the ATH.  The best macrocyclic ligand was 37b (when used in a glovebox) 
which gave full conversion but low ee.  The PNNP acyclic ligand 82 has good 
activity, better than the macrocyclic ligand 23 in some cases,1 and gave the 
products with moderate ee (Figure 137). 
44 
81 82 
84 
83 
85 86 
87 
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Figure 137 – The best ligands for iron catalysed ATH. 
The conditions for the ATH of acetophenone were optimised for PNNP ligand 
82, including reaction time, temperature, base, mol% of base, and ligand/iron 
ratios. Once the optimum conditions were found, a variety of acetophenone 
type substrates were reduced to demonstrate the substrate scope, including 
one imine substrate.  
A comparison of the macrocyclic ligands tested for the iron catalysed ATH 
suggests that the phosphorus donor atoms are important for activity.  The 22-
membered macrocycle 23 from literature which has 2 phosphorus atoms gave 
98% conversion (entry xii) whereas the amino analogue 65 gave no conversion 
(entry vii).  Also, the macrocyclic ligands 37b, 37c and 37d which have 2 
phosphorus donors gave good conversions whereas 37e, where one of the 
phosphorus atoms is replaced with an NH, and 63, where one of the 
phosphorus atoms is removed, gave very low conversions. 
Suggestions for future work include the testing of different conditions for the 
ATH using the macrocyclic ligands 37b, 37c and 37d in a glovebox.  Firstly, 
shorter reaction times should be investigated to see if there is any racemisation 
due to reaction reversibility.  Then other conditions such as base, temperature, 
metal sources and ligand/iron ratio could be investigated. 
Also, different conditions for the in-situ formation of the catalyst should be 
investigated, such as time and temperature.   This may be especially important 
37b 
82 
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for PNNP ligand 86, because the complex formation with rhodium (Figure 127) 
was much slower than for PNNP ligand 82.  Some procedures in literature 
leave the ligand and metal stirring overnight before the addition of base and 
substrate.15, 37, 38 
The synthesis of well-defined iron complexes using the PNNP ligands 82 and 
86, similar to Morris’s group,41, 42, 45, 58 could help to understand the 
mechanism.  Mechanistic studies, for example, deuterium labelling studies or 
following the reaction by NMR, could be carried out. 
The use of different base metals, such as nickel, manganese, and cobalt could 
also be investigated for all ligands.  
Suggestions for other ligands to be made (Figure 138) would include PNNP 
ligand 113 which could be compared with PNNP ligands previously made 
where the phenyl groups are in between the nitrogens.36   Also, macrocyclic 
ligand 114 could be made, which is the macrocyclic version of the PNNP ligand 
82 and could be compared to the 22-membered macrocycle 23. 
 
Figure 138 – Suggestions for other ligands. 
  
114 
113 
Chapter 6. Experimental 
109 
 
Chapter 6. Experimental 
Chemicals were purchased from commercial suppliers and were used without 
further purification.  Solvents were dried using an MBraun SPS 5 800.  NMR 
spectra were recorded using a Bruker 400 MHz spectrometer at 298 K.  Me4Si 
was used as the internal standard, J values are recorded in Hz and chemical 
shifts are given in ppm.  Multiplicities are abbreviated as s (singlet), d (doublet), 
t (triplet), q (quartet), sept (septet), m (multiplet), br (broad).  Mass 
Spectrometry was performed using either Agilent QTOF 7200/6530B or 
Micromass LCT mass spectrometer.  CHN analysis was performed using a 
Thermo Flash Smart instrument and CHNS analysis was performed using an 
Elementar Vario Micro Cube instrument. Analytical TLC was performed with 
0.25 mm silica gel plates which were visualised under UV light or with iodine.  
A Cellulose-C column was used for chiral HPLC. 
 
 Synthesis of (S)-1,1,1-trimethyl-N-(1-
phenylethyl)silanamine 38 
Triethylamine (4.95 ml, 35.5 mmol, 3.5 eq.) was added to a 
solution of (S)-phenylethylamine 35a (1.29 ml, 10 mmol) in 
DCM (20 ml).  The mixture was cooled to 0 °C and 
trimethylsilyl chloride (3.96 ml, 31.2 mmol, 3.1 eq.) was added dropwise.  On 
addition, the solution turns from clear and colourless to cloudy and white.  This 
was allowed to warm to room temperature and was stirred overnight (16.5 h).  
The next day, the volatiles were removed under vacuum and the residue was 
extracted with hexane (5 x 10 ml).  The solvent was evaporated to give a yellow 
oil.  This was purified by vacuum distillation to give yellow oil 38 (0.81 g, 42%).  
1H NMR (400 MHz; CDCl3; Me4Si) -0.01 (9H, s, Si(CH3)3), 1.37 (3H, d, J = 6.6, 
CHCH3), 1.55 (1H, br s, NH), 4.04 (1H, m, CHCH3), 7.16-7.40 (5H, m, Ar-H);  
CAS number 121443-77-4. 
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 Synthesis of (S)-2,2,5,5-tetramethyl-1-(1-phenylethyl)-
1,2,5-azadisilolidine 4172 
A solution of 1,2-bis(chlorodimethylsilyl)ethane (2.16 g, 10 
mmol) in anhydrous DCM (3.75 ml) was added dropwise over 
25 minutes to a solution of (S)-phenylethylamine 35a (1.29 
ml, 10 mmol) in DCM (6.25 ml) containing triethylamine (2.79 ml, 20 mmol, 2 
eq.).  On addition, there was a very slight increase in temperature and the clear 
colourless solutions turned cloudy and white.  The mixture was stirred at room 
temperature under nitrogen for 2 hours and was then filtered through sintered 
glass.  A white solid was filtered off, but some still remained in the filtrate.  The 
solvent was evaporated and the residue was dissolved in petroleum ether (~ 
20 ml).  The mixture was filtered again and the solvent removed to give a pale-
yellow oil 41 (2.3 g, 87%).  1H NMR (400 MHz; CDCl3; Me4Si) -0.14 (6H, s, 
Si(CH3)2), 0.05 (6H, s, Si(CH3)2), 0.68 (4H, s, SiCH2CH2Si), 1.51 (3H, d, J = 
6.9, CH(CH3)), 4.34 (1H, q, J = 6.9, CH(CH3)), 7.15-7.36 (5H, m, Ar-H);  m/z 
(CI) 264.2 (M+H)+ (calculated: 264.2), 248.1 (M-CH3)+, 122.1 (M-
SiMe2CH2CH2SiMe2)+, 105.1 (M-NSiMe2CH2CH2SiMe2)+. 
 
 Synthesis of (S)-N,N-dimethyl-1-phenylethan-1-amine 
4376 
Formic acid (2.7 ml, 70.4 mmol, 3.5 eq.) and formaldehyde (35% 
aq., 3.7 ml, 50.3 mmol, 2.5 eq.) were added to (S)-
phenylethylamine 35a (2.6 ml, 20.1 mmol).  The mixture was 
heated to 90 °C and stirred for 24h.  The solution was then cooled to room 
temperature and 6 M HCl (7 ml, 2.1 eq.) was added.  The resulting mixture 
was extracted with ether (3 x 6 ml).  The aqueous layer was made basic using 
50% aq. NaOH solution (5 ml) and was extracted with ether (3 x 6 ml).  The 
organics were dried with MgSO4 and the solvent removed to give a yellow oil 
(2.04 g).  This was purified by column chromatography (EtOAc/hexane 20/80 
to 50/50) to give a slightly yellow oil 43 (1.58 g, 53%).  1H NMR (400 MHz; 
CDCl3; Me4Si) 1.37 (3H, d, J = 6.7, (CH3)CH), 2.20 (6H, s, (CH3)2N), 3.24 (1H, 
q, J = 6.7, CH(CH3)), 7.2-7.35 (5H, m, Ar-H);  m/z (CI) 172.1 (M+Na)+ 
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(calculated: 172.1), 171.1 (M+Na-H)+, 105.1 (M-N(CH3)2)+;  CAS number 
17279-31-1. 
 
 Synthesis of (1S,1'S)-1,1'-((phenylphosphanediyl)bis-
(2,1-phenylene))bis(N,N-dimethylethan-1-amine) 4473 
To a solution n-BuLi (2.5 M, 2.8 ml) in hexane (6.7 ml) in oven-
dried glassware under a nitrogen atmosphere were added ether 
(5 ml) and (S)-N,N-dimethyl-1-phenylethylamine 43 (1.1 ml, 6.7 
mmol).  The mixture was refluxed for 5h and then was cooled to 
-78 °C and a solution of dichlorophenylphosphine (0.51 ml, 2.85 
mmol, 0.425 eq.) in ether (3.4 ml) was added dropwise.  After stirring overnight, 
the solvent was evaporated and ethanol (0.5 ml) then water (5 ml) were added.  
The product was extracted with DCM (3 x 5 ml), then dried with MgSO4 and 
the solvent removed to give a thick yellow oil (1.37 g).  This was purified by 
column chromatography (90% hexane/EtOAc + 2% Et3N) to give a clear oil 44 
(0.60 g, 52%).  1H NMR (400 MHz; CDCl3; Me4Si) 1.04 (3H, d, J = 6.5, 
(CH3)CH), 1.16 (3H, d, J = 6.5, (CH3)CH), 2.14 (12H, s, 2x(CH3)2N), 3.98 (1H, 
quintet, J = 6.5, CH(CH3)), 4.11 (1H, quintet, J = 6.5, CH(CH3)), 6.82 (2H, m, 
Ar-H), 7.10 (2H, tdd, J = 7.5, 3.4, 1.2, Ar-H), 7.21 (2H, m, Ar-H), 7.28-7.38 (5H, 
m, Ar-H), 7.58 (2H, m, Ar-H);  31P{1H} NMR  (162 MHz; CDCl3) -29.4 (s);  m/z 
(CI) 405.2 (M+H)+ (calculated: 405.25), 360.2 (M-NMe2)+. 
 
 Synthesis of 2-(2-bromophenyl)-1,3-dioxolane 4983 
2-Bromobenzaldehyde (10 ml, 85.7 mmol) was dissolved in toluene 
(36 ml), and ethylene glycol (5.73 ml, 102.8 mmol) and p-
toluenesulfonic acid (91 mg, 0.48 mmol) were added.  The solution 
was refluxed in Dean-Stark apparatus (not under nitrogen) until 
water no longer condensed.  The mixture was then made slightly basic using 
ethanolic potassium hydroxide (1 M, ~0.7 ml), then diluted with toluene (40 ml), 
washed with water (50 ml), dried with potassium carbonate and concentrated 
to give a clear colourless oil 49 (19.4 g, 99%).  1H NMR (400 MHz; CDCl3; 
Me4Si) 4.1 (4H, m, OCH2CH2O), 6.1 (1H, s, Ar-CH), 7.2 (1H, dt, J = 1.8, 7.6, 
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Ar-H), 7.3 (1H, dt, J = 1.0, 7.5, Ar-H), 7.56 (1H, dd, J = 1.1, 8.0, Ar-H), 7.60 
(1H, dd, J = 1.8, 7.7, Ar-H);  m/z (CI) 229 (M+H)+ (calculated: 228.99), 231 
(M+H)+, 185 (M-OCH2CH2)+, 187 (M-OCH2CH2)+, 149.1 (M-Br)+, 73 (M-PhBr)+;  
CAS number 34824-58-3. 
 
 Synthesis of bis(2-(1,3-dioxolan-2-yl)phenyl)-
(phenyl)phosphane 5082 
2-(2-bromophenyl)-1,3-dioxolane 49 (19 g, 82.9 mmol) was 
dissolved in dry THF (225 ml) under a nitrogen atmosphere in an 
oven-dried round bottomed flask and cooled to -78 °C.  A solution 
of n-BuLi in hexane (2.5 M, 36.2 ml, 90.4 mmol 1.09 eq.) was 
added dropwise over 40 minutes.  The mixture was stirred for 2 
hours at -78 °C and then dichlorophenylphosphine (5.63 ml, 41.5 mmol, 0.5 
eq.) was added dropwise and the reaction mixture was stirred overnight at 
room temperature.  The next day, water was added cautiously (~28 ml) and 
the layers were separated and the aqueous phase was extracted with toluene 
(2 x 60 ml).  The organics were washed with water (160 ml) and dried with 
MgSO4, filtered and concentrated to give a yellow oil.  Recrystallisation using 
methanol gave white crystals 50 (12.3 g, 73%).  1H NMR (400 MHz; CDCl3; 
Me4Si) 4.0 (8H, m, CH2CH2), 6.37 (2H, d, JHP = 5.0, Ar-CH), 6.93 (2H, ddd, JHH 
= 1.1, 7.7, JHP = 4.5, Ar-H), 7.17-7.34 (7H, m, Ar-H), 7.39 (2H, td, J = 1.2, 7.7, 
Ar-H), 7.68 (2H, ddd, JHH = 1.0, 7.7, JHP = 4.1, Ar-H);  31P{1H} NMR (162 MHz; 
CDCl3) -26.2 (s);  13C{1H} NMR (100 MHz; CDCl3) 65.4 (s, CH2CH2), 101.7 (d, 
JCP = 24.1, CH-O), 126.6 (d, JCP = 5.9, Ar), 128.4 (m, Ar), 129.2 (d, JCP = 19.7, 
Ar), 133.9 (d, JCP = 19.9, Ar), 134.3 (s, Ar), 135.9 (d, JCP = 18.2, Ar), 136.6 (d, 
JCP = 9.9, Ar), 141.5 (d, JCP = 21.8, Ar);  m/z (CI) 407.1 (M+H)+ (calculated: 
407.14), 363.1 (M-OCH2CH2)+, 349.1 (M-OCH2CH2O)+, 259.1 (M-(Ar-
COCH2CH2O)+;  CHN C24H23O4P calculated: C 70.93, H 5.70, found: C 70.78, 
H 5.71;  IR νmax/cm-1 2890 (C-H), 1478 (C=C), 1087 (C-O). 
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 Synthesis of 2,2'-(phenylphosphanediyl)-
dibenzaldehyde 4582 
Bis(2-(1,3-dioxolan-2-yl)phenyl)-(phenyl)phosphane 50 (4.3 g, 
10.58 mmol) was dissolved in acetone (120 ml) under a nitrogen 
atmosphere and p-toluenesulfonic acid (0.44 g, 2.34 mmol, 0.22 
eq.) and water (0.38 ml, 21.16 mmol, 2 eq.) were added.  The 
mixture was refluxed for 70 minutes.  After allowing the reaction to cool to room 
temperature, water (30.2 ml) was added, and the acetone was removed on a 
rotary evaporator until yellow crystals formed.  These were filtered off, washed 
with water and dried (1.84 g, 55%).  1H NMR (400 MHz; CDCl3; Me4Si) 6.94 
(2H, ddd, J = 1.0, 4.5, 7.5, Ar-H), 7.22-7.32 (2H, m, Ar-H), 7.32-7.42 (3H, m, 
Ar-H), 7.45 (2H, td, J = 1.4, 7.5, Ar-H), 7.53 (2H, td, J = 1.1, 7.6, Ar-H), 8.00 
(2H, ddd, J = 1.3, 3.9, 7.6, Ar-H), 10.5 (2H, d, JHP = 5.5, H-C=O);  31P{1H} NMR 
(162 MHz; CDCl3) -16.2 (s);  13C{1H} NMR (100 MHz, CDCl3) 129.0 (d, J = 7.6, 
Ar), 129.2 (s, Ar), 129.5 (s, Ar), 131.5 (d, J = 4.3, Ar), 133.9 (d, J = 37.0, Ar), 
134.59 (d, J = 21.6, Ar), 135.3 (d, J = 10.0, Ar), 138.5 (d, J = 15.6, Ar), 140.4 
(d, J = 24.9, Ar), 191.7 (d, J = 18.3, CHO);  m/z (CI) 319.1 (M+H)+ (calculated: 
319.09), 291.1 ((M+H)-CO)+;  CHN C20H15O2P calculated: C 75.47, H 4.75, 
found: C 75.17, H 4.83. 
 
 Synthesis of N,N'-((1E,1'E)-((phenylphosphanediyl)-
bis(2,1-phenylene))bis(methanylylidene))bis(2-
methylpropane-2-sulfinamide) 46 
2,2'-(Phenylphosphanediyl)dibenzaldehyde 45 (1.7 g, 5.36 
mmol) and (R)-2-methylpropane-2-sulfinamide 55 (1.3 g, 
10.73 mmol, 2 eq.) were dissolved in dry THF (22 ml) under 
a nitrogen atmosphere in an oven-dried 2-necked round 
bottomed flask fitted with a condenser.  Titanium(IV) 
tetraisopropoxide (6.35 ml, 21.45 mmol, 4 eq.) was added and the reaction 
mixture stirred overnight at 50 °C.  The next day, the mixture was cooled to 
room temperature, diluted with ethyl acetate (25 ml) and poured into brine (70 
ml) with rapid stirring.  The resulting mixture, containing a white solid, was 
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filtered through Celite.  The filtrate was transferred to a separatory funnel and 
the organic layer was washed with an equal volume of brine.  The organic layer 
was dried with MgSO4, filtered and concentrated to give the crude product, a 
yellow solid.  This was purified by column chromatography (70% 
hexane/EtOAc) to give the product, a white-yellow solid 46 (2.03 g, 72%).  1H 
NMR (400 MHz; CDCl3; Me4Si) 0.99 (9H, s, C(CH3)3), 1.09 (9H, s, C(CH3)3), 
6.87 (2H, m, Ar-H), 7.18-7.52 (9H, m, Ar-H), 7.96 (2H, m, Ar-H) 8.95 (1H, d, 
JHP = 4.10, HC=N), 9.07 (1H, d, JHP = 5.13, HC=N);  31P{1H} NMR (162 MHz; 
CDCl3) -15.1 (s);  13C{1H} NMR (100 MHz, CDCl3), 22.2 (s, (CH3)3), 22.3 (s, 
(CH3)3), 57.3 (s, CH(CH3)3), 57.4 (s, CH(CH3)3), 128.8 (d, JCP = 7.5, Ar), 128.9 
(d, JCP = 4.6, Ar), 129.2 (s, Ar), 130.3 (d, JCP = 4.4, Ar), 131.5 (d, JCP = 3.9, Ar), 
131.6 (d, JCP = 14.6, Ar), 133.7 (s, Ar), 134.5 (s, Ar), 134.7 (s, Ar), 134.9 (s, 
Ar), 136.0 (d, JCP = 10.8, Ar), 136.9 (d, JCP = 18.3, Ar), 137.3 (d, JCP = 17.7, 
Ar), 138.9 (d, JCP = 24.7, Ar), 139.4 (d, JCP = 20.1, Ar), 161.5 (s, C=N), 161.7 
(s, C=N), 161.9 (s, C=N);  m/z (ES) 547.2 (M+Na)+ (calculated: 547.16), 525.2 
(M+H)+;  CHN C28H33N2O2PS2 calculated: C 64.10, H 6.34, N 5.34, found: C 
63.76, H 6.33, N 5.24;  IR νmax/cm-1 3053 (C-H imine), 2922 (C-H), 1594 (C=C), 
1574 (C=N), 1086 (S=O). 
 
 General method for Grignard addition to diimine 46 
A solution of the Grignard reagent in ether or THF (4 eq.) 
was added to a solution of the diimine 46 (1 eq.) in DCM 
(DCM:Grignard reagent ratio = 3:1) at -48 °C under a 
nitrogen atmosphere in oven-dried glassware.  The mixture 
was stirred at this temperature for 4 hours, then warmed to 
room temperature and stirred overnight.  The next day, aqueous NH4Cl was 
added dropwise and the mixture was diluted with ethyl acetate.  The aqueous 
layer was extracted with ethyl acetate (x2), and the combined organic layers 
were dried with Na2SO4, filtered and concentrated.  The crude product was 
purified by column chromatography (ethyl acetate/hexane) to give the pure 
products in good yields. 
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6.9.1. N,N'-((1S,1'S)-((phenylphosphanediyl)bis(2,1-
phenylene))bis(ethane-1,1-diyl))bis(2-methylpropane-2-sulfinamide) 47a 
Mixture of diastereoisomers, d.r. 17:83 (0.36 g, about 
70%).  31P{1H} NMR (162 MHz; CDCl3) -28.9 (s), -28.6 (s);  
m/z (ES) 579.2 (M+Na)+ (calculated: 579.22). 
 
6.9.2. N,N'-((1S,1'S)-((phenylphosphanediyl)bis(2,1-phenylene))-
bis(phenylmethylene))bis(2-methylpropane-2-sulfinamide) 47b 
Major diastereoisomer (theoretically (S,S)): 
(0.6 g, 46%)  1H NMR (400 MHz; CDCl3; Me4Si) 1.15 (9H, 
s, tBu), 1.22 (9H, s, tBu), 1.68 (2H, br s, NH), 3.59 (1H, d, J 
= 2.6, CH(Ph)NH), 3.85 (1H, d, J = 3.6, CH(Ph)NH), 6.39 
(1H, dd, JHH = 2.9, JHP = 8.1, Ar-H), 6.53 (1H, dd, JHH = 3.6, 
JHP = 8.3, Ar-H), 6.67 (1H, ddd, JHH = 0.8, 6.8, JHP = 4.1, Ar-
H), 6.88 (1H, ddd, JHH = 0.9, 6.9, JHP = 4.1, Ar-H), 6.92-7.24 (15H, m, Ar-H), 
7.31 (1H, td, J = 0.8, 7.6, Ar-H), 7.39 (1H, td, J = 0.7, 7.5, Ar-H), 7.64 (1H, dd, 
JHH = 7.5, JHP = 4.2, Ar-H), 7.68 (1H, dd, JHH = 7.3, JHP = 4.4, Ar-H);  31P{1H} 
NMR (162 MHz; CDCl3) -27.8 (s);  13C{1H} NMR (100 MHz, CDCl3) 22.6 (s, 
CH3), 22.8 (s, CH3), 55.9 (s, C(CH3)3), 56.1 (s, C(CH3)3), 59.3 (d, J = 10.5, 
CH(Ph)NH), 59.8 (d, J = 9.8, CH(Ph)NH), 127.2 (d, J = 5.6, Ar), 127.4 (s, Ar), 
127.7 (s, Ar), 128.1 (d, J = 5.6, Ar), 128.2 (m, Ar), 128.6 (s, Ar), 128.7 (d, J = 
4.9, Ar), 129.0 (s, Ar), 129.2 (s, Ar), 134.1 (s, Ar), 134.3 (m, Ar), 134.4 (s, Ar), 
134.6 (s, Ar), 135.0 (m, Ar), 135.7 (d, J = 15.2, Ar), 141.2 (s, Ar), 141.6 (s, Ar), 
145.8 (d, J = 23.8, Ar), 146.1 (d, J = 23.8, Ar);  m/z (ES) 703.2551 (M+Na)+ 
(calculated: 703.2558);  CHNS C40H45N2O2PS2 calculated: C 70.56, H 6.66, N 
4.11, S 9.42, found: C 70.23, H 6.72, N 3.96, S 9.11;  IR νmax/cm-1 3195 (N-H), 
2959 (C-H), 1600 (C=C),1062 (S=O). 
Other diastereoisomer (unknown configuration): 
(0.14 g, 11%)  1H NMR (400 MHz; CDCl3; Me4Si) 1.07 (9H, s, tBu), 1.16 (9H, 
s, tBu), 1.66 (2H, br s, NH), 3.99 (1H, s, CH(Ph)NH), 4.75 (1H, s, CH(Ph)NH), 
6.69 (2H, d, JHP =  9.5, Ar-H), 6.78-6.98 (4H, m, Ar-H), 7.03-7.25 (9H, m, Ar-
H), 7.29-7.37 (3H, m, Ar-H), 7.39 (1H, t, JHH = 7.6, Ar-H), 7.44 (2H, d, JHH = 
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7.5, Ar-H), 7.55 (1H, dd, JHH = 7.3, JHP = 4.6, Ar-H), 7.93 (1H, dd, JHH = 7.3, 
JHP = 4.8, Ar-H);  31P{1H} NMR (162 MHz; CDCl3) -30.0 (s);  13C{1H} NMR (100 
MHz, CDCl3) 22.7 (s, CH3), 22.8 (s, CH3), 55.9 (s, C(CH3)3), 56.0 (s, C(CH3)3), 
58.8 (d, J = 27.9, CH(Ph)NH), 60.6 (d, J = 29.2, CH(Ph)NH), 115.6 (s, Ar), 
119.5 (s, Ar), 127.3 (s, Ar), 127.6 (d, J = 22.8, Ar), 128.2 (d, J = 6.6, Ar), 128.3 
(m, Ar), 128.6 (s, Ar), 128.8 (d, J = 5.0, Ar), 129.2 (d, J = 5.0, Ar), 129.3 (s, Ar), 
129.6 (d, J = 6.6, Ar), 133.8 (m, Ar), 134.0 (s, Ar), 134.9 (m, Ar), 135.0 (d, J = 
13.1, Ar), 135.3 (d, J = 13.6, Ar), 141.0 (s, Ar), 141.2 (s, Ar), 146.8 (d, J = 23.9, 
Ar), 147.5 (d, J = 23.1, Ar);  m/z (ES) 703.2547 (M+Na)+ (calculated: 
703.2558);  CHNS C40H45N2O2PS2 calculated: C 70.56, H 6.66, N 4.11, S 9.42, 
found: C 70.02, H 6.65, N 3.79, S 8.89;  IR νmax/cm-1 3181 (N-H), 2978 (C-H), 
1591 (C=C), 1059 (S=O). 
6.9.3. N,N'-((1S,1'S)-((phenylphosphanediyl)bis(2,1-phenylene))bis(p-
tolylmethylene))bis(2-methylpropane-2-sulfinamide) 47c 
Major diastereoisomer (theoretically (S,S)): 
(0.74 g, 47%)  1H NMR (400 MHz; CDCl3; Me4Si) 1.15 (9H, 
s, tBu), 1.22 (9H, s, tBu), 1.66 (2H, br s, NH), 2.15 (3H, s, 
Ar-CH3), 2.20 (3H, s, Ar-CH3), 3.55 (1H, d, J = 2.5, 
CH(Ar)NH), 3.76 (1H, d, J = 3.4, CH(Ar)NH), 6.30 (1H, dd, 
J = 2.5, 7.6, Ar-H), 6.48 (1H, dd, J = 3.2, 8.1, Ar-H), 6.63 
(1H, dd, J = 4.1, 7.3, Ar-H), 6.75 (2H, d, J = 7.9, Ar-H), 6.81-
6.91 (4H, m, Ar-H), 6.91-7.04 (4H, m, Ar-H), 7.08-7.23 (4H, 
m, Ar-H), 7.30 (1H, t, J = 7.6, Ar-H), 7.38 (1H, t, J = 7.4, Ar-H) 7.66 (2H, m, Ar-
H);  31P{1H} NMR (162 MHz; CDCl3) -27.8 (s);  m/z (CI) 731 (M+Na)+ 
(calculated: 731.29);  CHNS C42H49N2O2PS2 calculated: C 71.16, H 6.97, N 
3.95, S 9.04, found: C 69.6, H 6.85, N 3.64, S 8.91;  IR νmax/cm-1 3214 (br N-
H), 2919 (C-H), 1511 (C=C), 1062 (S=O). 
Minor diastereoisomer (unknown configuration): 
(0.17 g, 11%)  1H NMR (400 MHz; CDCl3; Me4Si) 1.07 (9H, s, tBu), 1.16 (9H, 
s, tBu), 1.64 (2H, br s, NH), 2.19 (3H, s, Ar-CH3), 2.27 (3H, s, Ar-CH3), 3.95 
(1H, s, CH(Ar)NH), 4.67 (1H, s, CH(Ar)NH), 6.61 (2H, d, J = 9.1, Ar-H), 6.72 
(1H, d, J = 8.4, Ar-H), 6.91 (5H, m, Ar-H), 7.03 (2H, d, J = 7.8, Ar-H), 7.13 (4H, 
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m, Ar-H), 7.20 (2H, d, J = 7.8, Ar-H), 7.31 (2H, d, J = 7.8, Ar-H), 7.38 (1H, t, J 
= 7.3, Ar-H), 7.57 (1H, dd, J = 4.7, 7.16, Ar-H), 7.91 (1H, dd, J = 4.5, 7.16, Ar-
H);  31P{1H} NMR (162 MHz; CDCl3) -29.7 (s);  m/z (CI) 731 (M+Na)+ 
(calculated: 731.29);  CHNS C42H49N2O2PS2 calculated: C 71.16, H 6.97, N 
3.95, S 9.04, found: C 70.72, H 6.98, N 3.53, S 8.37;  IR νmax/cm-1 3193 (br N-
H), 2920 (C-H), 1512 (C=C), 1058 (S=O). 
6.9.4. N,N'-((1S,1'S)-((phenylphosphanediyl)bis(2,1-phenylene))bis((3,5-
dimethylphenyl)methylene))bis(2-methylpropane-2-sulfinamide) 47d 
Major diastereoisomer (theoretically (S,S)): 
(0.4 g, 54%)  1H NMR (400 MHz; CDCl3; Me4Si) 1.13 (9H, 
s, tBu), 1.26 (9H, s, tBu), 1.83 (2H, br s, NH), 2.03 (6H, s, 
Ar-CH3), 2.08 (6H, s, Ar-CH3), 3.59 (1H, d, JHP = 2.2, 
CH(Ar)NH), 3.97 (1H, d, JHP = 3.5, CH(Ar)NH), 6.52 (2H, m, 
Ar-H), 6.62 (4H, s, Ar-H), 6.70 (1H, s, Ar-H), 6.76 (1H, dd, 
JHH = 7.5, JHP = 3.9, Ar-H) 6.87 (1H, dd, JHH = 7.5, JHP = 4.0, 
Ar-H), 7.00 (1H, t, J = 7.4, Ar-H), 7.07 (2H, t, J = 7.5, Ar-H), 
7.16 (2H, m, Ar-H), 7.22 (1H, d, J = 7.3, Ar-H), 7.35 (2H, t, 
J = 7.5, Ar-H), 7.55 (1H, dd, J = 4.3, 7.6, Ar-H), 7.74 (1H, dd, J = 4.4, 7.6, Ar-
H);  31P{1H} NMR (162MHz; CDCl3) -28.4 (s);  m/z (ES) 759.3156 (M+Na)+ 
(calculated: 759.3184);  CHNS C44H53N2O2PS2 calculated: C 71.71, H 7.25, N 
3.80, S 8.70, found: C 70.91, H 7.31, N 3.57, S 8.29;  IR νmax/cm-1 3223 (N-H), 
3195 (C-H), 1601 (C=C), 1064 (S=O). 
Another diastereoisomer (unknown configuration): 
(0.19 g, 27%)  1H NMR (400 MHz; CDCl3; Me4Si) 1.03 (9H, s, tBu), 1.18 (9H, 
s, tBu), 1.63 (2H, br s, NH), 2.10 (6H, s, Ar-CH3), 2.23 (6H, s, Ar-CH3), 3.62 
(1H, br s, CH(Ar)NH), 4.96 (1H, br s, CH(Ar)NH), 6.57 (1H, d, JHP = 9.8, Ar-H), 
6.61 (1H, d, JHP = 10.0, Ar-H), 6.68 (1H, s, Ar-H), 6.83 (1H, s, Ar-H), 6.84-6.89 
(1H, m, Ar-H), 6.90 (2H, s, Ar-H), 7.03 (2H, t, JHH and JHP = 7.4, Ar-H), 7.07 
(2H, s, Ar-H), 7.13 (2H, td, JHH = 3.0, 7.2, Ar-H), 7.19 (2H, t, JHH = 6.8, Ar-H), 
7.31 (1H, t, JHH = 7.4, Ar-H), 7.38 (1H, t, JHH = 7.6, Ar-H), 7.54 (1H, dd, JHH = 
7.3, JHP = 4.6, Ar-H), 7.94 (1H, dd, JHH = 7.3, JHP = 4.6, Ar-H);  31P{1H} NMR 
(162 MHz; CDCl3) -29.8 (s);  m/z (ES) 759.3170 (M+Na)+ (calculated: 
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759.3184);  CHNS C44H53N2O2PS2 calculated: C 71.71, H 7.25, N 3.80, S 8.70, 
found: C 70.72, H 7.25, N 3.61, S 8.48;  IR νmax/cm-1 3196 (N-H), 2915 (C-H), 
1601 (C=C), 1060 (S=O). 
Minor diastereoisomer (unknown configuration): 
(0.013 g, 2%, not pure)  1H NMR (400 MHz; CDCl3; Me4Si) 1.07 (9H, s, tBu), 
1.15 (9H, s, tBu), 1.75 (2H, br s, NH), 1.98 (6H, s, Ar-CH3), 2.07 (6H, s, Ar-
CH3), 3.56 (1H, d, JHP = 2.5, CH(Ar)NH), 3.62 (1H, d, JHP = 3.0, CH(Ar)NH), 
6.18-7.73 (19H, m, Ar-H);  31P{1H} NMR (162MHz; CDCl3) -27.1 (s). 
 
 Synthesis of (1S,1'S)-((phenylphosphanediyl)bis(2,1-
phenylene))bis(phenylmethanamine) 36b 
N,N'-((1S,1'S)-((phenylphosphanediyl)bis(2,1-phenylene))bis-
(phenylmethylene))bis(2-methylpropane-2-sulfinamide) 47b 
(1.92 g, 2.81 mmol) was dissolved in THF (6.2 ml) under a 
nitrogen atmosphere and 4 M HCl (2.8 ml, 11.26 mmol, 4 eq.) 
was added.  The mixture was stirred at room temperature for 3 
days, then 1 M NaOH (~11.5 ml) was added to basify the mixture.  The product 
was extracted with ethyl acetate (3 x 30 ml) and washed with 1 M NaOH (30 
ml), then water (30 ml).  The organic layer was dried with MgSO4, filtered and 
concentrated to give the crude product (1.33 g).  This was purified by column 
chromatography to give the pure product, a white solid (0.99 g, 74%).  1H NMR 
(400 MHz; CDCl3; Me4Si) 1.25 (4H, s, NH), 5.88 (1H, d, JHP = 7.9, CH(Ph)NH2), 
6.06 (1H, d, JHP = 7.7, CH(Ph)NH2), 6.82 (1H, ddd, J = 0.7, 4.2, 7.5, Ar-H), 
6.93 (1H, ddd, J = 1.0, 4.1, 7.6, Ar-H), 7.01-7.42 (20H, m, Ar-H), 7.48 (1H, dd, 
J = 4.6, 7.4, Ar-H);  31P{1H} NMR (162 MHz; CDCl3) -26.7 (s);  13C{1H} NMR 
(100 MHz, CDCl3) 56.2 (d, J = 15.2, CH(NH2)), 56.5 (d, J = 15.7, CH(NH2)), 
126.6 (d, J = 14.6, Ar), 127.1 (d, J = 11.4, Ar), 127.2 (d, J = 18.4, Ar), 127.7 (d, 
J = 2.6, Ar), 127.8 (d, J = 2.4, Ar), 128.1 (d, J = 10.6, Ar), 128.6 (d, J = 7.0, Ar), 
128.9 (s, Ar), 129.6 (d, J = 15.8, Ar), 134.1 (d, J = 5.7, Ar), 134.2 (d, J = 12.2, 
Ar), 134.3 (d, J = 20.1, Ar), 134.9 (d, J = 12.7, Ar), 136.1 (d, J = 9.6, Ar), 144.6 
(d, J = 12.2, Ar), 150.0 (d, J = 2.2, Ar), 150.3 (d, J = 1.5, Ar);  m/z (ES) 473.2 
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(M+H)+ (calculated: 473.2), 472.2 (M+), 471.2 (M-H), 456.2 (M-NH2);  CHN 
C32H29N2P calculated: C 81.33, H 6.19, N 5.93, found: C 80.68, H 6.17, N 5.83. 
 
 Synthesis of (1S,1'S)-((phenylphosphanediyl)bis(2,1-
phenylene))bis(p-tolylmethanamine) 36c 
N,N'-((1S,1'S)-((phenylphosphanediyl)bis(2,1-phenylene))bis(p-
tolylmethylene))bis(2-methylpropane-2-sulfinamide) 47c (0.74 
g, 1.04 mmol) was dissolved in a mixture of THF (2.3 ml) and 
DCM (4.3 ml) under a nitrogen atmosphere.  4 M HCl (1.04 ml, 
4.18 mmol, 4 eq.) was added and the reaction was stirred at 
room temperature for 3 days.  1 M NaOH (6.2 ml) was added to 
basify the mixture which was then extracted with ethyl acetate 
(3 x 16 ml).  The organics were washed with 1 M NaOH (16 ml) 
and then water (16 ml).  The organic solution was dried with 
MgSO4, filtered and the solvent was removed under reduced pressure to give 
the crude product (0.47 g).  This was purified by column chromatography (10% 
MeOH/DCM) to give the pure product, a white solid 36c (0.38 g, 73%).  1H 
NMR (400 MHz, CDCl3, Me4Si) 2.18 (3H, s, CH3), 2.25 (3H, s, CH3), 5.79 (1H, 
d, JHP = 7.9, CH(Ar)NH2), 6.01 (1H, d, JHP = 7.4, CH(Ar)NH2), 6.79 (1H, dd, JHH 
= 7.7, JHP = 4.3, Ar-H), 6.94 (5H, m, Ar-H), 7.04 (1H, t, JHH = 7.5, Ar-H), 7.08-
7.37 (12H, m, Ar-H), 7.39 (1H, dd, JHH = 7.4, JHP = 4.4, Ar-H), 7.51 (1H, dd, 
JHH = 7.6, JHP = 4.4, Ar-H);  31P{1H} NMR (162 MHz, CDCl3) -26.7 (s);  13C{1H} 
NMR (100 MHz, CDCl3) 20.9 (s, CH3), 21.0 (s, CH3), 56.0 (d, J = 25.4, 
CH(Ar)NH2), 56.2 (d, J = 25.9, CH(Ar)NH2), 126.9 (d, J = 1.2, Ar), 127.0 (s, 
Ar), 127.1 (d, J = 1.1, Ar), 127.3 (s, Ar), 127.6 (d, J = 5.1, Ar), 127.7 (d, J = 5.1, 
Ar), 128.6 (d, J = 6.9, Ar), 128.8 (d, J = 11.9, Ar), 129.6 (d, J = 26.6, Ar), 134.0 
(s, Ar), 134.2 (d, J = 4.0, Ar), 134.4 (s, Ar), 134.5 (s, Ar), 134.9 (d, J = 13.1, 
Ar), 136.0 (s, Ar), 136.2 (d, J = 9.5, Ar), 136.3 (s, Ar), 141.6 (d, J = 17.8, Ar), 
150.1 (d, J = 5.8, Ar), 150.3 (d, J = 6.3, Ar);  m/z (CI) 501.2 (M+H)+ (calculated: 
501.2), 485.2 (M-NH2)+, 484.2 (M-CH3)+, 468.2 (M-(2xNH2))+;  CHN C34H33N2P 
calculated: C 81.57, H 6.64, N 5.60, found: C 81.34, H 6.79, N 5.37;   
IR νmax/cm-1 3360 (br N-H), 3282 (br N-H), 2856-3050 (C-H), 1584 (C=C), 1177 
(C-N);  [α]D = -42.3° (c 1.42, DCM). 
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 Synthesis of (1S,1'S)-((phenylphosphanediyl)bis(2,1-
phenylene))bis((3,5-dimethylphenyl)methanamine) 36d 
N,N'-((1S,1'S)-((phenylphosphanediyl)bis(2,1-phenylene))bis((3,5 
-dimethylphenyl)methylene))bis(2-methylpropane-2-sulfinamide) 
47d (0.82 g, 1.11 mmol) was dissolved in THF (2.4 ml) under a 
nitrogen atmosphere.  4 M HCl (1.1 ml, 4.45 mmol, 4 eq.) was 
added and the mixture was stirred at room temperature for 3 days.  
1 M NaOH (6.5 ml) was added to basify the mixture, which was 
then extracted with ethyl acetate (3 x 20 ml).  The organics were 
washed with 1 M NaOH (20 ml) and water (20 ml) and then dried 
with MgSO4.  This was filtered off and the solvent was removed under reduced 
pressure to produce the crude product (0.55 g).  This was purified by column 
chromatography (10% MeOH/DCM) to give the pure product, an off-white solid 
36d (0.41 g, 70%).  1H NMR (400 MHz, CDCl3, Me4Si) 2.11 (6H, s, CH3), 2.12 
(6H, s, CH3), 5.96 (1H, d, JHP = 8.6, CH(Ar)NH2), 6.02 (1H, d, JHP = 8.1, 
CH(Ar)NH2), 6.70 (2H, s, Ar-H), 6.72 (2H, s, Ar-H), 6.79 (2H, s, Ar-H), 6.85 
(1H, dd, JHH = 7.5, JHP = 4.2, Ar-H), 6.92 (1H, dd, JHH = 7.6, JHP = 4.2, Ar-H), 
7.06 (1H, t, JHH = 7.4, Ar-H), 7.15 (1H, t, JHH = 7.4, Ar-H), 7.21 (2H, m, Ar-H), 
7.27-7.37 (5H, m, Ar-H), 7.48 (2H, td, JHH = 8.8, JHP = 4.7, Ar-H);  31P{1H} NMR 
(162 MHz, CDCl3) -27.8 (s);  13C{1H} NMR (100 MHz, CDCl3) 21.2 (CH3), 21.3 
(CH3), 56.0 (d, J = 11.5, CH(NH2)), 56.2 (d, J = 11.8, CH(NH2)), 124.9 (d, J = 
2.1, Ar), 126.9 (s, Ar), 127.2 (s, Ar), 127.7 (d, J = 5.1, Ar), 127.9 (d, J = 4.6, 
Ar), 128.2 (s, Ar), 128.3 (s, Ar), 128.5 (d, J = 7.1, Ar), 128.7 (s, Ar), 129.7 (s, 
Ar), 134.0 (d, J = 11.3, Ar), 134.3 (s, Ar), 134.4 (d, J = 25.3, Ar), 135.0 (d, J = 
12.7, Ar), 136.1 (d, J = 8.9, Ar), 137.5 (d, J = 13.6, Ar), 144.3 (d, J = 18.5, Ar), 
150.5 (s, Ar);  m/z (ES) 529.2765 (M+H)+ (calculated: 529.2773);  CHN 
C36H37N2P calculated: C 81.79, H 7.05, N 5.30, found: C 80.82, H 7.13, N 4.98. 
 
 General method for cyclisation 
The diamine (1 eq.) and sodium sulfate (13 eq.) were placed in a 2-necked 
flask fitted with a condenser.  Degassed chloroform (dried with molecular 
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sieves overnight) was added so that the concentration of the diamine was 
0.002 M.  This mixture was heated to 50 °C and a solution of the dialdehyde 
(1 eq., 0.023 M in chloroform) was added dropwise via a dropping funnel over 
8-10 hours.  After the addition, the reaction was stirred for 48 hours, then 
cooled to room temperature, filtered and concentrated to give the crude 
product. 
6.13.1. (3Z,5S,9S,10Z,14Z,16S,20S,21Z)-5,7,9,16,18,20-hexaphenyl-
4,10,15,21-tetraaza-7,18-diphospha-1,2,12,13(1,3),6,8,17,19(1,2)-
octabenzenacyclodocosaphane-3,10,14,21-tetraene 58a 
(0.09 g, 30%)  1H NMR (400 MHz, CDCl3, 
Me4Si) 6.23 (2H, d, JHP = 7.6, CH(Ph)N), 
6.67 (2H, d, JHP = 8.0, CH(Ph)N), 6.82 
(2H, dd, JHH = 7.0, JHP = 3.6, Ar-H), 6.86 
(2H, dd, JHH = 7.2, JHP = 4.0, Ar-H), 6.93 
(2H, t, JHH = 7.2, Ar-H), 7.00 (2H, d, JHH = 
7.6, Ar-H), 7.05-7.11 (4H, m, Ar-H), 7.16 
(4H, t, JHH = 7.6, Ar-H), 7.24 (2H, m, Ar-H), 7.36 (20H, m, Ar-H), 7.55 (10H, m, 
Ar-H), 7.71 (4H, m, Ar-H), 8.06 (2H, d, JHH = 8.0, Ar-H), 8.18 (2H, dd, JHH = 
7.2, JHP = 4.0, Ar-H), 8.28 (2H, s, N=CH);  31P{1H} NMR (162 MHz, CDCl3)  
-23.1 (s);  m/z (ES) 1293.5142 (M+H)+ (calculated: 1293.5154). 
6.13.2. (10S,11E,22E,24S)-5,10,17,24-tetraphenyl-5,10,17,24-
tetrahydrotetrabenzo[c,f,k,n][1,9]diaza[5,13]diphosphacyclohexa-decine 
58c 
(1.22 g, 96%) 1H NMR (400 MHz; CDCl3; Me4Si) 6.06 
(1H, d, JHP = 7.1, CH(Ph)N), 6.54 (1H, d, JHP = 5.1, 
CH(Ph)N), 6.87-7.70 (34H, m, Ar-H), 8.16 (1H, m, Ar-H), 
8.42 (1H, m, Ar-H), 9.54 (1H, d, JHP = 4.1, HC=N), 10.27 
(1H, d, JHP = 7.8, HC=N);  31P{1H} NMR (162 MHz; 
CDCl3) -30.81 (1P, d, J = 8.9), -24.81 (1P, d, J = 8.9);  m/z (ES) 755.274 (M+H)+ 
(calculated: 755.2745);  CHN C52H40N2P2 calculated: C 82.74, H 5.34, N 3.71, 
found: C 79.92, H 5.51, N 3.51. 
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6.13.3. (10S,11E,22E,24S)-5,17-diphenyl-10,24-di-p-tolyl-5,10,17,24-
tetrahydrotetrabenzo[c,f,k,n][1,9]diaza[5,13]diphosphacyclohexa-decine 
58e 
(0.37 g, quantitative) 1H NMR (400 MHz, CDCl3, Me4Si) 
2.20 (3H, s, CH3), 2.25 (3H, s, CH3), 6.01 (1H, d, JHP = 
7.0, CH(Ar)N), 6.49 (1H, d, JHP = 5.1, CH(Ar)N), 6.80 
(2H, m, Ar-H), 6.87 (3H, m, Ar-H), 6.98 (4H, m, Ar-H), 
7.13 (5H, m, Ar-H), 7.33 (13H, m, Ar-H), 7.44 (3H, m, Ar-
H), 7.52 (1H, dd, JHH = 7.7, JHP = 4.2, Ar-H), 7.60 (2H, br 
s, Ar-H), 8.15 (1H, m, Ar-H), 8.41 (1H, m, Ar-H), 9.51 
(1H, d, JHP = 4.0, HC=N), 10.24 (1H, d, JHP = 7.9, HC=N);  
31P{1H} NMR (162 MHz, CDCl3) -30.77 (1P, d, J = 9.4), -
25.66 (1P, d, J = 9.4);  13C{1H} NMR (100 MHz, CDCl3) 19.9 (s, CH3), 20.0 (s, 
CH3), 73.5 (d, J = 19.5, CH(Ar)N), 73.8 (d, J = 17.4, CH(Ar)N), 126.0 (s, Ar), 
126.2 (m. Ar), 126.4 (s, Ar), 127.4 (s, Ar), 127.6 (m, Ar), 127.8 (m, Ar), 128.2 
(d, J = 11.5, Ar), 128.7 (s, Ar), 129.0 (m, Ar), 129.2 (d, J = 5.2, Ar), 129.4 (s, 
Ar), 129.9 (s, Ar), 130.5 (s, Ar), 132.6 (d, J = 19.1, Ar), 132.9 (s, Ar), 133.2 (d, 
J = 10.7, Ar), 133.4 (s, Ar), 133.6 (d, J = 14.5, Ar), 134.3 (s, Ar), 134.4 (s, Ar), 
134.5 (m, Ar), 134.9 (s, Ar), 135.0 (s, Ar), 135.1 (s, Ar), 135.2 (d, J = 2.9, Ar), 
135.4 (s, Ar), 136.0 (d, J = 3.8, Ar), 137.4 (d, J = 19.7, Ar), 139.1 (d, J = 20.5, 
Ar), 139.5 (s, Ar), 139.8 (d, J = 22.1, Ar), 140.3 (s, Ar), 146.1 (d, J = 7.9, Ar), 
146.3 (d, J = 7.6, Ar), 158.7 (dd, J = 3.5, J = 25.3, C=N), 160.0 (dd, J = 4.5, J 
= 35.2, C=N);  m/z (ES) 783.3072 (M+H)+ (calculated: 703.3058);  CHN 
C54H44N2P2 calculated: C 82.84, H 5.67, N 3.58, found: C 77.63, H 5.60, N 
3.13. 
6.13.4. (10S,11E,22E,24S)-10,24-bis(3,5-dimethylphenyl)-5,17-
diphenyl-5,10,17,24-
tetrahydrotetrabenzo[c,f,k,n][1,9]diaza[5,13]-
diphosphacyclohexadecine 
(0.37 g, quantitative) 1H NMR (400 MHz, CDCl3, Me4Si) 
2.11 (6H, s, 2 x CH3), 2.15 (6H, s, 2 x CH3), 5.96 (1H, d, 
JHP = 6.9, CH(Ar)N), 6.53 (2H, s, Ar-H), 6.57 (1H, d, JHP 
= 6.0, CH(Ar)N), 6.64 (2H, s, Ar-H), 6.68 (1H, s, Ar-H), 
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6.75 (1H, s, Ar-H), 6.92 (1H, m, Ar-H), 7.08-7.19 (4H, m, Ar-H), 7.29-7.42 (12H, 
m, Ar-H), 7.46 (4H, m, Ar-H), 7.61 (3H, m, Ar-H), 8.16 (1H, m, Ar-H), 8.46 (1H, 
m, Ar-H), 9.48 (1H, d, JHP = 4.0, HC=N), 10.29 (1H, d, JHP = 8.2, HC=N);  
31P{1H} NMR (162 MHz, CDCl3) -31.24 (1P, d, J = 8.2),  
-24.45 (1P, d, J = 8.2);  13C{1H} NMR (100 MHz, CDCl3) 21.3 (s, CH3), 21.3 (s, 
CH3), 75.2 (d, J = 13.2, CH(Ar)N), 75.4 (d, J = 14.1, CH(Ar)N), 124.9 (s, Ar), 
125.3 (s, Ar), 127.1 (s, Ar), 127.2 (m, Ar), 127.4 (s, Ar), 128.1 (s, Ar), 128.5-
128.9 (m, Ar), 129.2 (d, J = 14.7, Ar), 129.8 (s, Ar), 130.0 (m, Ar), 130.2 (d, J 
= 5.0, Ar), 130.5 (s, Ar), 130.9 (s, Ar), 131.5 (s, Ar), 133.5 (s, Ar), 133.7 (m, 
Ar), 134.2 (m, Ar), 134.5 (m, Ar), 134.7 (s, Ar), 135.1 (d, J = 11.1, Ar), 135.7 
(s, Ar), 135.9 (s, Ar), 136.1 (s, Ar), 136.3 (d, J = 6.8, Ar), 136.4 (s, Ar), 137.1 
(s, Ar), 137.5 (s, Ar), 143.2 (s, Ar), 144.2 (s, Ar), 147.0 (d, J = 22.3, Ar), 147.5 
(d, J = 22.3, Ar), 159.7 (dd, J = 2.7, J = 26.7, C=N), 160.9 (dd, J = 3.8, J = 
36.0, C=N);  m/z (ES) 811.3369 (M+H)+ (calculated: 811.3371);  CHN 
C56H48N2P2 calculated: C 82.94, H 5.97, N 3.45, found: C 79.87, H 6.11, N 
2.98. 
6.13.5. (10E,12S,22S,23E)-12,17,22-triphenyl-5,12,17,22-
tetrahydrotetrabenzo[c,f,k,n][1,5,9]triaza[13]phosphacyclohexa-decine 
58d 
(0.34 g, quantitative) 1H NMR (400 MHz, CDCl3, Me4Si) 
6.55 (1H, s, CH(Ph)N), 6.71 (1H, d, J = 9.4, CH(Ph)N), 
6.79 (1H, t, J = 7.2, Ar-H), 6.84 (1H, m, Ar-H), 6.88-6.95 
(3H, m, Ar-H), 6.98 (2H, d, J = 7.2, Ar-H), 7.06-7.53 (22H, 
m, Ar-H), 7.59 (1H, d, J = 8.0, Ar-H), 8.01 (1H, d, J = 7.7, 
Ar-H), 8.31 (1H, s, HC=N), 9.10 (1H, s, HC=N),  12.23 (1H, s, NH);  31P{1H} 
NMR (162 MHz, CDCl3) -15.4 (s);  13C{1H} NMR (100 MHz, CDCl3) 73.0 (s, 
CH(Ph)N), 73.2 (s, CH(Ph)N), 111.8 (s, Ar), 116.8 (s, Ar), 118.6 (s, Ar), 123.6 
(s, Ar), 126.3 (s, Ar), 127.0 (m, Ar), 127.4 (s, Ar), 127.9 (m, Ar), 128.2 (s, Ar), 
128.7 (s, Ar), 128.9 (d, J = 7.7, Ar), 129.6 (s, Ar), 130.3 (s, Ar), 130.5 (s, Ar), 
130.7 (s, Ar), 130.8 (d, J = 4.6, Ar), 131.3 (s, Ar), 131.4 (d, J = 5.1, Ar), 132.4 
(s, Ar), 134.2 (s, Ar), 136.1 (d, J = 22.1, Ar), 137.5 (d, J = 21.1, Ar), 140.7 (s, 
Ar), 141.1 (s, Ar), 144.5 (s, Ar), 146.2 (s, Ar), 160.6 (d, J = 2.8, C=N), 164.6 (s, 
C=N);  m/z (ES) 662.2728 (M+H)+ (calculated: 662.2725). 
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6.13.6. (3S,4E,9E,11S)-3,7,11-triphenyl-4,10-diaza-7-phospha-
1,2(1,3),6,8(1,2)-tetrabenzenacycloundecaphane-4,9-diene 71 
1H NMR (400 MHz, CDCl3, Me4Si) 5.63 (1H, s, C-
H(Ph)N),  5.98 (1H, s, CH(Ph)N), 6.80 (1H, dd, J = 7.3, J 
= 3.8, Ar-H), 6.93 (1H, dd, J = 7.6, J = 3.4, Ar-H), 6.96-
7.62 (26H, m, Ar-H), 7.85 (2H, m, Ar-H), 8.29 (1H, s, Ar-
H), 8.85 (1H, s, HC=N), 9.14 (1H, d, J = 2.2, HC=N);  
31P{1H} NMR (162 MHz, CDCl3) -18.1 (s);  m/z 647.3 (M+H)+ (calculated: 
647.26). 
6.13.7. (10S,11E,22E,24S)-10,24-dimethyl-17-phenyl-5,10,17,24-
tetrahydrotetrabenzo[c,f,k,n][1,5,9]triaza[13]phosphacyclohexa-decine 
79 
(0.094 g, quantitative) Note: the 1H NMR spectrum for 
this compound was too impure to assign the peaks.  
31P{1H} NMR (162 MHz, CDCl3) -24.3 (s). 
 
 General procedure for the reduction of the imine 
macrocycles 
Sodium borohydride (52 eq.) was put into an oven-dried 2-necked round 
bottomed flask fitted with a condenser under nitrogen.  To this was added a 
solution of the imine macrocycle in DCM (0.066 M) at 0 °C.  An equal volume 
of methanol was added slowly and this mixture was stirred for 4 hours at 0 °C, 
and then heated to 40 °C for 24 hours.  The reaction mixture was allowed to 
cool to room temperature and water was added slowly.  The mixture was 
extracted with ethyl acetate (x 5), washed with water and brine, dried with 
Na2SO4 and concentrated to give the crude product.  This was purified by 
column chromatography to give the pure product. 
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6.14.1. (5S,9S,16S,20S)-5,7,9,16,18,20-hexaphenyl-4,10,15,21-
tetraaza-7,18-diphospha-1,2,12,13(1,3),6,8,17,19(1,2)-
octabenzenacyclodocosaphane 37a 
(0.11 g, 22%) 1H NMR (400 MHz; CDCl3, 
Me4Si) 3.05 (2H, d, JHH = 12.6, CH2), 3.40 
(2H, d, JHH = 12.6, CH2), 3.48 (2H, d, JHH 
= 13.0, CH2), 3.57 (2H, d, JHH = 13.0, 
CH2), 5.69 (2H, d, JHP = 8.4, CH(Ph)NH), 
5.89 (2H, d, JHP = 8.0, CH(Ph)NH), 6.76 
(2H, dd, JHH = 7.5, JHP = 4.2, Ar-H), 6.84 
(2H, dd, JHH = 7.7, JHP = 3.8, Ar-H), 6.92 (2H, s, Ar-H), 6.97-7.48 (52H, m, Ar-
H), 7.53 (2H, dd, JHH = 7.8, JHP = 4.2, Ar-H), 7.92 (2H, dd, JHH = 7.6, JHP = 4.4, 
Ar-H);  31P{1H} NMR (162 MHz; CDCl3) -26.62 (s);  13C{1H} NMR (100 MHz, 
CDCl3) 52.4 (s, CH2), 52.8 (s, CH2), 63.5 (d, J = 24.6, CH(Ph)NH), 64.4 (d, J = 
24.6, CH(Ph)NH), 125.7 (m, Ar), 126.7 (m, Ar), 126.9 (s, Ar), 127.1 (m, Ar), 
127.4 (s, Ar), 127.7 (s, Ar), 127.9 (s, Ar), 128.0 (s, Ar), 128.2 (d, J = 10.8, Ar), 
128.6 (m, Ar), 128.8 (s, Ar), 129.4 (s, Ar), 129.8 (s, Ar), 134.1 (d, J = 17.4, Ar), 
134.6 (d, J = 20.3, Ar), 135.4 (d, J = 12.8, Ar), 136.1 (d, J = 10.5, Ar), 141.0 
(m, Ar), 143.1 (d, J = 15.1, Ar), 148.0 (d, J = 23.7, Ar), 148.3 (d, J = 23.1, Ar);  
m/z (ES) 1301.5769 (M+H)+ (calculated:1301.5780);  CHN C92H78N4P2 
calculated: C 84.90, H 6.04, N 4.30, found: C 83.28, H 6.23, N 4.13. 
6.14.2. (10S,24S)-5,10,17,24-tetraphenyl-5,10,11,12,17,22,23,24-
octahydrotetrabenzo[c,f,k,n][1,9]diaza[5,13]diphosphacyclohexa-decine 
37b 
(0.67 g, 69%) 1H NMR (400 MHz; CDCl3; Me4Si) 3.42 
(1H, d, JHH = 11.0, CH(H)NH), 3.49 (1H, d, JHH = 11.4, 
CH(H)NH), 4.14 (1H, dd, JHH = 11.4, JHP = 3.8, 
CH(H)NH), 4.50 (1H, dd, JHH = 11.0, JHP = 5.7, 
CH(H)NH), 5.49 (1H, d, JHP = 5.7, CH(Ph)NH), 5.66 (1H, 
d, JHP = 4.8, CH(Ph)NH), 6.75 (1H, dd, JHH = 6.8, JHP = 3.8, Ar-H) 6.79 (1H, 
dd, JHH = 7.5, JHP = 3.8, Ar-H), 6.88 (1H, dd, JHH = 6.8, JHP = 3.8, Ar-H), 7.00 
(1H, dd, JHH 6.5, JHP = 3.8, Ar-H), 7.03-7.64 (32H, m, Ar-H);  31P{1H} NMR (162 
MHz; CDCl3; Me4Si) -26.8 (1P, d, J = 66.5), -23.4 (1P, d, J = 66.5);  13C{1H} 
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NMR (100 MHz, CDCl3) 51.9 (d, J = 17.9, CH2), 52.2 (s, J = 15.7, CH2), 65.1 
(d, J = 12.2, CH(Ph)NH), 65.3 (d, J = 14.5, CH(Ph)NH), 126.9 (d, J = 1.4, Ar), 
127.6 (s, Ar), 127.7 (s, Ar), 127.8 (s, Ar), 128.2 (d, J = 3.9, Ar), 128.4 (d, J = 
10.3, Ar), 128.6 (m, Ar), 128.9 (d, J = 6.7, Ar), 129.3 (s, Ar), 129.4 (s, Ar), 129.5 
(d, J = 4.4, Ar), 129.6 (s, Ar), 129.8 (d, J = 4.6, Ar), 131.0 (dd, J = 4.9, J = 9.5, 
Ar), 133.5 (m, Ar), 133.9 (s, Ar), 134.2 (d, J = 14.2, Ar), 134.8 (d, J = 14.8, Ar), 
135.0 (s, Ar), 135.2 (s, Ar), 135.7 (d, J = 11.9, Ar), 136.2 (d, J = 13.1, Ar), 136.5 
(d, J = 5.9, Ar), 136.6 (d, J = 3.0, Ar), 136.8 (d, J = 10.7, Ar), 141.5 (d, J = 8.9, 
Ar), 143.9 (d, J = 25.5, Ar), 144.4 (d, J = 26.7, Ar), 147.5 (d, J = 23.2, Ar), 147.9 
(d, J = 23.7, Ar);  m/z (ES) 759.3066 (M+H)+ (calculated:759.3058);  CHN 
C52H44N2P2 calculated: C 82.30, H 5.84, N 3.69, found: C 81.34, H 5.93, N 
3.62. 
6.14.3. (12S,22S)-12,17,22-triphenyl-5,10,11,12,17,22,23,24-
octahydrotetrabenzo[c,f,k,n][1,5,9]triaza[13]phosphacyclohexa-decine 
37e 
(0.15 g, 51%) 1H NMR (400MHz, CDCl3, Me4Si) 3.60 
(2H, d, J = 12.2, CH2), 3.78 (1H, d, J = 11.9, CH(H)NH), 
4.01 (1H, d, J = 12.2, CH(H)NH), 5.18 (1H, d, J = 4.3, 
CH(Ph)NH), 5.25 (1H, s, CH(Ph)NH), 6.49 (1H, d, J = 
7.3, Ar-H), 6.66 (3H, m, Ar-H), 6.79 (2H, m, Ar-H), 6.91 
(3H, m, Ar-H), 6.99-7.19 (5H, m, Ar-H), 7.20-7.43 (17H, m, Ar-H), 7.54 (1H, d, 
J = 7.9, Ar-H), 8.07 (1H, s, Ar(NH)Ar);  31P{1H} NMR (162 MHz, CDCl3) -18.1 
(s);  13C{1H} NMR (100 MHz, CDCl3) 49.4 (s, CH2), 51.2 (s, CH2), 60.5 (d, J = 
19.0, CH(Ph)NH), 65.4 (d, J = 12.7, CH(Ph)NH), 114.7 (s, Ar), 119.2 (s, Ar), 
121.3 (d, J = 26.8, Ar), 126.4 (s, Ar), 126.9 (s, Ar), 127.2 (s, Ar), 127.3 (s, Ar), 
127.7 (s, Ar), 127.9 (s, Ar), 128.2 (d, J = 1.5, Ar), 128.3 (s, Ar), 128.5 (d, J = 
5.0, Ar), 128.7 (d, J = 8.1, Ar), 128.9 (d, Ar), 129.2 (d, J = 5.0, Ar), 129.4 (m, 
Ar), 129.5 (s, Ar), 131.3 (s, Ar), 131.6 (s, Ar), 132.4 (s, Ar), 133.7 (s, Ar), 135.3 
(m, Ar), 137.1 (d, J = 12.5, Ar), 139.8 (s, Ar), 141.0 (s, Ar), 143.1 (s, Ar), 143.6 
(s, Ar), 146.6 (d, J = 22.9, Ar), 147.0 (d, J = 21.5, Ar);  m/z (ES) 666.3030 
(M+H)+ (calculated:666.3038);  CHN C46H40N3P calculated: C 82.98, H 6.06, 
N 6.31, found: C 82.24, H 6.13, N 6.04. 
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6.14.4. (10S,24S)-5,17-diphenyl-10,24-di-p-tolyl-
5,10,11,12,17,22,23,24-octahydrotetrabenzo[c,f,k,n][1,9]diaza[5,13]-
diphosphacyclohexadecine 37c 
(0.21 g, 72%) 1H NMR (400 MHz, CDCl3, Me4Si) 2.28 
(3H, s, CH3), 2.29 (3H, s, CH3), 3.40 (1H, d, JHH = 11.4, 
CH(H)NH), 3.48 (1H, d, JHH = 11.3, CH(H)NH), 4.12 (1H, 
m, CH(H)NH), 4.46 (1H, dd, JHH = 11.1, JHP = 5.4, 
CH(H)NH), 5.45 (1H, d, JHP = 5.6, CH(Ar)NH), 5.64 (1H, 
d, JHP = 4.8, CH(Ar)NH), 6.73 (1H, dd, JHH = 7.3, JHP = 
3.4, Ar-H), 6.79 (1H, dd, JHH = 7.6, JHP = 3.0, Ar-H), 6.86 
(1H, dd, JHH = 7.5, JHP = 3.8, Ar-H), 6.98 (1H, dd, JHH = 
7.3, JHP = 3.1, Ar-H), 7.01-7.25 (18H, m, Ar-H), 7.27-7.36 
(5H, m, Ar-H), 7.40-7.61 (7H, m, Ar-H);  31P{1H} NMR (162 MHz, CDCl3) -26.66 
(1P, d, J = 67.0), -23.29 (1P, d, J = 67.0);  13C{1H} NMR (100 MHz, CDCl3) 
21.1 (m, CH3), 52.1 (dd, J = 13.8, J = 23.0, CH2), 64.9 (dd, J = 16.5, J = 22.4, 
CH(Ar)NH), 127.5 (Ar), 127.6 (s, Ar), 128.1 (d, J = 6.1, Ar), 128.5 (m, Ar), 
128.7-129.5 (m, Ar), 129.6 (s, Ar), 129.7 (d, J = 4.7, Ar), 131.0 (dd, J = 5.0, J 
= 9.8, Ar), 133.5 (m, Ar), 133.9 (s, Ar), 134.1 (d, J = 7.2, Ar), 134.7 (d, J = 15.2, 
Ar), 135.0 (m, Ar), 135.0 (m, Ar), 135.7 (s, Ar), 135.8 (s, Ar), 136.0 (s, Ar), 
136.2 (s, Ar), 136.4 (s, Ar), 136.4 (s, Ar), 136.5 (s, Ar), 136.7 (s, Ar), 136.9 (d, 
J = 10.8, Ar), 138.4 (d, J = 8.8, Ar), 144.2 (dd, J = 27.1, J = 44.7, Ar), 147.9 
(dd, J = 23.6, J = 36.5, Ar);  m/z (ES) 787.3367 (M+H)+ (calculated: 787.3371);  
CHN C54H48N2P2 calculated: C 82.42, H 6.15, N 3.56, found: C 81.50, H 6.15, 
N 3.39. 
6.14.5. (10S,24S)-10,24-bis(3,5-dimethylphenyl)-5,17-diphenyl-
5,10,11,12,17,22,23,24-octahydrotetrabenzo[c,f,k,n][1,9]diaza[5,13]-
diphosphacyclohexadecine 37d 
(0.13 g, 39%) 1H NMR (400 MHz, CDCl3, Me4Si) 2.20 
(12H, s, CH3), 3.44 (1H, d, JHH = 11.4, CH(H)NH), 3.53 
(1H, d, JHH = 11.4, CH(H)NH), 4.10 (1H, dd, JHH = 11.0, 
JHP = 4.3, CH(H)NH), 4.44 (1H, dd, JHH = 11.0, JHP = 5.5, 
CH(H)NH), 5.42 (1H, d, JHP = 6.0, CH(Ar)NH), 5.70 (1H, 
d, JHP = 6.2, CH(Ar)NH), 6.71-6.82 (8H, m, Ar-H), 6.88 
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(1H, dd, JHH = 7.6, JHP = 3.9, Ar-H), 7.00-7.35 (16H, m, Ar-H), 7.41-7.61 (7H, 
m, Ar-H);  31P{1H} NMR (162 MHz, CDCl3) -26.62 (1P, d, J = 65.0), -23.26 (1P, 
d, J = 65.0);  13C{1H} NMR (100 MHz, CDCl3) 21.4 (m CH3), 52.2 (dd, J = 10.4, 
J = 23.2, CH2), 65.2 (dd, J = 14.6, J = 22.7, CH(Ar)NH), 125.9 (d, J = 6.8, Ar), 
127.4 (s, Ar), 127.6 (m, Ar), 128.5 (m, Ar), 128.9 (m, Ar), 129.3 (m, Ar), 129.5 
(d, J = 4.2, Ar), 129.7 (m, Ar), 130.9 (m, Ar), 133.5 (s, Ar), 133.7 (d, J = 14.3, 
Ar), 133.9 (d, J = 7.2, Ar), 134.1 (s, Ar), 134.9 (d, J = 15.2, Ar), 135.3 (s, Ar), 
135.5 (s, Ar), 135.8 (d, J = 12.6, Ar), 136.2 (d, J = 12.8, Ar), 136.5 (d, J = 14.9, 
Ar), 136.8 (dd, J = 12.4, J = 21.6, Ar), 137.4 (s, Ar), 137.6 (d, J = 7.1, Ar), 141.4 
(d, J = 15.6, Ar), 144.2 (dd, J = 26.6, J = 41.2, Ar), 147.9 (dd, J = 7.8, J = 24.5, 
Ar);  m/z (ES) 815.3678 (M+H)+ (calculated: 815.3684);  CHN C56H52N2P2 
calculated: C 82.53, H 6.43, N 3.44, found: C 81.56, H 6.47, N 3.25. 
6.14.6. (3S,11S)-3,7,11-triphenyl-4,10-diaza-7-phospha-
1,2(1,3),6,8(1,2)-tetrabenzenacycloundecaphane 63 
(0.14 g, 50%) 1H NMR (400 MHz, CDCl3, Me4Si) 3.75  
(1H, d, JHH = 12.6, CH(H)NH), 3.84 (1H, d, JHH = 13.6, 
CH(H)NH), 4.15 (1H, d, JHH = 13.6, CH(H)NH), 4.27 (1H, 
dd, JHH = 12.4, JHP = 3.3, CH(H)NH), 4.93 (1H, s, 
CH(Ph)NH), 5.05 (1H, s, CH(Ph)NH), 6.86 (1H, dd, JHH 
= 7.5, JHP = 4.6, Ar-H), 6.89-7.00 (3H, m, Ar-H), 7.09-7.17 (4H, m, Ar-H), 7.19-
7.24 (6H, m, Ar-H), 7.26-7.37 (9H, m, Ar-H), 7.40-7.49 (3H, m, Ar-H), 7.50-
7.59 (3H, m, Ar-H), 8.14 (1H, s, Ar-H), 8.48 (1H, s, Ar-H);  31P{1H} NMR (162 
MHz, CDCl3) -23.1 (s);  13C{1H} NMR (100 MHz, CDCl3) 50.7 (d, J = 19.6, CH2), 
51.6 (d, J = 18.5, CH2), 65.7 (s, CH(Ph)NH), 67.0(s, CH(Ph)NH), 125.0 (d, J = 
2.7, Ar), 125.9 (d, J = 5.5, Ar), 126.4 (s, Ar), 127.0 (d, J = 10.9, Ar), 127.2 (d, 
J = 8.7, Ar), 127.5 (s, Ar), 127.7 (s, Ar), 128.4 (d, J = 12.8, Ar), 128.5 (m, Ar), 
128.8 (d, J = 4.3, Ar), 129.0 (s, Ar), 129.7 (d, J = 4.8, Ar), 133.8 (d, J = 20.9, 
Ar), 134.5 (d, J = 14.3, Ar), 136.0 (d, J = 15.8, Ar), 136.6 (d, J = 15.4, Ar), 137.2 
(d, J = 9.5, Ar), 140.9 (d, J = 19.5, Ar), 143.5 (s, Ar), 143.9 (d, J = 8.6, Ar), 
144.1 (d, J = 9.5, Ar), 144.3 (d, J = 6.8, Ar), 144.7 (s, Ar), 145.0 (s, Ar);  m/z 
(ES) 651.2923 (M+H)+ (calculated: 651.2929). 
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6.14.7. (10S,24S)-10,24-dimethyl-17-phenyl-5,10,11,12,17,22,23,24-
octahydrotetrabenzo[c,f,k,n][1,5,9]triaza[13]phosphacyclohexa-decine 
64 
(0.042 g, 42%) 1H NMR (400 MHz, CDCl3, Me4Si) 1.09 
(3H, d, J = 6.3, CH3), 1.49 (3H, d, J = 6.7, CH3), 3.55 (1H, 
d, J = 12.1, CH(H)NH, 3.63 (1H, dd, J = 11.6, J = 1.7, 
CH(H)NH), 3.90 (1H, dd, J = 11.5, J = 2.7, CH(H)NH), 
3.99 (1H, q, J = 6.7, CH(CH3)), 4.07 (1H, q, J = 6.3, 
CH(CH3)), 4.17 (1H, dd, J = 12.1, J = 4.6, CH(H)NH), 6.72 (1H, dd, J = 7.5, J 
= 4.2, Ar-H), 6.82-6.97 (5H, m, Ar-H), 7.06-7.43 (15H, m, Ar-H), 8.80 (1H, s, 
ArNHAr);  31P{1H} NMR (162 MHz, CDCl3) -24.33 (s);  13C{1H} NMR (100 MHz, 
CDCl3) 20.1 (s, CH3), 20.2 (s, CH3), 50.6 (d, J = 22.9, CH2), 52.2 (d, J = 17.5, 
CH2), 53.6 (s, CH(Me)NH), 59.5 (s, CH(Me)NH), 116.8 (s, Ar), 119.8 (s, Ar), 
120.2 (s, Ar), 127.2 (d, J = 5.2, Ar), 127.6 (s, Ar), 127.7 (s, Ar), 128.4 (d, J = 
7.4, Ar), 128.8 (s, Ar), 129.0 (s, Ar), 129.3 (s, Ar), 129.5 (s, Ar), 129.6 (d, J = 
4.8, Ar), 130.7 (d, J = 4.3, Ar), 131.9 (s, Ar), 132.0 (s, Ar), 133.3 (s, Ar), 133.8 
(s, Ar), 134.5 (d, J = 21.2, Ar), 136.5 (m, Ar), 142.2 (s, Ar), 143.2 (s, Ar);  m/z 
(ES) 542.2707 (M+H)+ (calculated: 542.2725);  CHN C36H36N3P calculated: C 
79.83, H 6.70, N 7.76, found: C 78.38, H 6.68, N 7.05. 
6.14.8. (11aR,15aR,28aR,32aR)-
5,10,11,11a,12,13,14,15,15a,16,17,22,27,28,28a,29,30,31,32,32a,33,34-
docosahydrohexabenzo[b,f,i,m,q,t][1,4,8,12,15,19]hexaazacyclodocosin
e 65 
(0.058 g, 90%) 1H NMR (400 MHz, CDCl3, Me4Si) 
1.08 (5H, m, Cy), 1.17 (4H, m, Cy), 1.66 (5H, d, J = 
6.8, Cy), 2.07 (2H, br s, Cy), 2.26 (4H, br s, Cy), 
3.51 (4H, d, J = 11.7, 2 x CH2Ar), 3.74 (4H, d, J = 
11.7, 2 x CH2Ar), 6.75 (4H, t, J = 7.4, Ar-H), 7.08 
(4H, d, J = 7.3, Ar-H), 7.12 (4H, t, J = 7.3, Ar-H), 
7.33 (4H, d, J = 8.0, Ar-H), 8.35 (2H, s, ArNHAr);  
13C{1H} NMR (100 MHz, CDCl3) 25.2 (CH2CH2), 33.1 (CH2CHNH), 50.6 
(ArCH2NH), 62.5 (CHNH), 116.6 (Ar), 119.5 (Ar), 127.9 (Ar), 128.5 (Ar), 130.4 
(Ar), 143.3 (Ar);  m/z (ES) 615.4171 (M+H)+ (calculated: 615.4175);  CHN 
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C40H50N6 calculated: C 78.14, H 8.20, N 13.67, found: C 77.08, H 8.41, N 
12.70. 
 
 Synthesis of [1,1'-biphenyl]-3,3'-dicarbaldehyde 59 
To a degassed mixture of water (120 ml) and THF (300 ml) under 
nitrogen was added 3-bromobenzaldehyde 66 (4.44 g, 24.1 mmol), 
3-formylphenylboronic acid 67 (5.4 g, 35.9 mmol), potassium 
carbonate (6 g) and Pd(PPh3)4 (0.6 g, 2 mol%).  The mixture was 
heated to 80 °C for 62 hours.  The THF was removed on a rotary evaporator 
and the aqueous solution was extracted with DCM (3 x 120 ml).  The organic 
layers were dried with MgSO4, filtered and concentrated to give the crude 
product, a pale-yellow solid.  This was purified by column chromatography 
(100% DCM) to give a white solid 59 (4.57 g, 91%).  1H NMR (400 MHz, CDCl3, 
Me4Si) 7.67 (2H, t, J = 7.7 Hz, Ar-H), 7.92 (4H, dd, J = 7.5, 4.5 Hz, Ar-H), 8.15 
(2H, s, Ar-H), 10.12 (2H, s, CHO);  13C{1H} NMR (100 MHz, CDCl3) 128.00 
(Ar), 129.46 (Ar), 129.79 (Ar), 132.98 (Ar), 137.11 (Ar), 140.71 (Ar), 192.00 
(CHO). 
 
 Synthesis of (R,R)-N,N'-((1E,1'E)-[1,1'-biphenyl]-3,3'-
diylbis(methaneylylidene))bis(2-methylpropane-2-
sulfinamide) 68 
Dialdehyde 59 (2.1 g, 10 mmol) was dissolved in THF (30 
ml) in an oven-dried flask under nitrogen.  Ti(OiPr)4 (12 ml, 
40 mmol) was added and the resulting solution was stirred 
for 10 minutes. A solution of (R)-t-butanesulfinamide (2.42 
g, 20 mmol) in THF (10 ml) was added and the mixture was 
stirred at 50 °C for 18 h. The reaction was quenched with brine and filtered 
through Celite. The filtrate was washed with brine, and the organics were dried 
over anhydrous Na2SO4, filtered and concentrated.  The crude product was 
purified by column chromatography (30% EtOAc, 70% petroleum ether) to give 
68 (2.46 g, 60%) as a white solid.  1H NMR (400 MHz, CDCl3, Me4Si) 1.28 
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(18H, s, 6 x CH3), 7.60 (2H, t, J = 8.0, Ar-H), 7.78 (2H, d, J = 8.0, Ar-H), 7.87 
(2H, d, J = 7.6, Ar-H), 8.11 (2H, s, Ar-H), 8.67 (2H, s, 2 x HC=N);  13C{1H} NMR 
(100 MHz, CDCl3) 22.7 (CH3), 57.9 (CH(CH3)3), 127.7 (Ar), 129.0 (Ar), 129.6 
(Ar), 131.1 (Ar), 141.0 (Ar), 162.5 (C=N);  m/z 439.1 (M+Na)+ (calculated: 
439.1). 
 
 Synthesis of (R,R)-N,N'-((1S,1'S)-[1,1'-biphenyl]-3,3'-
diylbis(phenylmethylene))bis(2-methylpropane-2-sulfinamide) 
69 
A solution of 68 (1.95 g, 4.68 mmol) in DCM (13.7 ml) in an 
oven-dried round bottomed flask under nitrogen was cooled 
to -48 °C and PhMgBr (15 ml, 3.0 M/Et2O, 15.44 mmol) was 
added over 20 minutes.  The mixture was stirred at this 
temperature for 50 minutes and was allowed to warm to 
room temperature overnight.  The reaction was quenched with saturated 
ammonium chloride and extracted with EtOAc (x 2). The combined organics 
were dried over anhydrous Na2SO4, filtered, and concentrated.  The residue 
was purified by column chromatography (100%EtOAc) to give 69 (0.6 g, 18%).  
1H NMR (400 MHz, CDCl3, Me4Si) 1.28 (18H, s, 6 x CH3), 3.73 (2H, d, J = 2.2, 
NH), 5.70 (2H, d, J = 2.2, CH(Ph)NH), 7.23-7.28 (2H, m, Ar-H), 7.33 (4H, t, J 
= 7.7, Ar-H), 7.37- 7.48 (10H, m, Ar-H), 7.60 (2H, s, Ar-H);  13C{1H} NMR (100 
MHz, CDCl3) 22.7 (CH3), 53.4 (C(CH3)3), 55.9 (CH(Ph)), 62.2 (CH(Ph)), 126.5 
(Ar), 126.7 (Ar), 126.9 (Ar), 127.3 (Ar), 128.9 (Ar), 129.1 (Ar), 141.2 (Ar), 141.8 
(Ar), 142.6 (Ar);  m/z 573.3 (M+H)+ (calculated: 573.26). 
 
 Synthesis of (1S,1'S)-[1,1'-biphenyl]-3,3'-
diylbis(phenylmethan-amine) 70 
To a solution of 69 (0.6 g, 1 mmol) in THF (6.6 ml) was added a 
solution of HCl in 1,4-dioxane (4 M, 2.1 ml, 8.4 mmol) at room 
temperature. The resulting mixture was then stirred at room 
temperature for 72 h. The precipitate was filtered and washed 
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with diethyl ether to give the white HCl salt. To this salt was added dropwise a 
2 M K2CO3 solution until the mixture reached pH 11. The mixture was extracted 
with ethyl acetate and the combined organics were washed with brine, dried 
over Na2SO4, filtered, and the solvent removed to give 70 (0.2 g, 52%).  1H 
NMR (400 MHz, CDCl3, Me4Si) 5.27 (2H, s, 2 x CH(Ph)NH2), 7.23 (2H, m, Ar-
H), 7.29-7.45 (14H, m, Ar-H), 7.60 (2H, s, Ar-H);  13C{1H} NMR (100 MHz, 
CDCl3) 59.84 (CH(Ph)NH), 125.80 (Ar), 125.92 (Ar), 126.93 (Ar), 127.01 (Ar), 
128.52 (Ar), 128.88 (Ar), 141.40 (Ar), 145.48 (Ar), 146.10 (Ar);  m/z 364.2 (M+) 
(calculated: 364.2). 
 
 Synthesis of (R,R)-N,N'-((1E,1'E)-(azanediylbis(2,1-
phenylene))-bis(methaneylylidene))bis(2-methylpropane-2-
sulfinamide) 76 
Dialdehyde 61 (0.29 g, 1.3 mmol) and sulfinamide 55 (0.35 
g, 2.86 mmol) were dissolved in THF (5.2 ml) in an oven-
dried round bottomed flask under nitrogen.  Ti(OiPr)4 (1.5 
ml, 5.2 mmol) was added and the mixture was heated to 50 
°C overnight.  Next day, the mixture was cooled to room 
temperature and diluted with ethyl acetate (5.2 ml).  The mixture was poured 
into brine (15 ml) with rapid stirring, and then filtered through Celite.  The filtrate 
was washed with brine, dried with MgSO4, filtered and concentrated to give the 
crude product as a thick yellow oil.  This was purified by column 
chromatography (70% hexane/ethyl acetate) to give the pure product 76 as a 
thick yellow oil which slowly solidifies (0.43 g, 76%).  1H NMR (400 MHz, 
CDCl3, Me4Si) 1.16 (18H, s, 6 x CH3), 7.05 (2H, td, J = 1.0, J = 7.4, Ar-H), 7.39 
(2H, td, J = 1.4, J = 7.8, Ar-H), 7.54 (2H, d, J = 8.2, Ar-H), 7.66 (2H, dd, J = 
1.5, J = 7.6, Ar-H), 8.67 (2H, 2 x HC=N), 10.79 (1H, s, NH);  13C{1H} NMR (100 
MHz, CDCl3) 22.41 (CH3), 57.69 (C(CH3)3), 118.52 (Ar), 121.20 (Ar), 121.94 
(Ar), 132.93 (Ar), 134.85 (Ar), 143.22 (Ar), 162.25 (C=N);  m/z (ES) 432.1785 
(M+H)+ (calculated: 432.1779). 
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 Synthesis of (R,R)-N,N'-((1S,1'S)-(azanediylbis(2,1-
phenylene))-bis(ethane-1,1-diyl))bis(2-methylpropane-2-
sulfinamide) 77 
The chiral diimine 76 (0.12 g, 0.28 mmol) was dissolved in 
dry DCM (2.2 ml) in an oven-dried round bottomed flask 
under nitrogen.  The solution was cooled to -48 °C and 
methylmagnesium bromide (0.37 ml, 3 M/ether, 1.1 mmol) 
was added dropwise over 10 minutes, during which time the 
solution turned from clear yellow to red.  This was stirred for 4 hours at -48 °C, 
then left at room temperature overnight.  The next day, aqueous ammonium 
chloride (1.5 ml) was added slowly, during which time the mixture became 
warm.  Ethyl acetate (approx. 2 ml) was added and the layers were separated.  
The aqueous layer was extracted with ethyl acetate (2 x 3 ml) and the organics 
were dried with Na2SO4, filtered and concentrated to give the crude product.  
This was purified by column chromatography (70% ethyl acetate/petroleum 
ether + 2% Et3N) to give the pure product 77 as a thick orange oil (0.09 g, 
69%).  1H NMR (400 MHz, CDCl3, Me4Si) 1.20 (18H, s, CH(CH3)3), 1.60 (6H, 
d, J = 6.8, CH(CH3)NH), 3.75 (2H, d, J = 3.3, NH), 4.82 (2H, dq, J = 3.6, J = 
6.7, CH(CH3)NH), 6.56 (1H, s, ArNHAr), 6.93 (2H, dd, J = 0.8, J = 8.0, Ar-H), 
6.98 (2H, dt, J = 1.0, J = 7.5, Ar-H), 7.17 (2H, dt, J = 1.5, J = 7.9, Ar-H), 7.34 
(2H, dd, J = 1.4, J = 7.7, Ar-H);  m/z (ES) 486.2232 (M+Na)+ (calculated: 
486.2225). 
 
 Synthesis of bis(2-((S)-1-aminoethyl)phenyl)amine 78 
The disulfinamide 77 (0.16 g, 0.34 mmol) was dissolved in THF 
(2.3 ml) and a solution of HCl in dioxane (1.35 ml, 2 M, 8 eq.) 
was added slowly.  The mixture was stirred for 3 days at room 
temperature and then the white precipitate was filtered off and 
washed with ether.  This was then dissolved in water (5 ml) and 
a 2 M solution of potassium carbonate was added until the mixture became pH 
10.  The product was extracted with ethyl acetate (5 x 5 ml) and the organics 
were washed with water and brine, dried with Na2SO4, filtered and the solvent 
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removed to give a light orange-brown oil 78 (0.055 g, 62%).  1H NMR (400 
MHz, CDCl3, Me4Si) 1.47 (6H, d, J = 6.5, CH3), 4.33 (2H, q, J = 6.2, 
CH(CH3)NH), 6.88 (2H, t, J = 7.3, Ar-H), 7.13 (2H, t, J = 7.6, Ar-H), 7.22 (2H, 
d, J = 8.1, Ar-H), 7.29 (2H, d, J = 7.6, Ar-H), 8.88 (1H, br s, ArNHAr);  m/z (ES) 
256.1809 (M+H)+ (calculated: 256.1814). 
 
 Synthesis of (S)-1-[2-(diphenylphosphino)phenyl]-
ethylamine 81 
(S)-Phenylethylamine 35a (1.26 ml, 10 mmol) was dissolved in 
dry ether (10 ml) in an oven-dried round bottomed flask under 
nitrogen.  The solution was cooled to -35 °C (using a 
MeOH/H2O/dry ice bath), and n-butyllithium (2.5 M in hexanes, 4 ml, 10 mmol) 
was added dropwise with stirring.  On addition of n-BuLi, the solution turned 
from clear and colourless to cloudy and white.  After the solution was stirred at 
-35 °C for 20 minutes, Me3SiCl (1.39 ml, 11 mmol) was added slowly.  After 
stirring at -35 °C for 1 hour, more n-BuLi (2.5 M in hexanes, 12 ml, 30 mmol) 
was added dropwise, during which time the reaction mixture turned slightly 
yellow.  This was then left to stir for 3 hours at -35 °C, then warmed to room 
temperature and left to stir overnight.  The next day, the yellow solution was 
cooled to -35 °C and a solution of ClPPh2 (1.8 ml, 10 mmol) in dry ether (10 
ml) was added dropwise over 45 minutes.  The solution was stirred for 3 hours 
at -35 °C and then warmed to room temperature and stirred for 4 hours.  1 M 
HCl was added slowly until the reaction mixture became clear.  During the 
addition of HCl, the mixture became slightly warm.  The layers were separated 
and the aqueous layer was extracted with ether (4 x 10 ml).  The organic layers 
were combined, dried with Na2SO4 and concentrated using a rotary evaporator 
to give the crude product as an orange oil (3.6 g).  This was purified by column 
chromatography (hexane/EtOAc, 8/1 to 1/1, with 1-2% triethylamine) to give 
the product 81, a white solid (0.9768 g, 32%).  1H NMR (400 MHz; CDCl3; 
Me4Si) 1.24 (3H, d, J = 6.2, CH(CH3)NH2), 1.48 (2H, br s, NH2), 4.90 (1H, m, 
J = 6.6, CH(CH3)NH2), 6.84 (1H, ddd, J = 1.2, 4.4, 7.6, Ar-H), 7.13 (1H, td, J = 
1.2, 7.4, Ar-H), 7.20 – 7.42 (11H, m, Ar-H), 7.60 (1H, ddd, J = 1.0, 4.2, 7.7, Ar-
H); 31P{1H} NMR (162 MHz; CDCl3) -16.44 (s); m/z (CI) 306.14 (M+H)+ 
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(calculated: 306.14), 289.1 (M-NH3)+, 228.1 (M-Ph)+, 187.1 (M-
PhCH(CH3)NH2)+. 
 
 Synthesis of (R)-N-(2-(diphenylphosphaneyl)-
benzylidene)-2-methylpropane-2-sulfinamide 89 
2-(diphenylphosphaneyl)benzaldehyde 88 (2 g, 6.89 mmol) 
and sulfinamide 55 (0.84 g, 6.89 mmol) were dissolved in 
THF (28 ml) to form a yellow solution.  Titanium 
isopropoxide (4.1 ml, 13.78 mmol, 2 eq.) was added which turned the solution 
orange.  The mixture was heated to 50 °C and was left to stir overnight.  The 
next day, the mixture was cooled to room temperature and diluted with ethyl 
acetate (20 ml).  Then the mixture was poured into brine (40 ml) with rapid 
stirring.  The mixture was filtered through Celite, removing a white solid.  The 
filtrate was washed with brine, dried with MgSO4, filtered and the solvent 
removed to give the crude product as a thick orange oil (2.6 g).  This was 
purified by column chromatography (85% hexane/ethyl acetate) to give the 
pure product 89 as a thick yellow oil (1.85 g, 68%).  1H NMR (400 MHz, CDCl3, 
Me4Si) 1.08 (9H, s, CH3), 6.96 (1H, dd, JHH = 7.5, JHP = 4.3, Ar-H), 7.20-7.27 
(4H, m, Ar-H), 7.28-7.39 (7H, m, Ar-H), 7.45 (1H, t, J = 7.6, Ar-H), 7.98 (1H, 
dd, JHH = 7.0, JHP = 3.2, Ar-H), 9.12 (1H, d, JHP = 4.7, HC=N);  31P{1H} NMR 
(162 MHz, CDCl3) -12.3. 
 
 Synthesis of (R)-N-((S)-1-(2-(diphenylphosphaneyl)-
phenyl)-2-methylpropyl)-2-methylpropane-2-sulfinamide 90 
The chiral imine 89 (0.3 g, 0.76 mmol) was dissolved in dry 
DCM (6 ml) in an oven-dried round bottomed under 
nitrogen.  The solution was cooled to -48 °C and 
isopropylmagnesium bromide (0.52 ml, 1.52 mmol, 2 M/ether, 2 eq.) was 
added slowly.  After stirring for 4 hours at -48 °C, the mixture was allowed to 
warm to room temperature and was left to stir overnight.  The next day, the 
mixture was cooled to 0 °C and a saturated solution of ammonium chloride 
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(3.9 ml) was added slowly.  Ethyl acetate (10 ml) was added and the layers 
were separated.  The aqueous layer was extracted with ethyl acetate (2 x 8 
ml) and the organics were dried with Na2SO4, filtered and the solvent was 
removed to give the crude product (0.29 g).  This was purified by column 
chromatography (50% ethyl acetate/hexane) to give the pure product 90 (0.22 
g, 66%).  1H NMR (400 MHz, CDCl3, Me4Si) 0.98-1.11 (15H, m, 5 x CH3), 3.44 
(1H, br m, NH), 4.43 (1H, dd, J = 7.9, J = 14.0, CH(CH3)2), 4.64 (1H, ddd, JHH 
= 5.4, JHH = 14.0, JHP = 1.9, CH(iPr)NH), 6.92 (1H, ddd, JHH = 7.5, JHP = 4.3, 
JHP = 0.9, Ar-H), 7.18-7.28 (4H, m, Ar-H), 7.29-7.38 (8H, m, Ar-H), 7.47 (1H, 
dd, JHH = 7.5, JHP = 4.6, Ar-H);  31P{1H} NMR (162 MHz, CDCl3) -16.3 (s);  m/z 
(ES) 438.2020 (M+H)+ (calculated: 438.2020). 
 
 Synthesis of (R)-2-methyl-N-(2-methylpropylidene)-
propane-2-sulfinamide 9297 
(R)-t-butanesulfinamide 55 (10.51 g, 86.73 mmol), pyridinium 
p-toluenesulfonate (1.1 g, 4.34 mmol), and magnesium sulfate 
(52 g, 434 mmol) were placed into a round bottomed flask.  
DCM (145 ml) was added followed by isobutyraldehyde 91 (15.8 ml, 173.5 
mmol).  This mixture was stirred for 24 hours at room temperature, then filtered 
through Celite.  The solvent was evaporated to give the crude product (16.6 
g).  This was purified by column chromatography (75% hexane/ethyl acetate) 
to give the pure product 92 as a clear, colourless oil (11.0 g, 72%).  1H NMR 
(400 MHz, CDCl3, Me4Si) 1.16 (3H, d, CH(CH3)), 1.18 (3H, d, J = 1.8, 
CH(CH3)), 1.19 (9H, s, J = 2.1, C(CH3)3), 2.72 (1H, m, CH(CH3)2), 7.99 (1H, d, 
J = 4.3, HC=N);  13C{1H} NMR (100 MHz, CDCl3) 18.9 (CH(CH3)2), 22.3 
(C(CH3)3), 34.8 (CH(CH3)2), 56.4 (C(CH3)3), 173.5 (C=N);  m/z (ES) 176.1106 
(M+H)+ (calculated: 176.1109). 
 
Chapter 6. Experimental 
137 
 
 Synthesis of (R)-2-methyl-N-((R)-2-methyl-1-
phenylpropyl)propane-2-sulfinamide 9397 
The chiral sulfinimine 92 (1.4 g, 7.99 mmol) was dissolved in 
dry DCM (48 ml) in an oven-dried round bottomed flask under 
nitrogen.  The solution was cooled to -48 °C and 
phenylmagnesium bromide (5.3 ml, 15.97 mmol, 3M/ether) was added slowly.  
This was stirred for 5 hours at -48 °C, then was allowed to warm to room 
temperature and was stirred overnight.  A solution of saturated ammonium 
chloride (16.6 ml) was added slowly and the mixture was extracted with ethyl 
acetate (3 x 25 ml).  The organics were dried with Na2SO4, filtered and the 
solvent was removed to give the crude product as a yellow oil (2.1 g).  This 
was purified by column chromatography (50% ethyl acetate/hexane) to give 
the pure product 93 as a white solid (1.46 g, 72%).  1H NMR (400 MHz, CDCl3, 
Me4Si) 0.81 (3H, d, J = 6.8, CH(CH3), 0.93 (3H, d, J = 6.8, CH(CH3), 1.24 (9H, 
s, C(CH3)3), 2.22 (1H, octet, J = 6.8, CH(CH3)2), 3.45 (1H, d, J = 5.2, NH), 4.16 
(1H, t, J = 5.8, CH(Ph)NH), 7.23-7.29 (3H, m, Ar-H), 7.29-7.35 (2H, m, Ar-H);  
13C{1H} NMR (100 MHz, CDCl3) 18.0 (CH(CH3)), 19.3 (CH(CH3)), 22.7 
(C(CH3)3), 32.9 (CH(CH3)2), 56.0 (C(CH3)3), 65.0 (CH(Ph)NH), 127.5 (Ar), 
127.7 (Ar), 128.3 (Ar), 140.9 (Ar);  m/z (ES) 276.1394 (M+Na)+ (calculated: 
276.1398). 
 
 Synthesis of (R)-2-methyl-1-phenylpropan-1-amine 9497 
The amine 93 (9.6 g, 38.1 mmol) was dissolved in MeOH (19.5 
ml).  A solution of HCl in dioxane (19 ml, 76.1 mmol, 4 M, 2 eq.) 
was added and the solution was stirred for 30 minutes at room 
temperature.  Most of the solvent was removed on a rotary evaporator and 
then diethyl ether was added and the precipitate was filtered (6.6 g, 94%).  This 
was dissolved in MeOH (20 ml) and 2 M potassium carbonate (40 ml) was 
added.  The product was extracted with DCM (3 x 40 ml), washed with brine 
(100 ml), dried with Na2SO4, filtered and concentrated to give the pure product 
94 as a pale yellow oil (5.32 g, 94%).  1H NMR (400 MHz, CDCl3, Me4Si) 0.77 
(3H, d, J = 6.7, CH3), 0.98 (3H, d, J = 6.7, CH3), 1.46 (2H, br s, NH), 1.85 (1H, 
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octet, J = 6.7, CH(CH3)2), 3.60 (1H, d, J = 7.2, CH(iPr)NH2), 7.19-7.34 (5H, m, 
Ar-H);  13C{1H} NMR (100 MHz, CDCl3) 18.9 (CH3), 19.8 (CH3), 35.5 
(CH(CH3)2), 62.5 (CH(iPr)NH2), 126.8 (Ar), 127.0 (Ar), 128.2 (Ar), 145.5 (Ar);  
m/z (ES) 150.1276 (M+H)+ (calculated: 150.1283). 
 
 Synthesis of (R)-1-(2-(diphenylphosphaneyl)phenyl)-2-
methylpropan-1-amine 85 
(R)-2-methyl-1-phenylpropan-1-amine 94 (0.67 g, 4.5 mmol) 
was dissolved in dry ether (4.5 ml) in an oven-dried round 
bottomed flask under nitrogen.  The solution was cooled to -35 
°C (using a MeOH/H2O/dry ice bath), and n-butyllithium (2.5 M in hexanes, 
1.79 ml, 4.5 mmol, 1 eq.) was added dropwise with stirring.  On addition of n-
BuLi, the solution turned slightly yellow.  After the solution was stirred at -35 
°C for 15 minutes, Me3SiCl (0.63 ml, 4.9 mmol, 1.1 eq.) was added slowly.  
After stirring at -35 °C for 1 hour, more n-BuLi (2.5 M in hexanes, 5.38 ml, 13.5 
mmol, 3 eq.) was added dropwise.  This was then left to stir for 3 hours at -35 
°C, then warmed to room temperature and left to stir overnight.  The next day, 
the cloudy yellow solution was cooled to -35 °C and a solution of ClPPh2 (0.80 
ml, 4.5 mmol, 1 eq.) in dry ether (4.5 ml) was added dropwise over 45 minutes.  
The solution was stirred for 3 hours at -35 °C and then warmed to room 
temperature and stirred for 4 hours.  1 M HCl was added slowly until the 
reaction mixture became clear.  During the addition of HCl, the mixture became 
slightly warm.  The layers were separated and the aqueous layer was extracted 
with ether (3 x 5 ml).  The organic layers were combined, dried with Na2SO4 
and concentrated using a rotary evaporator to give the crude product as a 
yellow oil (1.63 g).  This was purified by column chromatography (40% ethyl 
acetate/hexane + 2% Et3N) to give the product 85, a yellow-orange oil (0.28 g, 
18%).  1H NMR (400 MHz, CDCl3, Me4Si) 0.67 (3H, d, J = 6.8, CH3), 1.00 (3H, 
d, J = 6.6, CH3), 1.44 (2H, br s, NH2), 1.96 (1H, octet, J = 6.8, CH(CH3)2), 4.46 
(1H, t, J = 8.1, CH(iPr)NH2), 6.90 (1H, ddd, J = 1.0, J = 4.1, J = 7.7, Ar-H), 7.13 
(1H, dt, J = 1.1, J = 7.5, Ar-H), 7.22-7.41 (11H, m, Ar-H), 7.51 (1H, dd, J = 4.2, 
J = 8.3, Ar-H);  31P{1H} NMR (162 MHz, CDCl3) -16.7 (s);  13C{1H} NMR (100 
MHz, CDCl3) 16.7 (s, CH3), 18.2 (s, CH3), 32.9 (d, J = 1.3, CH(CH3)2), 56.7 (d, 
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J = 24.2, CH(iPr)NH2), 124.3 (d, J = 5.3, Ar), 124.7 (s, Ar), 126.3-126.6 (m, Ar), 
127.2 (s, Ar), 131.4-131.7 (m, Ar), 132.0 (d, J = 19.8, Ar), 133.2 (d, J = 12.0, 
Ar), 134.7 (d, J = 10.9, Ar), 135.3 (d, J = 10.9, Ar), 148.5 (d, J = 22.8, Ar);  m/z 
(ES) 334.1725 (M+H)+ (calculated: 334.1725). 
 
 Synthesis of N1,N2-bis((S)-1-(2-
(diphenylphosphanyl)phenyl)ethyl)ethane-1,2-diamine 82 
Dibromoethane (36 µl, 0.413 mmol, 1 eq.) was 
added slowly to a mixture of (S)-1-[2-
(diphenylphosphino)phenyl]ethylamine 81 (0.54 g, 
1.77 mmol, 4.3 eq.) and triethylamine (0.12 ml, 0.825 mmol, 2 eq.) at 110 °C 
under a nitrogen atmosphere.  (The triethylamine was dried with molecular 
sieves overnight prior to use).  After about 5 minutes stirring, the mixture 
became thick.  The temperature was increased to 130 °C and the mixture was 
stirred for 22 h at this temperature.  The mixture was then allowed to cool and 
0.6 ml of a saturated KOH solution was added carefully.  DCM (3 ml) was 
added, the layers were separated and the aqueous layer was extracted with 
DCM (3 x 3 ml).  The organics were washed with H2O (5 ml) and saturated 
brine (5 ml), dried with Na2SO4 and the solvent was removed under vacuum.  
Purification by column chromatography (10% MeOH/DCM) gave the product 
82, a white solid (0.0524 g, 20%).  1H NMR (400 MHz; CDCl3; Me4Si) 1.25 (6H, 
d, J = 6.6, CH3), 2.5 (4H, br s, CH2CH2), 2.65 (2H, br s, NH), 4.61 (2H, m, J = 
6.6, CH(CH3)NH), 6.87 (2H, ddd, J = 1.0, 4.2, 7.6, Ar-H), 7.11 – 7.41 (24H, m, 
Ar-H), 7.62 (2H, dd, J = 4.1, 7.4, Ar-H); 31P{1H} NMR (162 MHz; CDCl3) -17.2 
(s); 13C{1H} NMR (100 MHz, CDCl3) 22.5 (s, CH3), 44.7 (s, CH2), 54.0 (d, J = 
27.1, CH(CH3)NH), 126.4 (d, J = 4.8, Ar), 127.8 (s, Ar), 128.6 (d, J = 3.2, Ar), 
128.7 (d, J = 2.9, Ar), 128.9 (d, J = 10.5, Ar), 129.9 (s, Ar), 133.5 (s, Ar), 133.9 
(d, J = 9.4, Ar), 134.2 (d, J = 9.4, Ar), 135.6 (d, J = 13.4, Ar), 135.9 (d, J = 9.2, 
Ar), 136.4 (d, J = 10.2, Ar);  m/z (ES) 637.3 (M+H)+ (calculated: 637.29), 289.1 
(M-NHCH2CH2NHCH(CH3)PhPPh2)+;  CHN C42H42N2P2 calculated: C 79.22, H 
6.65, N 4.40, found: C 75.70, H 6.41, N 4.13. 
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 Synthesis of N1,N2-bis((R)-1-(2-(diphenyl-
phosphaneyl)phenyl)-2-methylpropyl)ethane-1,2-diamine 86 
(R)-1-(2-(diphenylphosphaneyl)phenyl)-2-
methylpropan-1-amine 85 (1.57 g, 4.7 mmol) was 
transferred to an oven-dried Schlenk flask under 
nitrogen.  Triethylamine (0.31 ml, 2.19 mmol) was added and the mixture was 
heated to 110 °C.  Dibromoethane (94 μl, 1.09 mmol) was added and the 
temperature was increased to 130 °C and was stirred at this temperature 
overnight.  The next day, the mixture was cooled to 60 °C and a saturated KOH 
solution (1.64 ml) was added carefully.  After cooling to room temperature, the 
product was extracted with DCM (3 x 7 ml) and washed with water (20 ml) and 
brine (20 ml).  The organic layer was dried with Na2SO4, filtered and 
concentrated to give the crude product (1.5 g).  This was purified by column 
chromatography (10% MeOH/DCM) to give the pure product 86 as a white 
solid (0.38 g, 50%).  1H NMR (400 MHz, CDCl3, Me4Si) 0.59 (6H, d, J = 6.8, 2 
x CH3), 1.05 (6H, d, J = 6.7, 2 x CH3), 2.08 (2H, br m, CH(CH3)2), 2.26 (2H, br 
d, J = 8.0, CH2), 2.49 (2H, br d, J = 8.0, CH2), 4.42 (2H, br m, CH(iPr)NH), 4.68 
(2H, br s, NH), 7.02 (2H, dd, J = 3.9, J = 7.4, Ar-H), 7.12-7.34 (18H, m, Ar-H), 
7.39 (2H, t, J = 7.6, Ar-H), 7.6 (2H, br s, Ar-H);  31P{1H} NMR (162 MHz, CDCl3, 
Me4Si) -19.1 (s);  13C{1H} NMR (100 MHz, CDCl3) 17.1 (s, CH3), 18.0 (s, CH3), 
32.0 (s, CH(CH3)2), 42.9 (br s, CH2), 62.7 (m, CH(iPr)NH), 125.2 (br s, Ar), 
126.3 (d, J = 6.9, Ar), 126.5 (d, J = 21.4, Ar), 127.5 (s, Ar), 131.4 (d, J = 19.5, 
Ar), 131.8 (d, J = 20.2, Ar), 132.5 (s, Ar), 133.9 (m, Ar), 134.4 (d, J = 14.1, Ar), 
134.8 (d, J = 10.8, Ar);  m/z (ES) 693.3523 (M+H)+ (calculated: 693.3527);  
CHN C46H50N2P2 calculated: C 79.74, H 7.27, N 4.04, found: C 76.30, H 7.20, 
N 3.96. 
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 Synthesis of (1E,1'E)-N,N'-((1S,1'S)-((phenylphos-
phanediyl)bis(2,1-phenylene))bis(phenylmethylene))-bis(1-
phenylmethanimine) 99 
The diamine 36b (50 mg, 0.11 mmol) and Na2SO4 (0.18 g, 
1.27 mmol, 12 eq.) were placed in an oven-dried reaction 
tube under nitrogen.  Chloroform (1.2 ml) was added 
followed by benzaldehyde (22.5 mg, 0.21 mmol, 2 eq.).  
The mixture was heated to 50 °C overnight, then cooled to room temperature, 
filtered and the solvent was removed to give the crude imine product 99 (0.057 
g, 83%).  1H NMR (400 MHz, CDCl3, Me4Si) 6.33 (1H, d, JHP = 7.5, CH(Ph)N), 
6.49 (1H, d, JHP = 7.5, CH(Ph)N), 6.79 (2H, m, Ar-H), 6.95 (1H, t, J = 7.5, Ar-
H), 7.07 (2H, t, J = 7.8, Ar-H), 7.12-7.21 (3H, m, Ar-H), 7.23-7.37 (15H, m, Ar-
H), 7.39 (2H, d, J = 7.6, Ar-H), 7.44 (4H, d, J = 7.6, Ar-H), 7.54-7.58 (2H, m, 
Ar-H and HC=N), 7.66 (1H, dd, JHH = 7.7, JHP = 4.4, Ar-H), 7.73 (1H, s, HC=N), 
7.77 (1H, dd, JHH = 6.9, JHP = 4.4, Ar-H);  31P{1H} NMR (162 MHz, CDCl3) -23.9 
(s);  m/z (ES) 649.2775 (M+H)+ (calculated: 649.2773). 
 
 Synthesis of (1S,1'S)-1,1'-((phenylphosphane-
diyl)bis(2,1-phenylene))bis(N-benzyl-1-phenylmethanamine) 
84 
Sodium borohydride (0.15 g, 4.01 mmol, 52 eq.) was placed 
in an oven-dried Radley’s tube under nitrogen.  A solution of 
the diimine 99 (50 mg, 0.077 mmol) in DCM (1.1 ml) was 
added at 0 °C.  Methanol (1.1 ml) was added slowly and the 
mixture was stirred at 0 °C for 3 hours and then was warmed 
to 40 °C and left to stir overnight.  The next day, the mixture was cooled to 
room temperature and water (1.2 ml) was added slowly.  The product was 
extracted with ethyl acetate (3 x 3 ml), washed with water and brine, dried with 
Na2SO4, filtered and concentrated to give the crude product (0.039 g).  This 
was purified by column chromatography (85% hexane/ethyl acetate) to give 
the pure product 84, a white solid (0.021 g, 42%).  1H NMR (400 MHz, CDCl3, 
Me4Si) 2.97 (1H, d, JHH = 12.8, CH(H)), 3.26 (1H, d, JHH = 12.8, CH(H)), 3.51 
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(2H, s, CH2), 5.57 (1H, d, JHP = 7.8, CH(Ph)NH), 5.87 (1H, d, JHP = 7.4, 
CH(Ph)NH), 6.76 (1H, dd, JHH = 7.6, JHP = 3.8, Ar-H), 6.91 (1H, dd, JHH = 6.8, 
JHP = 4.1, Ar-H), 6.97 (2H, d, JHH = 6.8, Ar-H), 7.03 (1H, t, JHH = 7.6, Ar-H), 
7.06-7.39 (24H, m, Ar-H), 7.45 (4H, m, Ar-H), 7.57 (1H, dd, JHH = 7.6, JHP = 
4.3, Ar-H), 7.73 (1H, dd, JHH = 7.6, JHP = 4.3, Ar-H);  31P{1H} NMR (162 MHz, 
CDCl3) -26.0 (s);  13C{1H} NMR (100 MHz, CDCl3) 52.3 (CH2), 52.4 (CH2), 63.8 
(d, J = 8.1, CH(Ph)NH), 64.0 (d, J = 7.2, CH(Ph)NH), 126.7 (s, Ar), 126.8 (d, J 
= 1.5, Ar), 126.9 (s, Ar), 127.3 (d, J = 15.6, Ar), 127.7 (d, J = 1.7, Ar), 127.9-
128.3 (m, Ar), 128.7 (d, J = 7.3, Ar), 128.9 (s, Ar), 129.3 (s, Ar), 129.7 (s, Ar), 
134.1 (d, J = 10.9, Ar), 134.5 (d, J = 20.6, Ar), 134.9 (d, J = 13.3, Ar), 135.4 (d, 
J = 12.7, Ar), 136.3 (d, J = 10.3, Ar), 140.5 (s, Ar), 143.1 (s, Ar), 143.3 (s, Ar), 
147.9 (d, J = 22.9, Ar), 148.2 (d, J = 23.2, Ar);  m/z (ES) 653.3088 (M+H)+ 
(calculated: 653.3086). 
 
 Synthesis of 1,1'-((phenylphosphanediyl)bis(2,1-
phenylene))bis(N-((S)-1-(2-(diphenylphosphaneyl)-
phenyl)ethyl)methanimine) 100 
2,2'-(phenylphosphanediyl)-dibenzaldehyde 45 (0.2 g, 
0.63 mmol), (S)-1-[2-(diphenylphosphino)phenyl]ethyl-
amine 81 (0.38 g, 1.26 mmol, 2 eq.) and sodium sulfate 
(1.16 g, 8.17 mmol, 13 eq.) were placed in an oven-dried 
round bottomed flask fitted with a condenser under 
nitrogen.  Chloroform (2 ml) was added and the mixture was heated to 50 °C 
for 2 days.  Then the mixture was filtered and the solvent was evaporated to 
give the crude diimine 100 (0.56 g, 99%).  1H NMR (400 MHz, CDCl3, Me4Si) 
1.08 (3H, d, J = 6.4, CH3), 1.13 (3H, d, J = 6.4, CH3), 5.25 (2H, sept, J = 6.4, 
CH(CH3)N), 6.74-6.84 (4H, m, Ar-H), 7.03 (2H, t, J = 6.6, Ar-H), 7.12-7.36 
(40H, m, Ar-H), 7.42 (1H, dd, J = 4.5, J = 7.7, Ar-H), 7.68 (2H, m, Ar-H), 8.53 
(1H, d, J = 4.5, HC=N), 8.56 (1H, d, J = 4.4, HC=N);  31P{1H} NMR (162 MHz, 
CDCl3) -17.3 (1P, s), -16.8 (1P, s), -16.7 (1P, s);  m/z (ES) 893.3314 (M+H)+ 
(calculated: 893.3343). 
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 Synthesis of (1S,1'S)-N,N'-(((phenylphosphanediyl)-
bis(2,1-phenylene))bis(methylene))bis(1-(2-(diphenyl-
phosphaneyl)phenyl)ethan-1-amine) 87 
Sodium borohydride (1.16 g, 30.66 mmol) was placed in 
an oven-dried 2-necked flask under nitrogen.  A solution 
of the diimine 100 (0.53 g, 0.59 mmol) in DCM (8.4 ml) 
was added at 0 °C, followed by the slow addition of 
methanol (8.4 ml).  The mixture was stirred for 4 hours 
at 0 °C, then warmed to 40 °C and stirred overnight.  The next day, more DCM 
(7 ml) was added and the mixture was stirred for a further 6 hours.  Then the 
mixture was cooled to room temperature and water (8.8 ml) was added slowly.  
After stirring for 1h45m the product was extracted with ethyl acetate (3 x 20 
ml), washed with water and brine, dried with Na2SO4, filtered and concentrated 
to give the crude product, a white solid (0.52 g, 99%).  1H NMR (400 MHz, 
CDCl3, Me4Si) 0.87 (3H, d, JHH = 6.5, CH3), 0.89 (3H, d, JHH = 6.5, CH3), 3.56 
(1H, d, JHH = 12.7, CH(H)), 3.67 (2H, s, CH2), 3.72 (1H, dd, JHH = 12.4, JHP = 
1.6, CH(H)), 4.53 (2H, m, CH(CH3)NH), 6.75-6.87 (4H, m, Ar-H), 7.09 (4H, m, 
Ar-H), 7.17-7.33 (34H, m, Ar-H), 7.45 (3H, m, Ar-H), 7.59 (1H, m, Ar-H);  
31P{1H} NMR (162 MHz, CDCl3) -25.8 (1P, s), -17.9 (1P, s), -17.6 (1P, s);  
13C{1H} NMR (100 MHz, CDCl3) 23.6 (s, CH3), 23.7 (s, CH3), 50.4 (d, J = 2.3, 
CH2), 50.6 (d, J = 2.2, CH2), 54.6 (dd, J = 11.6, 25.2, CH(Me)NH), 126.1 (t, J 
= 4.4, Ar), 126.7 (s, Ar), 127.2 (s, Ar), 128.4-128.7 (m, Ar), 128.9 (d, J = 2.5, 
Ar), 129.4 (s, Ar), 129.9 (d, J = 4.5, Ar), 133.5 (d, J = 8.9, Ar), 133.7 (s, Ar), 
133.9 (m, Ar), 134.2 (d, J = 3.1, 20.1, Ar), 134.4 (s, Ar), 134.9 (dd, J = 5.3, 
13.9, Ar), 135.6 (d, J = 13.7, Ar), 136.0 (d, J = 13.4, Ar), 136.9 (m, Ar), 137.0 
(m, Ar), 137.4 (d, J = 8.1, Ar), 137.5 (d, J = 8.4, Ar), 144.9 (dd, J = 5.3, 24.8, 
Ar), 150.2 (dd, J = 7.3, 22.2, Ar);  m/z (ES) 897.3652 (M+H)+ (calculated: 
897.3656);  CHN C60H55N2P3 calculated: C 80.34, H 6.18, N 3.12, found: C 
78.93, H 6.76, N 2.69. 
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 Synthesis of 1-phenylethan-1-one oxime123 
Acetophenone (0.58 ml, 5 mmol), hydroxylamine hydrochloride 
(0.52 g, 7.5 mmol, 1.5 eq.), sodium acetate (1.03 g, 12.5 mmol, 
2.5 eq.), ethanol (4 ml) and water (12 ml) were placed in a round 
bottomed flask fitted with a condenser.  The mixture was heated to reflux 
overnight.  The next day, the mixture was cooled to room temperature, poured 
into a beaker and cooled to 0 °C.  The precipitate was filtered off, washed with 
water and dried under vacuum to give the product as a fluffy white solid (0.37 
g, 54%).  1H NMR (400 MHz, CDCl3, Me4Si) 2.3 (3H, s, CH3), 7.39 (3H, m, Ar-
H), 7.63 (2H, m, Ar-H), 8.47 (1H, s, OH);  m/z (ES) 136.0758 (M+H)+ 
(calculated: 136.0762). 
 
 Synthesis of P,P-diphenyl-N-(1-
phenylethylidene)phosphinic amide124 
1-phenylethan-1-one oxime (0.36 g, 2.66 mmol) and 
triethylamine (0.74 ml, 5.33 mmol, 2 eq.) were placed in an 
oven-dried flask under nitrogen.  A 1/1 mixture of n-pentane 
and DCM (5.3 ml) was added and the mixture was cooled to -78 °C.  
Chlorodiphenylphosphine (0.48 ml, 2.66 mmol, 1 eq.) was added slowly over 
15 minutes, during which time the clear colourless solution turned cloudy and 
slightly yellow.  The mixture was stirred for 40 minutes at -78 °C, then was 
allowed to warm to room temperature overnight.  The next day, the mixture 
was filtered through Celite and the filtrate was washed with water and brine, 
dried with MgSO4, filtered and concentrated to give the crude product as a 
yellow oil (0.9 g).  This was purified by column chromatography (85% ethyl 
acetate/hexane) to give the pure product as a white solid (0.56 g, 66%).  1H 
NMR (400 MHz, CDCl3, Me4Si) 2.97 (3H, d, JHP = 2.1, CH3), 7.40-7.51 (8H, m 
Ar-H), 7.53-7.58 (1H, m, Ar-H), 7.98 (4H, ddd, JHH = 7.5, JHH = 1.4, JHP = 11.9, 
Ar-H), 8.09 (2H, m, Ar-H);  31P{1H} NMR (162 MHz, CDCl3) 18.9 (s);  m/z (ES) 
342.1023 (M+Na)+ (calculated: 342.1024). 
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 Synthesis of P,P-diphenyl-N-(1-phenylethyl)-phosphinic 
amide54 
P,P-diphenyl-N-(1-phenylethylidene)phosphinic amide (30 
mg, 0.094 mmol) was dissolved in THF (0.3 ml) and sodium 
borohydride (14 mg, 0.37 mmol, 4 eq.) was added.  The 
mixture was stirred overnight at room temperature.  A 
saturated solution of ammonium chloride (3 ml) was added carefully and the 
product was extracted with DCM (3 x 3 ml), dried with MgSO4, filtered and 
concentrated to give the crude product (0.0316 g, quantitative yield).  1H NMR 
(400 MHz, CDCl3, Me4Si) 1.58 (3H, d, J = 6.8, CH3), 3.17 (1H, dd, J = 5.5, J = 
9.7, NH), 4.40 (1H, m, CH(CH3)NH), 7.21-7.40 (10H, m, Ar-H), 7.40-7.54 (6H, 
m, Ar-H), 7.79-7.86 (2H, m, Ar-H), 7.88-7.97 (3H, m, Ar-H);  31P{1H} NMR (162 
MHz, CDCl3) 22.5 (s);  m/z (CI) 322.1360 (M+H)+ (calculated: 322.1361). 
 
 Synthesis of N-benzyl-1-phenylethan-1-imine125 
Acetophenone (1.75 ml, 15 mmol), benzylamine (1.64 ml, 15 
mmol) and p-toluenesulfonic acid monohydrate (0.031 g, 0.17 
mmol, 0.011 eq.) were dissolved in toluene (50 ml) in a round 
bottomed flask fitted with a Dean-Stark trap.  The mixture was heated to reflux 
overnight during which time, the clear colourless mixture turned yellow.  Then 
the mixture was cooled to room temperature during which time it became 
cloudy.  This was filtered through Celite, and the solvent was evaporated to 
give the crude product as a yellow-orange oil (2.6 g).  This was dissolved in 
petroleum ether and cooled in the freezer overnight to give a pale-yellow solid 
which was filtered off and dried (1.68 g, 54%).  1H NMR (400 MHz, CDCl3, 
Me4Si) 2.34 (3H, s, CH3), 4.75 (2H, s, CH2), 7.25 (1H, m, Ar-H), 7.32-7.45 (1H, 
m, Ar-H), 7.87 (2H, m, Ar-H);  13C{1H} NMR (100 MHz, CDCl3) 15.9 (CH3), 55.7 
(CH2), 126.6 (Ar), 126.8 (Ar), 127.7 (Ar), 128.3 (Ar), 128.4 (Ar), 129.6 (Ar), 
140.6 (Ar), 141.1 (Ar), 166.0 (C=N);  m/z (CI) 210.1273 (M+H)+ (calculated: 
210.1283);  CAS number 14428-98-9. 
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 Synthesis of N-benzyl-1-phenylethan-1-amine 
N-benzyl-1-phenylethan-1-imine (0.1 g, 0.53 mmol) was 
dissolved in ethanol (0.5 ml) and sodium borohydride (30 mg, 
0.79 mmol, 1.5 eq.) was added.  The mixture was stirred for 4 
hours at room temperature, then was diluted with water (1.8 ml), transferred to 
a separating funnel adding ethyl acetate (5.3 ml) and water (5.3 ml).  The 
product was extracted with ethyl acetate (2 x 3.5 ml), washed with brine (5.3 
ml), dried with Na2SO4, filtered and concentrated to give the product (0.107 g, 
96%).  1H NMR (400 MHz, CDCl3, Me4Si) 1.37 (3H, d, J = 6.7, CH3), 3.59 (1H, 
d, J = 13.0, CH(H)), 3.66 (1H, d, J = 13.0, CH(H)), 3.81 (1H, q, J = 6.7, 
CH(CH3)NH), 7.21-7.38 (10H, m, Ar-H);  13C{1H} NMR (100 MHz, CDCl3) 24.5 
(CH3), 51.7 (CH2), 57.5 (CH(CH3)NH), 126.7 (Ar), 126.9 (Ar), 127.0 (Ar), 128.2 
(Ar), 128.4 (Ar), 128.5 (Ar), 140.6 (Ar), 145.6 (Ar);  m/z (CI) 212.1442 (M+H)+ 
(calculated: 212.1439);  CAS number 3193-62-2. 
 
 General procedure for the synthesis of racemic 
alcohols 
The ketone (1 eq.) was dissolved in ethanol (1 M) and sodium borohydride (1.5 
eq.) was added.  The reaction was stirred at room temperature for 1 - 2 hours, 
then diluted with water.  The mixture was transferred to a separating funnel 
and ethyl acetate and water were added.  The product was extracted with ethyl 
acetate (x 2), washed with brine and dried with Na2SO4, filtered and 
concentrated to give the products. 
6.40.1. 1-(o-tolyl)ethan-1-ol 
(0.38 g, 94%) 1H NMR (400 MHz, CDCl3, Me4Si) 1.47 (3H, d, J = 
6.3, CH3CH(OH)), 1.71 (1H, s, OH), 2.35 (3H, s, Ar-CH3), 5.13 (1H, 
q, J = 6.4, CH(OH)CH3), 7.15 (2H, m, Ar-H), 7.23 (1H, m, Ar-H), 
7.51 (1H, d, J = 7.6, Ar-H);  13C{1H} NMR (100 MHz, CDCl3) 18.9 (Ar-CH3), 
23.9 (CH3), 66.8 (CH(OH)), 124.5 (Ar), 126.4 (Ar), 127.2 (Ar), 130.4 (Ar), 134.2 
(Ar), 143.9 (Ar);  m/z (CI) 119.0852 (M-OH)+ (calculated: 119.0861);  CAS 
number 7287-82-3. 
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6.40.2. 1-(4-methoxyphenyl)ethan-1-ol 
(0.45 g, 99%) 1H NMR (400 MHz, CDCl3, Me4Si) 1.48 (3H, d, 
J = 6.5, CH3CH(OH)), 1.74 (1H, s, OH), 3.81 (3H, s, Ar-CH3), 
4.86 (1H, q, J = 6.5, CH(OH)), 6.88 (2H, d, J = 8.6, Ar-H), 7.30 
(2H, d, J = 8.6, Ar-H);  13C{1H} NMR (100 MHz, CDCl3) 25.0 (CH3CH(OH)), 
55.3 (CH3O-Ar), 69.9 (CH(OH)), 113.8 (Ar), 126.7 (Ar), 138.1 (Ar), 158.9 (Ar);  
m/z (CI) 135.0809 (M-OH)+ (calculated: 135.1860);  CAS number 3319-15-1. 
6.40.3. 1-(2,6-dimethylphenyl)ethan-1-ol 
(0.012 g, 3%, product was not separated from starting material) 1H 
NMR (400 MHz, CDCl3, Me4Si) 1.54 (3H, d, J = 6.9, CH3CH(OH)), 
1.71 (1H, s, OH), 2.45 (6H, s, Ar-CH3), 5.40 (1H, q, J = 6.9, 
CH(OH)), (Ar-H overlapped with peaks for starting material);  13C{1H} NMR 
(100 MHz, CDCl3) 20.7 (Ar-CH3), 21.5 (CH3CH(OH)), 67.6 (CH(OH)), 126.9 
(Ar), 129.4 (Ar), 135.7 (Ar), 140.6 (Ar);  m/z (CI) 133.0815 (M-OH)+ (calculated: 
133.1017);  CAS number 19447-06-4. 
6.40.4. 2-methyl-1-phenylpropan-1-ol 
(0.41 g, 92%) 1H NMR (400 MHz, CDCl3, Me4Si) 0.80 (3H, d, J 
= 6.8, CH3), 1.00 (3H, d, J = 6.6, CH3), 1.81 (1H, br m, OH), 1.96 
(1H, octet, J = 6.8, CH(CH3)2), 4.36 (1H, dd, J = 1.3, J = 6.8, 
CH(OH)), 7.24-7.37 (5H, m, Ar-H);  13C{1H} NMR (100 MHz, CDCl3) 18.3 (CH3), 
19.0 (CH3), 35.3 (CH(CH3)2), 80.0 (CH(OH)), 126.6 (Ar), 127.4 (Ar), 128.2 (Ar), 
143.7 (Ar);  m/z (CI) 133.1015 (M-OH)+ (calculated: 133.1017);  CAS number 
611-69-8. 
 
 General procedure for AH at AZ 
Each ligand (0.016 mmol) was weighed out into 4 ml sample vials.  These were 
then put into a glove box and were dissolved in DCM (4 ml each).  Then 0.5 
ml samples (0.002 mmol) were taken out using an Eppendorf pipette and 
placed into 6 smaller sample vials for each ligand.  The solvent was then 
removed using a Genevac. 
Fe3(CO)12 (approx. 1 mg (0.8-0.9 mg), 0.002 mmol) was weighed out into each 
of the 15 ligand sample vials in a glove box using an automatic weighing 
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machine.  Then a solution of acetophenone (84 µl) and KOH (9 mg) in 
methanol (6 ml) was prepared and 0.341 ml of this solution was added to each 
reaction (acetophenone, 0.04 mmol; KOH, 0.008 mmol; MeOH, 0.336 ml). The 
sample vials were then transferred into a clam shell.  The clam shell was 
tightened and then removed from the glove box and put into the SPR 
(screening pressure reactor).  The system was purged with nitrogen and then 
the nitrogen pressure was held for 10 minutes to check for any leaks.  After 
this, the system was evacuated and refilled with hydrogen four times.  The 
reaction was heated to 45 °C and then the pressure was increased to 100 bar 
and the shaker was started.  The reaction was left for 16 hours at 45 °C, and 
then was cooled to 30 °C before stopping the shaking and releasing the 
hydrogen pressure.  The system was then evacuated and refilled with nitrogen 
4 times.  The clam shell was disconnected from the SPR and put back into the 
glove box. 
In the glove box, 70 µl of each reaction were transferred into HPLC vials, then 
diluted up to 1 ml with methanol and submitted for analysis by SFC.  Samples 
of acetophenone, racemic 1-phenylethanol and (R)-1-phenylethanol (1 mg/ml) 
were prepared for comparison. 
 
 General procedure for ATH at AZ 
The ligands (0.5 - 2 mol%) were weighed out into sample vials and were placed 
into a glove box.  Fe3(CO)12 (approx. 1 mg, 0.5 - 2 mol%) was weighed into 
these using an automatic weighing machine.  Isopropanol was added and the 
reactions were stirred at 60 °C for 30 minutes.  Then a solution of base (12 
mol%) in isopropanol was added and the reactions were stirred for a further 
10 minutes.  Then acetophenone was added and the reactions were stirred 
overnight.  The reactions were cooled down and a sample from each reaction 
was placed into HPLC vials and diluted up to 1 ml with methanol for SFC 
analysis. 
 
Chapter 6. Experimental 
149 
 
 General procedure for ATH at University of Liverpool 
The ligand and iron source were weighed out into an oven-dried reaction flask.  
Then the flask was connected to a Schlenk line and the air was removed and 
replaced with nitrogen at least 3 times.  Dry isopropanol was added and the 
reaction was heated to the specified temperature for 30 minutes.  Then a 
solution of base/isopropanol was added and the reaction was stirred for a 
further 10 minutes.  Then the substrate was added and the reaction was stirred 
for the stated time, after which the solvent was removed on a rotary evaporator.  
If NMR analysis showed formation of product, the product was then extracted 
with ether, washed with water, dried with MgSO4, filtered and concentrated in 
order to remove the base before HPLC analysis. 
6.43.1. 1-phenylethanol 
(33.5 mg, 91% yield, 40-55% ee) 1H NMR (400 MHz, CDCl3, 
Me4Si) 1.48 (3H, d, J = 6.5, CH3), 2.05 (1H, br s, OH), 4.87 (1H, q, 
J = 6.5, CH(OH)), 7.23-7.29 (1H, m, Ar-H), 7.30-7.38 (4H, m, Ar-
H);  13C{1H} NMR (100 MHz, CDCl3) 25.2 (CH3), 70.4 (CH(OH)), 125.4 (Ar), 
127.5 (Ar), 128.5 (Ar), 145.9 (Ar);  m/z (CI) 105.0702 (M-OH)+ (calculated: 
105.0704). 
6.43.2. 1-(p-tolyl)ethan-1-ol 
(96% conversion, 29% ee) 1H NMR (400 MHz, CDCl3, Me4Si) 
1.47 (3H, d, J = 6.1, CH(OH)CH3), 1.92 (1H, br s, OH), 2.34 (3H, 
s, Ar-CH3), 4.85 (1H, q, J = 6.2, CH(OH)), 7.15 (2H, d, J = 7.7, 
Ar-H), 7.25 (2H, d, J = 7.7, Ar-H);  13C{1H} NMR (100 MHz, CDCl3) 21.1 (Ar-
CH3), 25.1 (CH(CH3)OH), 70.2 (CH(OH)), 125.4 (Ar), 129.2 (Ar), 137.1 (Ar), 
142.9 (Ar);  m/z (CI) 119.0859 (M-OH)+ (calculated: 119.0861). 
6.43.3. 1-(o-tolyl)ethan-1-ol 
(>99% conversion, 68% ee) 1H NMR (400 MHz, CDCl3, Me4Si) 
1.45 3H, d, J = 6.5, CH(CH3)), 1.87 (1H, br s, OH), 2.33 (3H, s, Ar-
CH3), 5.11 (1H, q, J = 6.4, CH(OH)), 7.12 (1H, d, J = 7.1, Ar-H), 
7.16 (1H, td, J = 1.3, J = 7.5, Ar-H), 7.22 (1H, t, J = 7.6, Ar-H), 7.50 (1H, d, J = 
7.5, Ar-H);  13C{1H} NMR (100 MHz, CDCl3) 18.9 (Ar-CH3), 23.9 (CH(CH3)OH), 
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66.8 (CH(OH)), 124.5 (Ar), 126.4 (Ar), 130.4 (Ar), 134.2 (Ar), 143.9 (Ar);  m/z 
(CI) 119.0855 (M-OH)+ (calculated: 119.0861). 
6.43.4. 1-(4-(trifluoromethyl)phenyl)ethan-1-ol 
(>99% conversion, 23% ee) 1H NMR (400 MHz, CDCl3, Me4Si) 
1.49 (3H, d, J = 6.7, CH3), 2.19 (1H, br s, OH), 4.94 (1H, q, J 
= 6.5, CH(OH)), 7.47 (2H, d, J = 8.3, Ar-H), 7.59 (2H, d, J = 
8.1, Ar-H);  13C{1H} NMR (100 MHz, CDCl3) 25.4 (CH3), 69.8 (CH(OH)), 120.1 
(Ar), 122.8 (Ar), 125.4 (q, J = 3.6, Ar), 125.6 (Ar), 129.6 (q, J = 32.3, CF3), 
149.7 (Ar);  m/z (CI) 173.0571 (M-OH)+ (calculated: 173.0578). 
6.43.5. 1-(4-methoxyphenyl)ethan-1-ol 
(82% conversion, 35% ee) 1H NMR (400 MHz, CDCl3, Me4Si) 
1.46 (3H, d, J = 6.4, CH(OH)CH3), 2.01 (1H, br s, OH), 3.79 
(3H, s, OCH3), 4.83 (1H, q, J = 6.4, CH(OH)), 6.87 (2H, d, J = 
8.3, Ar-H), 7.28 (2H, d, J = 8.8, Ar-H);  13C{1H} NMR (100 MHz, CDCl3) 25.0 
(CH3CH(OH)), 55.3 (CH3O-Ar), 69.9 (CH(OH)), 113.8 (Ar), 126.7 (Ar), 138.1 
(Ar), 158.9 (Ar);  m/z (CI) 135.0810 (M-OH)+ (calculated: 135.1860). 
6.43.6. 2-methyl-1-phenylpropan-1-ol 
(98% conversion, 58% ee) 0.79 (3H, d, J = 6.9, CH3), 0.99 (3H, 
d, J = 6.9, CH3), 1.88-2.01 (2H, m, CH(CH3)2 and OH), 4.34 (1H, 
d, J = 6.9, CH(OH)), 7.23-7.35 (5H, m, Ar-H);  13C{1H} NMR (100 
MHz, CDCl3, Me4Si) 18.3 (CH3), 19.0 (CH3), 35.3 (CH(CH3)2), 80.0 (CH(OH)), 
126.6 (Ar), 127.4 (Ar), 128.2 (Ar), 143.7 (Ar);  m/z (CI) 133.1015 (M-OH)+ 
(calculated: 133.1017). 
6.43.7. 1-(2,6-dimethylphenyl)ethan-1-ol 
(6% conversion, 71% ee) 1H NMR (400 MHz, CDCl3, Me4Si) 1.53 
(3H, d, J = 6.6, CHCH3), 2.44 (6H, s, Ar-CH3), 5.39 (1H, q, J = 6.8, 
CH(OH)), (Ar-H overlapped with peaks for starting material);  
13C{1H} NMR (100 MHz, CDCl3) 20.6 (Ar-CH3), 21.5 (CH3CH(OH)), 67.6 
(CH(OH)), 126.9 (Ar), 129.4 (Ar), 135.7 (Ar), 140.6 (Ar);  m/z (CI) 133.1011 
(M-OH)+ (calculated: 133.1017). 
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6.43.8. P,P-diphenyl-N-(1-phenylethyl)phosphinic amide 
(0.019 g, 20%) 1H NMR (400 MHz, CDCl3, Me4Si) 1.57 (3H, d, 
J = 6.4, CH3), 3.21 (1H, br m, NH), 4.39 (1H, m, CHNH), 7.21-
7.39 (7H, m, Ar-H), 7.39-7.52 (4H, m, Ar-H), 7.82 (2H, m, Ar-
H), 7.91 (2H, m, Ar-H);  31P{1H} NMR (162 MHz, CDCl3) 22.6 
(s);  13C{1H} NMR (100 MHz, CDCl3) 26.0 (d, J = 3.3, CH3), 51.1 (s, CHNH), 
125.9 (s, Ar), 127.1 (s, Ar), 128.4 (s, Ar), 128.5 (d, J = 3.6, Ar), 128.6 (m, Ar), 
131.5 (Ar), 131.7-132.0 (m, Ar), 132.4 (Ar), 132.5 (Ar), 132.7 (Ar), 133.8 (Ar), 
145.1 (d, J = 6.7, Ar);  m/z (CI) 322.1355 (M+H)+ (calculated: 322.1361). 
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 Crystal structure data for 62 
Crystal data and structure refinement: 
_chemical_formula_moiety           'C52 H46 N2 P2, C H Cl3, 2(B F4)' 
_chemical_formula_sum              'C52 H46 B3 Cl3 F8 N2 P2' 
_chemical_formula_weight           1051.63 
_space_group_crystal_system        'orthorhombic' 
_space_group_name_H-M_alt          'P 21 21 21' 
_cell_length_a                     11.2657(7) 
_cell_length_b                     15.2832(8) 
_cell_length_c                     30.3398(17) 
_cell_angle_alpha                  90 
_cell_angle_beta                   90 
_cell_angle_gamma                  90 
_cell_volume                       5223.8(5) 
_cell_formula_units_Z              4 
_cell_measurement_temperature      296(2) 
_exptl_absorpt_coefficient_mu      0.303 
_exptl_crystal_density_diffrn      1.337 
_exptl_crystal_F_000               2160 
_diffrn_reflns_av_R_equivalents    0.0519 
_diffrn_reflns_av_unetI/netI       0.0528 
_diffrn_reflns_limit_h_max         13 
_diffrn_reflns_limit_h_min         -14 
_diffrn_reflns_limit_k_max         19 
_diffrn_reflns_limit_k_min         -18 
_diffrn_reflns_limit_l_max         37 
_diffrn_reflns_limit_l_min         -36 
_diffrn_reflns_number              53110 
_diffrn_reflns_theta_max           26.433 
_diffrn_reflns_theta_min           1.342 
_diffrn_radiation_type             MoK\a 
_diffrn_radiation_wavelength       0.71073 
_reflns_number_total               10641 
_refine_ls_goodness_of_fit_ref     0.941 
_refine_ls_number_parameters       631 
_refine_ls_number_reflns           10641 
_refine_ls_number_restraints       0 
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_refine_ls_R_factor_all            0.0634 
_refine_ls_R_factor_gt             0.0473 
_refine_ls_wR_factor_gt            0.1262 
_refine_ls_wR_factor_ref           0.1395 
REM Highest difference peak  0.837,  deepest hole -0.464 
Fractional atomic coordinates: 
loop_ 
  _atom_site_label 
  _atom_site_type_symbol 
  _atom_site_fract_x 
  _atom_site_fract_y 
  _atom_site_fract_z 
  _atom_site_U_iso_or_equiv 
  _atom_site_adp_type 
  _atom_site_occupancy 
  _atom_site_site_symmetry_order 
  _atom_site_calc_flag 
  _atom_site_refinement_flags_posn 
  _atom_site_refinement_flags_adp 
  _atom_site_refinement_flags_occupancy 
  _atom_site_disorder_assembly 
  _atom_site_disorder_group 
 P001 P 0.66260(9) 0.28720(6) 0.38481(3) 0.0203(2) Uani 1 1 d . . . . . 
 P002 P 0.61141(10) 0.55009(6) 0.35384(3) 0.0192(2) Uani 1 1 d . . . . . 
 Cl00 Cl 1.05869(15) 0.30756(13) 0.10311(5) 0.0694(5) Uani 1 1 d . . . . . 
 Cl1 Cl 0.88824(16) 0.44869(10) 0.09997(6) 0.0647(4) Uani 1 1 d . . . . . 
 Cl2 Cl 0.80992(16) 0.26904(11) 0.09658(6) 0.0668(5) Uani 1 1 d . . . . . 
 F006 F 0.3656(2) 0.41834(16) 0.38041(8) 0.0327(6) Uani 1 1 d . . . . . 
 F007 F 0.8077(2) 0.38476(16) 0.28384(8) 0.0347(6) Uani 1 1 d . . . . . 
 F008 F 0.8755(3) 0.33068(17) 0.21880(9) 0.0423(7) Uani 1 1 d . . . . . 
 F009 F 0.8496(3) 0.47639(17) 0.22741(10) 0.0462(8) Uani 1 1 d . . . . . 
 F00A F 0.2567(3) 0.3849(2) 0.31922(9) 0.0476(8) Uani 1 1 d . . . . . 
 F00B F 0.9973(3) 0.4073(2) 0.26464(10) 0.0500(8) Uani 1 1 d . . . . . 
 F00C F 0.2137(3) 0.32371(19) 0.38580(10) 0.0500(8) Uani 1 1 d . . . . . 
 N00D N 0.4919(3) 0.39137(19) 0.30111(10) 0.0206(7) Uani 1 1 d . . . . . 
 H00A H 0.5179 0.4099 0.3272 0.025 Uiso 1 1 calc R . . . . 
 H00B H 0.4132 0.3875 0.3028 0.025 Uiso 1 1 calc R . . . . 
 F00E F 0.1754(3) 0.4661(2) 0.37327(12) 0.0610(9) Uani 1 1 d . . . . . 
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 N00F N 0.9370(3) 0.4096(2) 0.36321(11) 0.0242(8) Uani 1 1 d . . . . . 
 H00C H 1.0118 0.4279 0.3614 0.029 Uiso 1 1 calc R . . . . 
 H00D H 0.9144 0.3931 0.3364 0.029 Uiso 1 1 calc R . . . . 
 C00G C 0.7849(4) 0.2137(2) 0.36931(13) 0.0207(8) Uani 1 1 d . . . . . 
 C00H C 0.4962(4) 0.5943(2) 0.31748(13) 0.0187(8) Uani 1 1 d . . . . . 
 C00I C 0.3428(4) 0.7017(2) 0.30296(14) 0.0239(9) Uani 1 1 d . . . . . 
 H00I H 0.3028 0.7525 0.3110 0.029 Uiso 1 1 calc R . . . . 
 C00J C 0.5229(4) 0.4608(2) 0.26659(12) 0.0182(8) Uani 1 1 d . . . . . 
 H00J H 0.6089 0.4704 0.2674 0.022 Uiso 1 1 calc R . . . . 
 C00K C 0.8586(4) 0.5576(2) 0.34387(13) 0.0214(9) Uani 1 1 d . . . . . 
 C00L C 0.7496(4) 0.5949(2) 0.33172(12) 0.0193(8) Uani 1 1 d . . . . . 
 C00M C 0.4611(3) 0.5468(2) 0.27961(13) 0.0184(8) Uani 1 1 d . . . . . 
 C00N C 0.9029(4) 0.2464(2) 0.37036(13) 0.0214(9) Uani 1 1 d . . . . . 
 C00O C 0.7657(4) 0.1317(3) 0.35071(14) 0.0250(9) Uani 1 1 d . . . . . 
 H00O H 0.6895 0.1083 0.3506 0.030 Uiso 1 1 calc R . . . . 
 C00P C 0.5313(4) 0.2246(2) 0.36816(13) 0.0205(8) Uani 1 1 d . . . . . 
 C00Q C 0.5730(4) 0.4331(2) 0.18754(14) 0.0254(9) Uani 1 1 d . . . . . 
 H00Q H 0.6492 0.4532 0.1936 0.030 Uiso 1 1 calc R . . . . 
 C00R C 0.4852(4) 0.2377(2) 0.32550(13) 0.0203(8) Uani 1 1 d . . . . . 
 C00S C 0.8594(4) 0.4848(2) 0.37828(14) 0.0226(9) Uani 1 1 d . . . . . 
 H00S H 0.7782 0.4622 0.3799 0.027 Uiso 1 1 calc R . . . . 
 C00T C 0.5405(4) 0.3017(2) 0.29327(13) 0.0226(9) Uani 1 1 d . . . . . 
 H00E H 0.6260 0.3022 0.2970 0.027 Uiso 1 1 calc R . . . . 
 H00F H 0.5231 0.2836 0.2633 0.027 Uiso 1 1 calc R . . . . 
 C00U C 0.9631(4) 0.5871(3) 0.32462(15) 0.0287(10) Uani 1 1 d . . . . . 
 H00U H 1.0350 0.5611 0.3320 0.034 Uiso 1 1 calc R . . . . 
 C00V C 0.4904(4) 0.4277(2) 0.22110(13) 0.0217(9) Uani 1 1 d . . . . . 
 C00W C 0.4725(4) 0.1674(2) 0.39674(14) 0.0249(9) Uani 1 1 d . . . . . 
 H00W H 0.5017 0.1588 0.4251 0.030 Uiso 1 1 calc R . . . . 
 C00X C 0.4362(4) 0.6713(2) 0.32834(14) 0.0242(9) Uani 1 1 d . . . . . 
 H00X H 0.4595 0.7028 0.3531 0.029 Uiso 1 1 calc R . . . . 
 C00Y C 0.3096(4) 0.6565(2) 0.26594(14) 0.0247(9) Uani 1 1 d . . . . . 
 H00Y H 0.2473 0.6769 0.2486 0.030 Uiso 1 1 calc R . . . . 
 C00Z C 0.3843(4) 0.1921(2) 0.31295(14) 0.0241(9) Uani 1 1 d . . . . . 
 H00Z H 0.3547 0.1996 0.2846 0.029 Uiso 1 1 calc R . . . . 
 C010 C 0.9314(4) 0.3310(2) 0.39390(13) 0.0224(9) Uani 1 1 d . . . . . 
 H01A H 1.0072 0.3248 0.4088 0.027 Uiso 1 1 calc R . . . . 
 H01B H 0.8714 0.3416 0.4162 0.027 Uiso 1 1 calc R . . . . 
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 C011 C 0.5891(4) 0.6118(2) 0.40449(13) 0.0236(9) Uani 1 1 d . . . . . 
 C012 C 0.9939(4) 0.1989(3) 0.35112(14) 0.0257(9) Uani 1 1 d . . . . . 
 H012 H 1.0707 0.2212 0.3513 0.031 Uiso 1 1 calc R . . . . 
 C013 C 0.9607(4) 0.6558(3) 0.29413(15) 0.0294(10) Uani 1 1 d . . . . . 
 H013 H 1.0310 0.6756 0.2816 0.035 Uiso 1 1 calc R . . . . 
 C014 C 0.3696(4) 0.5795(2) 0.25415(13) 0.0227(9) Uani 1 1 d . . . . . 
 H014 H 0.3472 0.5499 0.2287 0.027 Uiso 1 1 calc R . . . . 
 C015 C 0.8926(4) 0.5143(2) 0.42452(14) 0.0269(10) Uani 1 1 d . . . . . 
 C016 C 0.8580(4) 0.0845(2) 0.33245(15) 0.0295(10) Uani 1 1 d . . . . . 
 H016 H 0.8433 0.0294 0.3206 0.035 Uiso 1 1 calc R . . . . 
 C017 C 0.3713(4) 0.1236(2) 0.38338(15) 0.0285(10) Uani 1 1 d . . . . . 
 H017 H 0.3332 0.0858 0.4028 0.034 Uiso 1 1 calc R . . . . 
 C018 C 0.3264(4) 0.1355(2) 0.34154(15) 0.0272(10) Uani 1 1 d . . . . . 
 H018 H 0.2583 0.1060 0.3326 0.033 Uiso 1 1 calc R . . . . 
 C019 C 0.7503(4) 0.6640(2) 0.30133(13) 0.0239(9) Uani 1 1 d . . . . . 
 H019 H 0.6789 0.6903 0.2935 0.029 Uiso 1 1 calc R . . . . 
 C01A C 0.6686(4) 0.6750(3) 0.41990(14) 0.0279(9) Uani 1 1 d . . . . . 
 H01C H 0.7342 0.6904 0.4030 0.034 Uiso 1 1 calc R . . . . 
 C01B C 0.3777(4) 0.3946(2) 0.21186(14) 0.0266(9) Uani 1 1 d . . . . . 
 H01D H 0.3218 0.3891 0.2342 0.032 Uiso 1 1 calc R . . . . 
 C01C C 0.6542(4) 0.2849(3) 0.44465(13) 0.0256(9) Uani 1 1 d . . . . . 
 C01D C 0.9719(4) 0.1183(3) 0.33154(15) 0.0297(10) Uani 1 1 d . . . . . 
 H01E H 1.0330 0.0874 0.3180 0.036 Uiso 1 1 calc R . . . . 
 C01E C 0.4914(5) 0.5892(3) 0.43048(15) 0.0340(11) Uani 1 1 d . . . . . 
 H01F H 0.4384 0.5467 0.4208 0.041 Uiso 1 1 calc R . . . . 
 C01F C 0.8550(4) 0.6941(3) 0.28267(14) 0.0283(10) Uani 1 1 d . . . . . 
 H01G H 0.8536 0.7399 0.2625 0.034 Uiso 1 1 calc R . . . . 
 C01G C 0.5427(5) 0.4089(3) 0.14494(15) 0.0368(12) Uani 1 1 d . . . . . 
 H01H H 0.5985 0.4136 0.1225 0.044 Uiso 1 1 calc R . . . . 
 C01H C 0.9981(5) 0.5579(3) 0.43336(16) 0.0386(12) Uani 1 1 d . . . . . 
 H01I H 1.0506 0.5706 0.4106 0.046 Uiso 1 1 calc R . . . . 
 C01I C 0.5692(4) 0.3399(3) 0.46411(15) 0.0338(11) Uani 1 1 d . . . . . 
 H01J H 0.5158 0.3700 0.4463 0.041 Uiso 1 1 calc R . . . . 
 C01J C 0.3498(5) 0.3701(3) 0.16927(15) 0.0372(12) Uani 1 1 d . . . . . 
 H01K H 0.2747 0.3480 0.1632 0.045 Uiso 1 1 calc R . . . . 
 C01K C 0.7329(4) 0.2407(3) 0.47161(14) 0.0335(11) Uani 1 1 d . . . . . 
 H01L H 0.7901 0.2043 0.4593 0.040 Uiso 1 1 calc R . . . . 
 C01L C 0.8147(5) 0.4977(3) 0.45873(15) 0.0346(11) Uani 1 1 d . . . . . 
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 H01M H 0.7438 0.4685 0.4532 0.042 Uiso 1 1 calc R . . . . 
 C01M C 0.5639(5) 0.3501(4) 0.50939(17) 0.0423(13) Uani 1 1 d . . . . . 
 H01N H 0.5075 0.3870 0.5219 0.051 Uiso 1 1 calc R . . . . 
 C01N C 0.6415(5) 0.3058(4) 0.53561(17) 0.0461(14) Uani 1 1 d . . . . . 
 H01O H 0.6376 0.3124 0.5660 0.055 Uiso 1 1 calc R . . . . 
 C01O C 0.4312(5) 0.3780(3) 0.13570(15) 0.0385(13) Uani 1 1 d . . . . . 
 H01P H 0.4108 0.3626 0.1070 0.046 Uiso 1 1 calc R . . . . 
 C01P C 0.6496(5) 0.7150(3) 0.46064(16) 0.0395(12) Uani 1 1 d . . . . . 
 H01Q H 0.7035 0.7564 0.4709 0.047 Uiso 1 1 calc R . . . . 
 C01Q C 0.7267(5) 0.2506(4) 0.51726(16) 0.0462(13) Uani 1 1 d . . . . . 
 H01R H 0.7792 0.2204 0.5354 0.055 Uiso 1 1 calc R . . . . 
 B01R B 0.8836(5) 0.4005(3) 0.24786(16) 0.0266(10) Uani 1 1 d . . . . . 
 C01S C 0.4732(6) 0.6306(4) 0.47094(18) 0.0488(14) Uani 1 1 d . . . . . 
 H01S H 0.4080 0.6159 0.4882 0.059 Uiso 1 1 calc R . . . . 
 C01T C 0.5535(6) 0.6942(3) 0.48549(17) 0.0478(14) Uani 1 1 d . . . . . 
 H01T H 0.5410 0.7224 0.5123 0.057 Uiso 1 1 calc R . . . . 
 B01U B 0.2525(5) 0.3995(4) 0.3653(2) 0.0377(13) Uani 1 1 d . . . . . 
 C01V C 1.0247(7) 0.5825(4) 0.4761(2) 0.0623(17) Uani 1 1 d . . . . . 
 H01V H 1.0964 0.6103 0.4821 0.075 Uiso 1 1 calc R . . . . 
 C01W C 0.9458(8) 0.5662(4) 0.5100(2) 0.073(2) Uani 1 1 d . . . . . 
 H01W H 0.9637 0.5838 0.5386 0.087 Uiso 1 1 calc R . . . . 
 C01X C 0.8418(7) 0.5243(3) 0.50138(18) 0.0578(18) Uani 1 1 d . . . . . 
 H01X H 0.7885 0.5134 0.5242 0.069 Uiso 1 1 calc R . . . . 
 C01Y C 0.9157(5) 0.3415(4) 0.11793(18) 0.0505(14) Uani 1 1 d . . . . . 
 H01Y H 0.9099 0.3405 0.1502 0.061 Uiso 1 1 calc R . . . . 
anisotropic displacement parameters: 
loop_ 
  _atom_site_aniso_label 
  _atom_site_aniso_U_11 
  _atom_site_aniso_U_22 
  _atom_site_aniso_U_33 
  _atom_site_aniso_U_23 
  _atom_site_aniso_U_13 
  _atom_site_aniso_U_12 
 P001 0.0215(5) 0.0200(4) 0.0195(5) -0.0006(4) -0.0009(4) -0.0005(4) 
 P002 0.0219(5) 0.0174(4) 0.0182(5) -0.0021(4) -0.0011(4) -0.0001(4) 
 Cl00 0.0541(10) 0.0981(12) 0.0559(10) -0.0025(9) -0.0167(8) 0.0265(9) 
 Cl1 0.0674(10) 0.0542(8) 0.0723(11) -0.0109(7) -0.0151(9) 0.0091(8) 
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 Cl2 0.0702(11) 0.0726(10) 0.0575(10) -0.0114(8) 0.0277(8) -0.0164(8) 
 F006 0.0252(14) 0.0434(14) 0.0295(14) -0.0070(11) 0.0039(11) -0.0019(11) 
 F007 0.0413(16) 0.0386(14) 0.0243(14) -0.0024(11) 0.0054(12) -0.0082(12) 
 F008 0.0533(19) 0.0435(14) 0.0302(15) -0.0158(12) 0.0036(14) -0.0048(14) 
 F009 0.059(2) 0.0349(13) 0.0445(17) 0.0128(12) -0.0116(15) -0.0109(14) 
 F00A 0.0305(16) 0.076(2) 0.0362(16) 0.0070(15) -0.0017(13) -0.0013(15) 
 F00B 0.0280(16) 0.072(2) 0.0502(19) -0.0158(16) -0.0058(14) -0.0002(15) 
 F00C 0.0493(19) 0.0512(17) 0.0495(19) 0.0089(14) 0.0096(16) -0.0137(15) 
 N00D 0.0292(19) 0.0166(15) 0.0158(17) 0.0010(13) 0.0000(15) 0.0022(14) 
 F00E 0.0447(19) 0.0509(17) 0.087(3) -0.0080(17) 0.0087(18) 0.0124(16) 
 N00F 0.032(2) 0.0203(16) 0.0201(18) -0.0021(13) 0.0023(16) 0.0002(15) 
 C00G 0.023(2) 0.0211(18) 0.018(2) 0.0004(15) -0.0032(16) 0.0030(17) 
 C00H 0.018(2) 0.0203(18) 0.018(2) 0.0022(15) 0.0023(16) -0.0012(16) 
 C00I 0.024(2) 0.0182(17) 0.029(2) 0.0009(16) 0.0077(19) 0.0033(17) 
 C00J 0.023(2) 0.0180(17) 0.0140(19) 0.0026(14) 0.0006(16) -0.0012(16) 
 C00K 0.025(2) 0.0173(16) 0.022(2) -0.0018(15) 0.0004(17) -0.0023(16) 
 C00L 0.027(2) 0.0156(17) 0.016(2) -0.0028(15) -0.0015(17) -0.0015(16) 
 C00M 0.021(2) 0.0162(16) 0.018(2) 0.0012(15) 0.0041(16) -0.0035(16) 
 C00N 0.025(2) 0.0209(18) 0.018(2) 0.0022(15) -0.0061(17) 0.0011(17) 
 C00O 0.025(2) 0.0231(18) 0.026(2) 0.0004(17) -0.0035(19) 0.0011(17) 
 C00P 0.024(2) 0.0172(17) 0.021(2) -0.0013(15) -0.0020(17) 0.0008(16) 
 C00Q 0.035(3) 0.0180(18) 0.023(2) 0.0018(15) 0.0048(19) -0.0021(17) 
 C00R 0.024(2) 0.0145(17) 0.022(2) -0.0011(15) 0.0019(17) 0.0027(15) 
 C00S 0.019(2) 0.0198(17) 0.029(2) 0.0007(16) 0.0020(18) 0.0008(16) 
 C00T 0.030(2) 0.0193(18) 0.018(2) -0.0019(15) -0.0017(17) 0.0046(17) 
 C00U 0.025(2) 0.026(2) 0.034(3) 0.0003(18) 0.0001(19) -0.0016(18) 
 C00V 0.031(2) 0.0146(17) 0.019(2) 0.0000(14) -0.0022(18) 0.0012(16) 
 C00W 0.028(2) 0.0237(19) 0.023(2) 0.0036(16) -0.0024(18) 0.0008(18) 
 C00X 0.028(2) 0.0206(18) 0.023(2) -0.0017(16) 0.0010(19) 0.0020(17) 
 C00Y 0.022(2) 0.0233(19) 0.029(2) 0.0068(17) 0.0011(18) 0.0009(17) 
 C00Z 0.027(2) 0.0220(18) 0.024(2) -0.0051(16) -0.0042(18) 0.0055(18) 
 C010 0.026(2) 0.0205(18) 0.021(2) 0.0001(16) -0.0039(18) 0.0026(17) 
 C011 0.030(2) 0.0215(18) 0.019(2) 0.0019(15) -0.0020(18) -0.0001(17) 
 C012 0.022(2) 0.0252(19) 0.030(2) -0.0017(17) -0.0034(19) 0.0039(17) 
 C013 0.028(2) 0.027(2) 0.033(3) 0.0026(18) 0.006(2) -0.0060(19) 
 C014 0.028(2) 0.0216(18) 0.019(2) 0.0021(15) -0.0003(18) -0.0046(17) 
 C015 0.038(3) 0.0187(17) 0.024(2) -0.0016(16) 0.002(2) 0.0049(18) 
 C016 0.032(3) 0.0190(18) 0.037(3) -0.0048(17) -0.007(2) 0.0042(18) 
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 C017 0.027(2) 0.0219(18) 0.037(3) 0.0026(17) 0.009(2) -0.0034(18) 
 C018 0.020(2) 0.0205(18) 0.041(3) -0.0029(17) -0.003(2) 0.0001(17) 
 C019 0.030(2) 0.0178(18) 0.024(2) 0.0012(16) -0.0013(19) 0.0018(17) 
 C01A 0.035(3) 0.0261(19) 0.023(2) -0.0054(16) -0.001(2) 0.0020(19) 
 C01B 0.033(2) 0.0230(18) 0.024(2) 0.0037(16) -0.0072(19) -0.0060(18) 
 C01C 0.025(2) 0.030(2) 0.022(2) -0.0031(17) -0.0015(18) -0.0060(19) 
 C01D 0.029(2) 0.026(2) 0.034(3) -0.0069(18) -0.003(2) 0.0055(19) 
 C01E 0.039(3) 0.036(2) 0.027(3) -0.0033(19) 0.005(2) -0.005(2) 
 C01F 0.037(3) 0.0192(17) 0.029(2) 0.0021(16) 0.001(2) -0.0036(18) 
 C01G 0.059(3) 0.029(2) 0.022(2) 0.0004(19) 0.005(2) 0.001(2) 
 C01H 0.046(3) 0.041(3) 0.029(3) -0.014(2) 0.002(2) -0.006(2) 
 C01I 0.027(3) 0.046(3) 0.028(3) -0.004(2) 0.003(2) -0.007(2) 
 C01J 0.060(3) 0.0219(19) 0.030(3) 0.0032(17) -0.018(2) -0.012(2) 
 C01K 0.034(3) 0.049(3) 0.018(2) 0.001(2) -0.001(2) 0.000(2) 
 C01L 0.043(3) 0.029(2) 0.032(3) 0.0074(19) 0.011(2) 0.004(2) 
 C01M 0.035(3) 0.056(3) 0.037(3) -0.011(2) 0.007(2) -0.013(2) 
 C01N 0.042(3) 0.071(3) 0.025(3) -0.005(2) 0.006(2) -0.021(3) 
 C01O 0.074(4) 0.021(2) 0.021(2) -0.0002(17) -0.017(2) -0.008(2) 
 C01P 0.052(3) 0.035(2) 0.031(3) -0.013(2) -0.010(2) 0.001(2) 
 C01Q 0.040(3) 0.073(4) 0.026(3) 0.005(3) -0.005(2) -0.006(3) 
 B01R 0.029(3) 0.027(2) 0.024(3) -0.0033(19) -0.001(2) -0.003(2) 
 C01S 0.061(4) 0.053(3) 0.032(3) -0.006(2) 0.021(3) 0.000(3) 
 C01T 0.073(4) 0.043(3) 0.028(3) -0.013(2) 0.002(3) 0.009(3) 
 B01U 0.027(3) 0.044(3) 0.043(3) 0.001(3) 0.006(2) 0.004(3) 
 C01V 0.085(5) 0.063(4) 0.040(3) -0.018(3) -0.005(3) -0.024(3) 
 C01W 0.137(7) 0.050(3) 0.031(3) -0.013(3) 0.000(4) -0.020(4) 
 C01X 0.104(6) 0.039(3) 0.031(3) 0.001(2) 0.023(3) 0.005(3) 
 C01Y 0.053(4) 0.073(4) 0.026(3) -0.003(3) -0.001(2) 0.013(3) 
 
bond lengths: 
loop_ 
  _geom_bond_atom_site_label_1 
  _geom_bond_atom_site_label_2 
  _geom_bond_distance 
  _geom_bond_site_symmetry_2 
  _geom_bond_publ_flag 
 P001 C00G 1.839(4) . ? 
 P001 C00P 1.833(4) . ? 
 P001 C01C 1.818(4) . ? 
 P002 C00H 1.832(4) . ? 
 P002 C00L 1.829(4) . ? 
 P002 C011 1.820(4) . ? 
 Cl00 C01Y 1.751(6) . ? 
 Cl1 C01Y 1.754(6) . ? 
 Cl2 C01Y 1.751(6) . ? 
 F006 B01U 1.384(6) . ? 
 F007 B01R 1.407(6) . ? 
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 F008 B01R 1.387(5) . ? 
 F009 B01R 1.371(6) . ? 
 F00A B01U 1.418(7) . ? 
 F00B B01R 1.383(6) . ? 
 F00C B01U 1.386(6) . ? 
 N00D H00A 0.8900 . ? 
 N00D H00B 0.8900 . ? 
 N00D C00J 1.532(5) . ? 
 N00D C00T 1.495(5) . ? 
 F00E B01U 1.359(6) . ? 
 N00F H00C 0.8900 . ? 
 N00F H00D 0.8900 . ? 
 N00F C00S 1.515(5) . ? 
 N00F C010 1.522(5) . ? 
 C00G C00N 1.420(6) . ? 
 C00G C00O 1.392(6) . ? 
 C00H C00M 1.415(5) . ? 
 C00H C00X 1.397(5) . ? 
 C00I H00I 0.9300 . ? 
 C00I C00X 1.384(6) . ? 
 C00I C00Y 1.370(6) . ? 
 C00J H00J 0.9800 . ? 
 C00J C00M 1.539(5) . ? 
 C00J C00V 1.515(5) . ? 
 C00K C00L 1.403(6) . ? 
 C00K C00S 1.525(5) . ? 
 C00K C00U 1.389(6) . ? 
 C00L C019 1.401(5) . ? 
 C00M C014 1.382(6) . ? 
 C00N C010 1.511(5) . ? 
 C00N C012 1.385(6) . ? 
 C00O H00O 0.9300 . ? 
 C00O C016 1.381(6) . ? 
 C00P C00R 1.409(6) . ? 
 C00P C00W 1.398(6) . ? 
 C00Q H00Q 0.9300 . ? 
 C00Q C00V 1.382(6) . ? 
 C00Q C01G 1.387(6) . ? 
 C00R C00T 1.516(5) . ? 
 C00R C00Z 1.387(6) . ? 
 C00S H00S 0.9800 . ? 
 C00S C015 1.520(6) . ? 
 C00T H00E 0.9700 . ? 
 C00T H00F 0.9700 . ? 
 C00U H00U 0.9300 . ? 
 C00U C013 1.400(6) . ? 
 C00V C01B 1.394(6) . ? 
 C00W H00W 0.9300 . ? 
 C00W C017 1.383(6) . ? 
 C00X H00X 0.9300 . ? 
 C00Y H00Y 0.9300 . ? 
 C00Y C014 1.403(6) . ? 
 C00Z H00Z 0.9300 . ? 
 C00Z C018 1.389(6) . ? 
 C010 H01A 0.9700 . ? 
 C010 H01B 0.9700 . ? 
 C011 C01A 1.398(6) . ? 
 C011 C01E 1.398(6) . ? 
 C012 H012 0.9300 . ? 
 C012 C01D 1.390(6) . ? 
 C013 H013 0.9300 . ? 
 C013 C01F 1.371(6) . ? 
 C014 H014 0.9300 . ? 
 C015 C01H 1.389(7) . ? 
 C015 C01L 1.383(6) . ? 
 C016 H016 0.9300 . ? 
 C016 C01D 1.383(6) . ? 
 C017 H017 0.9300 . ? 
 C017 C018 1.378(6) . ? 
 C018 H018 0.9300 . ? 
 C019 H019 0.9300 . ? 
 C019 C01F 1.387(6) . ? 
 C01A H01C 0.9300 . ? 
 C01A C01P 1.395(6) . ? 
 C01B H01D 0.9300 . ? 
 C01B C01J 1.382(6) . ? 
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 C01C C01I 1.404(6) . ? 
 C01C C01K 1.383(6) . ? 
 C01D H01E 0.9300 . ? 
 C01E H01F 0.9300 . ? 
 C01E C01S 1.396(7) . ? 
 C01F H01G 0.9300 . ? 
 C01G H01H 0.9300 . ? 
 C01G C01O 1.371(7) . ? 
 C01H H01I 0.9300 . ? 
 C01H C01V 1.383(7) . ? 
 C01I H01J 0.9300 . ? 
 C01I C01M 1.384(7) . ? 
 C01J H01K 0.9300 . ? 
 C01J C01O 1.376(7) . ? 
 C01K H01L 0.9300 . ? 
 C01K C01Q 1.395(7) . ? 
 C01L H01M 0.9300 . ? 
 C01L C01X 1.390(7) . ? 
 C01M H01N 0.9300 . ? 
 C01M C01N 1.362(8) . ? 
 C01N H01O 0.9300 . ? 
 C01N C01Q 1.394(8) . ? 
 C01O H01P 0.9300 . ? 
 C01P H01Q 0.9300 . ? 
 C01P C01T 1.357(8) . ? 
 C01Q H01R 0.9300 . ? 
 C01S H01S 0.9300 . ? 
 C01S C01T 1.400(8) . ? 
 C01T H01T 0.9300 . ? 
 C01V H01V 0.9300 . ? 
 C01V C01W 1.382(10) . ? 
 C01W H01W 0.9300 . ? 
 C01W C01X 1.361(10) . ? 
 C01X H01X 0.9300 . ? 
 C01Y H01Y 0.9800 . ? 
bond angles: 
loop_ 
  _geom_angle_atom_site_label_1 
  _geom_angle_atom_site_label_2 
  _geom_angle_atom_site_label_3 
  _geom_angle 
  _geom_angle_site_symmetry_1 
  _geom_angle_site_symmetry_3 
  _geom_angle_publ_flag 
 C00P P001 C00G 102.42(17) . . ? 
 C01C P001 C00G 106.42(19) . . ? 
 C01C P001 C00P 102.89(19) . . ? 
 C00L P002 C00H 104.13(17) . . ? 
 C011 P002 C00H 102.68(18) . . ? 
 C011 P002 C00L 103.47(18) . . ? 
 H00A N00D H00B 107.4 . . ? 
 C00J N00D H00A 108.2 . . ? 
 C00J N00D H00B 108.2 . . ? 
 C00T N00D H00A 108.2 . . ? 
 C00T N00D H00B 108.2 . . ? 
 C00T N00D C00J 116.3(3) . . ? 
 H00C N00F H00D 107.8 . . ? 
 C00S N00F H00C 109.0 . . ? 
 C00S N00F H00D 109.0 . . ? 
 C00S N00F C010 113.0(3) . . ? 
 C010 N00F H00C 109.0 . . ? 
 C010 N00F H00D 109.0 . . ? 
 C00N C00G P001 118.7(3) . . ? 
 C00O C00G P001 122.5(3) . . ? 
 C00O C00G C00N 118.1(4) . . ? 
 C00M C00H P002 119.9(3) . . ? 
 C00X C00H P002 120.7(3) . . ? 
 C00X C00H C00M 119.2(4) . . ? 
 C00X C00I H00I 120.2 . . ? 
 C00Y C00I H00I 120.2 . . ? 
 C00Y C00I C00X 119.6(4) . . ? 
 N00D C00J H00J 108.2 . . ? 
 N00D C00J C00M 108.2(3) . . ? 
 C00M C00J H00J 108.2 . . ? 
 C00V C00J N00D 109.6(3) . . ? 
 C00V C00J H00J 108.2 . . ? 
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 C00V C00J C00M 114.2(3) . . ? 
 C00L C00K C00S 118.8(3) . . ? 
 C00U C00K C00L 119.9(4) . . ? 
 C00U C00K C00S 121.3(4) . . ? 
 C00K C00L P002 119.7(3) . . ? 
 C019 C00L P002 121.9(3) . . ? 
 C019 C00L C00K 118.3(4) . . ? 
 C00H C00M C00J 121.3(3) . . ? 
 C014 C00M C00H 118.5(3) . . ? 
 C014 C00M C00J 120.2(3) . . ? 
 C00G C00N C010 120.7(4) . . ? 
 C012 C00N C00G 119.9(4) . . ? 
 C012 C00N C010 119.4(4) . . ? 
 C00G C00O H00O 119.5 . . ? 
 C016 C00O C00G 121.0(4) . . ? 
 C016 C00O H00O 119.5 . . ? 
 C00R C00P P001 118.4(3) . . ? 
 C00W C00P P001 122.6(3) . . ? 
 C00W C00P C00R 119.0(4) . . ? 
 C00V C00Q H00Q 119.8 . . ? 
 C00V C00Q C01G 120.3(4) . . ? 
 C01G C00Q H00Q 119.8 . . ? 
 C00P C00R C00T 122.2(4) . . ? 
 C00Z C00R C00P 118.8(4) . . ? 
 C00Z C00R C00T 118.9(4) . . ? 
 N00F C00S C00K 110.5(3) . . ? 
 N00F C00S H00S 106.7 . . ? 
 N00F C00S C015 111.2(3) . . ? 
 C00K C00S H00S 106.7 . . ? 
 C015 C00S C00K 114.7(3) . . ? 
 C015 C00S H00S 106.7 . . ? 
 N00D C00T C00R 109.8(3) . . ? 
 N00D C00T H00E 109.7 . . ? 
 N00D C00T H00F 109.7 . . ? 
 C00R C00T H00E 109.7 . . ? 
 C00R C00T H00F 109.7 . . ? 
 H00E C00T H00F 108.2 . . ? 
 C00K C00U H00U 119.8 . . ? 
 C00K C00U C013 120.3(4) . . ? 
 C013 C00U H00U 119.8 . . ? 
 C00Q C00V C00J 119.2(4) . . ? 
 C00Q C00V C01B 119.1(4) . . ? 
 C01B C00V C00J 121.6(4) . . ? 
 C00P C00W H00W 119.6 . . ? 
 C017 C00W C00P 120.8(4) . . ? 
 C017 C00W H00W 119.6 . . ? 
 C00H C00X H00X 119.4 . . ? 
 C00I C00X C00H 121.3(4) . . ? 
 C00I C00X H00X 119.4 . . ? 
 C00I C00Y H00Y 120.0 . . ? 
 C00I C00Y C014 120.0(4) . . ? 
 C014 C00Y H00Y 120.0 . . ? 
 C00R C00Z H00Z 119.1 . . ? 
 C018 C00Z C00R 121.8(4) . . ? 
 C018 C00Z H00Z 119.1 . . ? 
 N00F C010 H01A 108.9 . . ? 
 N00F C010 H01B 108.9 . . ? 
 C00N C010 N00F 113.3(3) . . ? 
 C00N C010 H01A 108.9 . . ? 
 C00N C010 H01B 108.9 . . ? 
 H01A C010 H01B 107.7 . . ? 
 C01A C011 P002 123.5(3) . . ? 
 C01E C011 P002 117.2(3) . . ? 
 C01E C011 C01A 119.1(4) . . ? 
 C00N C012 H012 119.6 . . ? 
 C00N C012 C01D 120.8(4) . . ? 
 C01D C012 H012 119.6 . . ? 
 C00U C013 H013 119.9 . . ? 
 C01F C013 C00U 120.3(4) . . ? 
 C01F C013 H013 119.9 . . ? 
 C00M C014 C00Y 121.3(4) . . ? 
 C00M C014 H014 119.3 . . ? 
 C00Y C014 H014 119.3 . . ? 
 C01H C015 C00S 122.1(4) . . ? 
 C01L C015 C00S 118.8(4) . . ? 
 C01L C015 C01H 119.1(4) . . ? 
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 C00O C016 H016 119.6 . . ? 
 C00O C016 C01D 120.8(4) . . ? 
 C01D C016 H016 119.6 . . ? 
 C00W C017 H017 119.7 . . ? 
 C00W C017 C018 120.6(4) . . ? 
 C018 C017 H017 119.7 . . ? 
 C00Z C018 H018 120.5 . . ? 
 C017 C018 C00Z 119.0(4) . . ? 
 C017 C018 H018 120.5 . . ? 
 C00L C019 H019 119.2 . . ? 
 C01F C019 C00L 121.5(4) . . ? 
 C01F C019 H019 119.2 . . ? 
 C011 C01A H01C 120.0 . . ? 
 C01P C01A C011 120.0(5) . . ? 
 C01P C01A H01C 120.0 . . ? 
 C00V C01B H01D 120.2 . . ? 
 C01J C01B C00V 119.6(4) . . ? 
 C01J C01B H01D 120.2 . . ? 
 C01I C01C P001 116.3(3) . . ? 
 C01K C01C P001 124.5(3) . . ? 
 C01K C01C C01I 118.8(4) . . ? 
 C012 C01D H01E 120.4 . . ? 
 C016 C01D C012 119.2(4) . . ? 
 C016 C01D H01E 120.4 . . ? 
 C011 C01E H01F 120.0 . . ? 
 C01S C01E C011 120.0(5) . . ? 
 C01S C01E H01F 120.0 . . ? 
 C013 C01F C019 119.6(4) . . ? 
 C013 C01F H01G 120.2 . . ? 
 C019 C01F H01G 120.2 . . ? 
 C00Q C01G H01H 119.8 . . ? 
 C01O C01G C00Q 120.5(5) . . ? 
 C01O C01G H01H 119.8 . . ? 
 C015 C01H H01I 120.1 . . ? 
 C01V C01H C015 119.8(5) . . ? 
 C01V C01H H01I 120.1 . . ? 
 C01C C01I H01J 119.5 . . ? 
 C01M C01I C01C 121.0(5) . . ? 
 C01M C01I H01J 119.5 . . ? 
 C01B C01J H01K 119.4 . . ? 
 C01O C01J C01B 121.1(5) . . ? 
 C01O C01J H01K 119.4 . . ? 
 C01C C01K H01L 119.9 . . ? 
 C01C C01K C01Q 120.2(5) . . ? 
 C01Q C01K H01L 119.9 . . ? 
 C015 C01L H01M 119.8 . . ? 
 C015 C01L C01X 120.4(5) . . ? 
 C01X C01L H01M 119.8 . . ? 
 C01I C01M H01N 120.1 . . ? 
 C01N C01M C01I 119.7(5) . . ? 
 C01N C01M H01N 120.1 . . ? 
 C01M C01N H01O 119.7 . . ? 
 C01M C01N C01Q 120.6(5) . . ? 
 C01Q C01N H01O 119.7 . . ? 
 C01G C01O C01J 119.3(4) . . ? 
 C01G C01O H01P 120.3 . . ? 
 C01J C01O H01P 120.3 . . ? 
 C01A C01P H01Q 119.6 . . ? 
 C01T C01P C01A 120.8(5) . . ? 
 C01T C01P H01Q 119.6 . . ? 
 C01K C01Q C01N 119.8(5) . . ? 
 C01K C01Q H01R 120.1 . . ? 
 C01N C01Q H01R 120.1 . . ? 
 F008 B01R F007 108.8(4) . . ? 
 F009 B01R F007 109.0(4) . . ? 
 F009 B01R F008 110.2(4) . . ? 
 F009 B01R F00B 111.2(4) . . ? 
 F00B B01R F007 106.9(4) . . ? 
 F00B B01R F008 110.7(4) . . ? 
 C01E C01S H01S 120.1 . . ? 
 C01E C01S C01T 119.8(5) . . ? 
 C01T C01S H01S 120.1 . . ? 
 C01P C01T C01S 120.2(5) . . ? 
 C01P C01T H01T 119.9 . . ? 
 C01S C01T H01T 119.9 . . ? 
 F006 B01U F00A 109.1(4) . . ? 
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 F006 B01U F00C 108.4(4) . . ? 
 F00C B01U F00A 108.7(4) . . ? 
 F00E B01U F006 112.0(5) . . ? 
 F00E B01U F00A 108.3(4) . . ? 
 F00E B01U F00C 110.2(4) . . ? 
 C01H C01V H01V 119.7 . . ? 
 C01W C01V C01H 120.6(6) . . ? 
 C01W C01V H01V 119.7 . . ? 
 C01V C01W H01W 120.1 . . ? 
 C01X C01W C01V 119.8(6) . . ? 
 C01X C01W H01W 120.1 . . ? 
 C01L C01X H01X 119.8 . . ? 
 C01W C01X C01L 120.3(6) . . ? 
 C01W C01X H01X 119.8 . . ? 
 Cl00 C01Y Cl1 111.1(3) . . ? 
 Cl00 C01Y H01Y 108.2 . . ? 
 Cl1 C01Y H01Y 108.2 . . ? 
 Cl2 C01Y Cl00 110.1(3) . . ? 
 Cl2 C01Y Cl1 110.8(3) . . ? 
 Cl2 C01Y H01Y 108.2 . . ? 
 
 
 
